0.9689869405	frontal cortex
0.9670033414	adenylyl cyclase
0.9664551930	glutathione peroxidase
0.9661205540	rheumatoid arthritis
0.9655445591	parkinson's disease
0.9648180989	mass spectrometry
0.9636066419	monoclonal antibody
0.9631771109	cytochrome p450
0.9625715622	adipose tissue
0.9625010857	escherichia coli
0.9621019426	reverse transcriptase
0.9610775100	lipid peroxidation
0.9603081033	endoplasmic reticulum
0.9600359456	skeletal muscle
0.9599889447	bovine serum albumin
0.9598626394	reactive oxygen species
0.9596861526	bone marrow
0.9586878323	nadph oxidase
0.9586570765	cyclic amp
0.9583387441	nucleus accumbens
0.9582340925	signal transduction
0.9579650118	alzheimer's disease
0.9573212688	flow cytometry
0.9573095428	heart failure
0.9568245192	western blot
0.9557032095	arachidonic acid
0.9556733332	nitric oxide
0.9556088581	alkaline phosphatase
0.9555547141	vitamin b6
0.9553006799	guinea pigs
0.9544324884	amino acids
0.9526457285	blood pressure
0.9520194197	body mass index
0.9510049906	fatty acids
0.9496905096	matrix metalloproteinase
0.9487101193	choroid plexus
0.9480361949	reverse transcription polymerase chain reaction
0.9480019347	cyclin d1
0.9478794636	steady state
0.9478111359	superoxide dismutase
0.9468691292	tyrosine kinase
0.9466751336	liquid chromatography
0.9460614514	oxidative stress
0.9457995539	luciferase reporter
0.9452627224	amino acid
0.9452516593	carbonic anhydrase
0.9452498168	qt interval
0.9451789467	hydrogen bond
0.9446625175	fatty acid
0.9444281940	high performance liquid chromatography
0.9440066261	western blotting
0.9436146129	neuropathic pain
0.9433858553	diabetes mellitus
0.9433324630	saccharomyces cerevisiae
0.9431516461	chronic obstructive pulmonary disease
0.9431268602	hepatocellular carcinoma
0.9429225156	dna damage
0.9427712141	prostate cancer
0.9423221299	glomerular filtration rate
0.9418671044	guinea pig
0.9405676546	folic acid
0.9397339187	retinoic acid
0.9395369748	clinical trials
0.9392881374	ethylene glycol
0.9391996484	cell line
0.9390963318	prefrontal cortex
0.9386951867	tricyclic antidepressants
0.9386535849	attention deficit hyperactivity disorder
0.9380897205	transforming growth factor
0.9376889615	half life
0.9373700977	peripheral blood mononuclear
0.9373637505	rt pcr
0.9371080032	poorly understood
0.9369109161	site directed mutagenesis
0.9369105421	heart rate
0.9367209999	tandem mass spectrometry
0.9366535631	histone h3
0.9364380878	organic anion transporting
0.9364196219	glutamic acid
0.9363500857	naturally occurring
0.9346843774	insulin resistance
0.9344629190	cerebrospinal fluid
0.9342125347	prostaglandin e2
0.9337226155	smooth muscle
0.9336965190	vascular endothelial growth factor
0.9334528737	nicotinic acetylcholine receptor
0.9333366178	major depressive disorder
0.9330438020	aryl hydrocarbon receptor
0.9329620117	hydrogen peroxide
0.9329162167	double blind
0.9325681218	small interfering rna
0.9323689450	platelet derived growth factor
0.9322443867	myocardial infarction
0.9321085171	breast cancer
0.9316054173	nicotinic acetylcholine receptors
0.9309503176	monoclonal antibodies
0.9303859882	plasminogen activator
0.9298369863	tumor necrosis factor
0.9296395950	pertussis toxin
0.9294260598	low density lipoprotein
0.9284362491	open reading frame
0.9280888133	thymidylate synthase
0.9278475053	vitamin b12
0.9271327976	mast cell
0.9268172228	gap junction
0.9268097421	factor ix
0.9267985679	histone deacetylase
0.9266766301	acetic acid
0.9265869639	allergic rhinitis
0.9263041205	patch clamp
0.9249953027	cell cycle arrest
0.9249882905	mesenchymal stem cells
0.9247959840	metabotropic glutamate
0.9237788810	bronchoalveolar lavage
0.9237403663	long term
0.9237010769	ascorbic acid
0.9226464878	wild type
0.9225764832	protein tyrosine phosphatase
0.9225098096	essential oil
0.9224132964	broad spectrum
0.9220360046	ovarian cancer
0.9214330322	weight loss
0.9210497043	polymerase chain reaction
0.9205947857	hypoxia inducible factor
0.9198955747	positron emission tomography
0.9197963772	monoamine oxidase
0.9197563815	sinapic acid
0.9196734028	infarct size
0.9196005156	brugada syndrome
0.9193496820	dipeptidyl peptidase
0.9190766347	lactate dehydrogenase
0.9189802376	pivotal role
0.9186835193	hydrogen bonds
0.9181967953	systolic blood pressure
0.9177224780	chinese hamster ovary
0.9167447200	enzyme linked immunosorbent assay
0.9166681137	hmg coa reductase
0.9164702892	dose dependently
0.9164326141	united states
0.9163166027	cell lines
0.9149669683	proximal tubule
0.9140912748	nf κb
0.9140734403	cell death
0.9137818243	synaptic plasticity
0.9133931696	acyl coa
0.9123513498	leydig cell
0.9122548344	colorectal cancer
0.9111048758	tyrosine kinases
0.9104970172	transcription factors
0.9104314450	spinal cord
0.9098589287	angiotensin ii
0.9098270914	body weight
0.9098112985	nitric oxide synthase
0.9088995399	tyrosine hydroxylase
0.9088034482	extracellular matrix
0.9083601822	drinking water
0.9083136391	cell cycle
0.9082237167	human umbilical vein endothelial cells
0.9081392295	hpa axis
0.9081082250	voltage gated
0.9080459146	spontaneously hypertensive
0.9070736172	high throughput screening
0.9068038089	aspartate aminotransferase
0.9065716784	gm csf
0.9064613556	adverse events
0.9062846160	short term
0.9062500082	multidrug resistance
0.9057603640	transcription factor
0.9057542894	electrophoretic mobility
0.9055403703	serine threonine
0.9054852777	ribonucleotide reductase
0.9045216626	carboxylic acid
0.9042506871	tnf α
0.9039883441	renal failure
0.9039620303	hydroxysteroid dehydrogenase
0.9033241181	mm hg
0.9013819232	anti inflammatory
0.9001772863	placebo controlled
0.8999135562	insulin sensitivity
0.8997895500	dissociation constant
0.8993304300	fibroblast growth factor
0.8987966298	mitogen activated protein kinase
0.8985128730	nonsteroidal anti inflammatory drugs
0.8983750712	high density lipoprotein
0.8967807702	paw edema
0.8957284178	left ventricular
0.8954428115	bile acids
0.8954091656	small molecule
0.8952745510	healthy volunteers
0.8950110306	histamine h1 receptor
0.8944509588	myocardial ischemia
0.8944507444	xenopus oocytes
0.8939579766	platelet aggregation
0.8936275417	atypical antipsychotic
0.8933267913	delayed rectifier
0.8932991899	inducible nitric oxide synthase
0.8931925576	cell viability
0.8928280492	cyclin dependent kinase
0.8927734771	microg kg
0.8926280605	hypothalamic pituitary adrenal
0.8924861661	extracellular signal regulated kinase
0.8922565464	insulin secretion
0.8918578244	epidermal growth factor receptor
0.8917620152	sprague dawley
0.8911414171	heat shock protein
0.8907286026	nicotinic acid
0.8902595391	western blot analysis
0.8902576534	alanine aminotransferase
0.8891166438	dna polymerase
0.8884838234	dominant negative
0.8878059820	structure activity relationship
0.8874381644	discriminative stimulus
0.8868591488	binding site
0.8865732871	kcnq2 q3
0.8865074413	nf kappab
0.8859782774	glutathione s transferase
0.8858333405	nuclear factor κb
0.8856978549	nasal mucosa
0.8853128667	pro inflammatory
0.8850913224	ng ml
0.8850557683	iib iiia
0.8850028270	human embryonic kidney
0.8847468570	synaptic transmission
0.8846726504	ibritumomab tiuxetan
0.8842984391	structure activity relationships
0.8841046386	airway smooth muscle
0.8840600615	amp activated protein kinase
0.8839266684	angiotensin converting enzyme
0.8837914297	animal models
0.8836942772	local anesthetics
0.8829541351	tgf β
0.8827704889	estrogen receptor
0.8826484265	voltage clamp
0.8822529457	eicosapentaenoic acid
0.8818933327	mg kg
0.8816832486	signaling pathways
0.8813124126	adenosine triphosphate
0.8812259351	mixed micelles
0.8806354726	positive inotropic effect
0.8805262205	food intake
0.8801557153	  ±  
0.8800135778	tnf alpha
0.8798007213	mast cells
0.8797939825	ang ii
0.8793541628	trna synthetase
0.8784282967	st segment elevation
0.8783062286	working memory
0.8780433125	cerebral cortex
0.8777235350	sh sy5y
0.8772562054	cyclo oxygenase
0.8770360085	male wistar rats
0.8763510830	  μg ml
0.8756001191	arterial pressure
0.8747523148	3beta adiol
0.8733994811	sodium channel
0.8725588269	binding sites
0.8724916125	knockout mice
0.8717882825	cell proliferation
0.8716240185	electron microscopy
0.8710593485	special issue entitled
0.8706069277	active metabolite
0.8690282566	cerebral ischemia
0.8687799746	density lipoprotein cholesterol
0.8687606913	myeloid leukemia
0.8678995263	dna methylation
0.8678122411	organic anion
0.8675909319	active site
0.8674462285	gsh px
0.8674337454	tumor growth
0.8672844447	blood vessels
0.8663357470	immune responses
0.8663104113	alpha 2a adrenoceptor
0.8658476816	peroxisome proliferator activated receptor
0.8653408477	proinflammatory cytokines
0.8653351243	hif 1α
0.8648288661	cross linking
0.8646134135	serine protease
0.8645587504	pi3k akt
0.8638931123	small molecules
0.8629795393	high fat diet
0.8622586247	pc12 cells
0.8622306738	micromol kg
0.8619262613	natriuretic peptide
0.8618109160	dependently inhibited
0.8617333513	microg ml
0.8614155823	hs crp
0.8608090522	dentate gyrus
0.8607049112	il 1β
0.8606016823	phase iii
0.8605975286	tumor suppressor
0.8604073068	hmg coa
0.8603595200	aldo keto
0.8588059388	breast cancer resistance protein
0.8577916660	kappa opioid
0.8575017548	tumor necrosis factor alpha
0.8573317571	bile acid
0.8567961529	adrenergic receptors
0.8566293127	tgf β1
0.8565397647	serine racemase
0.8563219858	p450 2a13
0.8561139881	cigarette smoke
0.8558149648	cell cycle progression
0.8556633202	epidermal growth factor
0.8553362504	β catenin
0.8551917581	blood brain barrier
0.8541094647	fxi pka4
0.8534854276	signaling pathway
0.8534159533	statistically significant
0.8523924725	molecular modeling
0.8518116990	peroxisome proliferator
0.8514648304	glycemic control
0.8511550425	dna fragmentation
0.8511074207	epithelial cells
0.8505320967	coronary artery
0.8504260863	nmda receptor
0.8484327391	transient receptor potential
0.8480862875	molecular weight
0.8477061901	fold higher
0.8471987092	biologically active
0.8465783494	nf kb
0.8464574258	drug metabolizing enzymes
0.8462215915	oxidative damage
0.8461961596	ifn gamma
0.8454998983	reporter gene
0.8453270137	p38 mapk
0.8449422059	clinical trial
0.8440588193	inflammatory diseases
0.8438799593	radioligand binding
0.8435874466	necrosis factor alpha
0.8434619289	transmembrane domain
0.8431178290	type 2 diabetes mellitus
0.8426790096	mda mb 231
0.8420694779	diastolic blood pressure
0.8420387107	hepg2 cells
0.8417931654	nuclear factor
0.8413387329	growth factors
0.8395844079	growth factor
0.8395605109	kg bw
0.8390947222	adrenergic receptor
0.8383169736	catalytic efficiency
0.8377243017	thyroid hormone
0.8376659466	androgen receptor
0.8375656479	high affinity
0.8371642399	consecutive days
0.8370625619	cognitive deficits
0.8365553034	glucose tolerance test
0.8364719449	opioid receptor
0.8353951841	mitogen activated protein
0.8348597424	pancreatic cancer
0.8348524586	genome wide
0.8338968403	cardiovascular disease
0.8324750896	previously reported
0.8323904964	cell adhesion
0.8306663770	combination therapy
0.8304357976	allosteric modulator
0.8299679719	molecular mass
0.8297967106	glp 1r
0.8288070692	adverse effects
0.8285941891	organic cation
0.8284989925	nuclear translocation
0.8276920842	low density lipoprotein cholesterol
0.8275796215	element binding protein
0.8271607425	brain derived neurotrophic factor
0.8262745767	ampa receptor
0.8261148349	real time polymerase chain reaction
0.8259769432	reading frame
0.8259681386	drug interaction
0.8259149718	long acting
0.8256539200	bone mineral
0.8255831742	ko mice
0.8253094166	null mice
0.8248488505	il 6
0.8234691547	anticancer activity
0.8233018617	mechanisms underlying
0.8224745047	progesterone receptor
0.8221022423	type iii
0.8219600062	receptor subtypes
0.8218411729	adp ribose
0.8211729017	positron emission
0.8208490072	weight gain
0.8207398221	ifn α2a
0.8203478322	canonical wnt
0.8202563475	real time pcr
0.8201783514	pgc 1α
0.8199644005	blood flow
0.8186754389	colon cancer
0.8185687431	insulin like growth factor
0.8183591268	male sprague dawley rats
0.8176023418	cell growth
0.8164309539	endothelial cells
0.8163668314	raas blockade
0.8151989538	gene transcription
0.8151449336	receptor antagonist
0.8151233062	db db
0.8151185136	rate constants
0.8147460685	insulin granules
0.8142638837	hif 1alpha
0.8140307052	ca3 region
0.8137630318	adrenoceptor subtype
0.8134935638	cell migration
0.8134794071	serotonin transporter
0.8133601175	blood glucose
0.8125574073	gene expression
0.8123483783	family members
0.8122894410	mg bid
0.8114403711	glucose tolerance
0.8114189207	phase ii
0.8112877192	releasing hormone
0.8107031298	topoisomerase ii
0.8104641183	cytotoxic effects
0.8103088073	bcl 2
0.8101243370	antiproliferative effects
0.8097331892	binding pocket
0.8094922922	neurodegenerative diseases
0.8092633374	adhesion molecule
0.8089996507	clinically relevant
0.8088046094	binding affinities
0.8087746314	mineralocorticoid receptor
0.8084857828	tissue factor
0.8081233388	angiotensin converting
0.8079809008	at1 receptor
0.8079323389	nerve agents
0.8077150669	glucocorticoid receptor
0.8070666823	alpha 1b
0.8062909304	β d glucuronide
0.8062403873	cardiovascular risk
0.8058241143	clinical practice
0.8052901163	leydig cells
0.8049503762	norepinephrine transporter
0.8048693003	thyroid cancer
0.8048240647	3t3 l1
0.8047035208	stem cell
0.8046439013	dna synthesis
0.8044381028	evidence suggests
0.8041180050	cytokine production
0.8038650998	intravenous administration
0.8038426196	freshly isolated
0.8035088880	er stress
0.8034372163	cancer cell lines
0.8024726399	opioid receptors
0.8021988146	abstract truncated at 250 words
0.8012589543	antitumor activity
0.8010015199	wistar rats
0.8002217992	a549 cells
0.8001938016	drug drug interactions
0.8000606624	protein phosphatase
0.8000047087	adrenoceptor antagonist
0.7999043233	fusion protein
0.7991875706	nude mice
0.7991232025	  mg kg
0.7988337530	fully understood
0.7986201443	beta blockers
0.7985480250	neuroprotective effects
0.7979235499	alpha 1a adrenoceptor
0.7964234075	response element
0.7963720756	heat shock
0.7962990878	toxic effects
0.7962005510	endothelial cell
0.7958876088	liver injury
0.7951906767	combined treatment
0.7941818719	binding mode
0.7938034660	ischemia reperfusion
0.7934608049	rat hepatocytes
0.7934525323	cell types
0.7933656940	mice lacking
0.7931510428	blood samples
0.7924568370	crystal structure
0.7921872795	adrenoceptor antagonists
0.7918806221	double strand
0.7918734440	male rats
0.7911999361	glucagon like peptide
0.7889513064	findings suggest
0.7882769649	channel blockers
0.7875411194	total cholesterol
0.7872163740	anticancer agents
0.7871431084	insulin sensitizing
0.7868767872	peroxisome proliferator activated receptor gamma
0.7866853940	brain regions
0.7865365237	clinical significance
0.7864135375	hek293 cells
0.7861431071	mu opioid
0.7857078616	long chain
0.7850636189	testosterone to estradiol
0.7849918741	reperfusion injury
0.7849386861	nuclear receptor
0.7847587436	pregnane x receptor
0.7840486761	half maximal
0.7836401643	anti proliferative
0.7834254530	long lasting
0.7834235598	nmda receptors
0.7833643473	healthy subjects
0.7833402813	hydroxyl group
0.7831704172	chinese hamster
0.7815493102	inhibitory potency
0.7813791616	extracellular signal regulated
0.7812977322	high throughput
0.7812577982	tgf beta
0.7810663642	dependent manner
0.7809993526	rat aorta
0.7808497983	sprague dawley rats
0.7808068739	case control study
0.7804693925	db db mice
0.7804390437	action potential
0.7793309541	human embryonic kidney 293
0.7790761861	mglu receptor
0.7785881990	vascular smooth muscle
0.7779296539	growth hormone
0.7774157718	aromatase inhibitor
0.7773926104	adrenoceptor agonist
0.7771883879	bone loss
0.7764170031	significantly attenuated
0.7761878529	safety profile
0.7761504041	cell culture
0.7758695881	female rats
0.7750655203	previous studies
0.7746887805	caspase 3
0.7746402290	acinar cells
0.7743656930	animal model
0.7742148292	partial agonist
0.7737676739	mk 801
0.7734092786	oral administration
0.7732490723	phasic da
0.7730079822	control subjects
0.7728368274	largely unknown
0.7724893934	anti diabetic
0.7723844186	patients undergoing
0.7723552246	cross linked
0.7719207811	clinical development
0.7717759270	low affinity
0.7717108078	promoter region
0.7716125937	pro apoptotic
0.7715736739	food and drug administration
0.7708139510	platelet activation
0.7704464852	newly synthesized
0.7703368921	  mg
0.7702969566	fp receptor
0.7692705016	underlying mechanisms
0.7692452500	signal transducer
0.7691029158	cell surface
0.7689130093	vascular endothelial
0.7686725526	chromaffin cells
0.7679022765	observations suggest
0.7678256646	gene encoding
0.7677675851	potassium channels
0.7674543635	qt syndrome
0.7673967366	methionine synthase
0.7672813143	type 2 diabetes
0.7666442542	beneficial effects
0.7665416263	lc ms
0.7659662054	protective effects
0.7657440201	subtype selective
0.7654561270	adrenoceptor density
0.7654150067	mtt assay
0.7653479965	human liver microsomes
0.7650422641	colon cancer cells
0.7649925792	endothelial dysfunction
0.7649538952	light chain
0.7648117676	excision repair
0.7647638885	ic50 values
0.7647365222	beta adrenergic
0.7641054458	remains unknown
0.7636785825	cell membrane
0.7635323528	lncap cells
0.7635258456	quality of life
0.7633912170	phosphodiesterase
0.7632174030	mouse model
0.7630143368	higher doses
0.7623936518	apoptotic cell death
0.7622457458	ifn alpha
0.7619098447	systemic administration
0.7618974106	pharmacological profile
0.7615352593	high performance liquid
0.7613823344	diabetic rats
0.7610280973	induces apoptosis
0.7604708035	heart disease
0.7599535574	mammalian target of rapamycin
0.7598543254	tissue distribution
0.7596274815	stem cells
0.7594895205	lps stimulated
0.7594795618	confidence interval
0.7586016041	free fatty acids
0.7584581663	mda mb
0.7580153044	silica nanoparticles
0.7578632446	ornithine
0.7574724803	derived neurotrophic factor
0.7574032998	h3 receptor
0.7572968313	transgenic mice
0.7569533539	inflammatory response
0.7568585766	actin rings
0.7562782782	rank order
0.7562226579	calcium channel
0.7561487420	anticancer drugs
0.7558182216	high risk
0.7556538224	ace inhibitor
0.7550269561	disease progression
0.7546171100	hypoxia
0.7545449100	endothelium dependent
0.7542282160	substrate specificity
0.7537619350	structure based
0.7536988176	protein kinase
0.7534610101	cardiac hypertrophy
0.7534596249	cox 2
0.7533449444	orally active
0.7533117580	drug metabolism
0.7531984103	hippocampal neurons
0.7531854867	chemokine
0.7528813695	low molecular weight
0.7528716494	mmp 9
0.7524878861	inverse agonists
0.7518541649	health
0.7516414153	beta adrenoceptor
0.7514434630	dopaminergic
0.7503959007	data suggest
0.7501689794	autoimmune
0.7500194706	constitutively active
0.7499876717	type ii
0.7499324768	renal interstitial
0.7498990965	hela cells
0.7498012360	ns 398
0.7495907517	glp 1
0.7494381996	tumor necrosis factor α
0.7492334868	lithium
0.7488336258	adiponectin levels
0.7483277151	progenitor cells
0.7483042001	drug interactions
0.7481483833	adenine
0.7480883120	single dose
0.7475928518	x ray
0.7474394631	response rate
0.7471986515	neural
0.7471297024	cancer risk
0.7469833554	center
0.7468882361	plasma membrane
0.7464489315	closely related
0.7463953088	rofecoxib
0.7456589355	neurological
0.7455936728	endocytosis
0.7455135027	transition
0.7452879188	oxalate
0.7452498466	drug resistance
0.7452456745	adiponectin
0.7452111620	sequencing
0.7451444920	evolution
0.7451375620	immune response
0.7450891184	drug design
0.7450437419	conjugated
0.7444161578	polymerization
0.7443070825	microarray
0.7442608873	carcinoma cells
0.7436986931	solvent
0.7434557022	fluorescent
0.7433197572	dynamic
0.7432386631	amino acid residues
0.7431771693	clinical relevance
0.7430079575	variability
0.7428715720	nitrogen
0.7426421724	cadmium
0.7424616825	aromatic
0.7423759797	cloning
0.7422063262	layer
0.7419844921	group ii
0.7419730613	aldehyde
0.7418866957	marine
0.7418401872	deficient mice
0.7418233780	anterior
0.7417985845	aromatase inhibitors
0.7417426689	newly
0.7416985412	cluster
0.7416778752	times higher
0.7416695740	lipase
0.7415772049	scanning
0.7414013385	structural features
0.7413326159	tas 102
0.7410481843	molecular docking
0.7408661999	hl60 cells
0.7408175424	outcome
0.7406347049	drug delivery
0.7402643890	learning and memory
0.7402059132	equilibrium
0.7401130939	hypertrophic
0.7401130939	adjusted
0.7399198787	airway epithelial
0.7399148728	lung tissue
0.7399075502	hormones
0.7398608359	surgery
0.7396295803	highly conserved
0.7394428140	x ray crystallography
0.7393836593	cell survival
0.7393106571	cannabinoid
0.7392857572	adrenoceptor subtypes
0.7392467612	arsenic
0.7390524512	glutamine
0.7387495221	excellent
0.7382622888	phospholipase
0.7381726383	low dose
0.7379404621	celecoxib
0.7379359781	wall
0.7377152258	treated animals
0.7374254351	genes encoding
0.7373862433	transplantation
0.7371241760	treated groups
0.7369710421	transcriptional activity
0.7368340771	preclinical
0.7367956905	endocrine
0.7366849162	colitis
0.7366491651	cavity
0.7363910849	metal
0.7362527955	mechanical
0.7361981274	risk factors
0.7359872406	aryl hydrocarbon
0.7358769321	beta 2 adrenoceptor
0.7357763524	peroxisome proliferator activated receptor alpha
0.7357673537	repeat
0.7357673537	carbohydrate
0.7357673537	distal
0.7357673537	volatile
0.7357151909	amino groups
0.7357065430	markedly reduced
0.7356551461	sex
0.7355029695	coagulation
0.7354876396	celecoxib and rofecoxib
0.7354166732	glutamate release
0.7352148632	joint
0.7348067184	antidepressant
0.7347845954	methylation
0.7345822868	diol
0.7345567217	amide
0.7345376926	zinc binding
0.7340512199	  μm
0.7340328470	areas
0.7340313295	surgical
0.7338696362	neuromuscular
0.7338571686	inorganic
0.7337308539	covalent
0.7336280596	maximal
0.7336201664	solid
0.7335550437	silencing
0.7334890403	prazosin
0.7330538920	calcitonin
0.7329930307	antidepressants
0.7328384403	fragment
0.7325267604	temporal
0.7321801470	treated rats
0.7320925370	spectroscopy
0.7316812989	esophageal
0.7314931743	pancreatic beta
0.7313167041	head
0.7312980070	cyslt1 receptor
0.7311464653	spin
0.7310030808	apolipoprotein
0.7308993230	consensus
0.7307325464	locomotor activity
0.7306324969	fish
0.7305296122	systemic
0.7304900975	sudden
0.7304523838	succinate
0.7304447965	imaging
0.7302119969	plant extracts
0.7301523649	growth inhibition
0.7301498809	renal function
0.7300842036	ros generation
0.7299544827	rapamycin
0.7299217717	composite
0.7299217717	gut
0.7297060990	immunoprecipitation
0.7296801561	cytotoxic effect
0.7295659959	pharmacology
0.7294614316	congenital
0.7292279072	  =  
0.7291229438	fasting plasma
0.7289407163	glucose homeostasis
0.7287763527	interference
0.7285510987	analysis revealed
0.7282192645	treating
0.7281651583	tumor cell lines
0.7281020808	human hepatocytes
0.7278813654	modifications
0.7277721131	zinc
0.7276982576	recent studies
0.7276616137	lipid metabolism
0.7274814587	pai 1
0.7274162513	enzymatic
0.7272462069	event
0.7271700733	protective effect
0.7271441773	phenylalanine
0.7270819757	red
0.7270686847	protease
0.7266131770	electronic
0.7265308734	citrus
0.7263729143	vehicle
0.7263476236	5 methyl urapidil
0.7261264659	apoptosis inducing
0.7260797148	materials
0.7260592008	replacement
0.7260381044	urea
0.7259768904	deficits
0.7259768904	concomitant
0.7258564087	hydrolase
0.7258475897	allergic
0.7258257445	adrenoceptor stimulation
0.7257138845	stimulating
0.7256891875	liver microsomes
0.7256063747	risk factor
0.7256010397	cyp2b6
0.7255907633	global
0.7254985261	terminal domain
0.7254285760	elacridar
0.7253735750	gold
0.7253417844	3β diol
0.7252283250	sleep
0.7251011152	metabolic pathway
0.7250446844	wt mice
0.7248872792	voltage
0.7248507893	diagnosis
0.7245258795	arthritis
0.7244819132	maximal response
0.7241678923	medical
0.7240366721	high fat
0.7238939482	antiviral activity
0.7238478488	guanosine
0.7235663698	pore
0.7233491876	dna repair
0.7233369887	previously shown
0.7232782116	basic
0.7231280936	mood
0.7231153966	platelet
0.7230450765	ros production
0.7230315117	depression
0.7230239855	oxytocin
0.7229679803	  μg
0.7228587670	mesenchymal
0.7225898800	norepinephrine
0.7223613951	peripheral blood
0.7221735746	nmda receptor antagonists
0.7221133900	c jun
0.7220203316	d2 receptor
0.7218979806	docking
0.7218921783	adrenal
0.7218901598	embryonic
0.7217845423	acidic
0.7217461060	advanced
0.7217086447	6 ohda
0.7214725394	male
0.7214071100	subcutaneous
0.7213925044	polymer
0.7213799407	transient
0.7212784180	alanine
0.7209285149	leukocyte
0.7209285149	linkage
0.7207198307	bde 47
0.7206516022	airway
0.7203399772	pair
0.7201062418	hyperactivity
0.7199017674	inhibitory activity
0.7196616118	significantly lower
0.7195695991	tight
0.7194470463	neuroprotective
0.7194376283	fracture
0.7194202279	activating
0.7193718899	systematic
0.7193220136	lung cancer
0.7191405685	androgen
0.7189694442	primary hepatocytes
0.7188914777	inotropic effects
0.7188708460	il 10
0.7188630952	agonistic activity
0.7187881108	ion
0.7187321646	men
0.7184215533	dopamine transporter
0.7183240469	obesity
0.7181799959	mcf 7
0.7181692173	racemic
0.7180716720	transcriptional activation
0.7179297339	steroidal
0.7179013396	area
0.7177644289	treated mice
0.7176333996	measures
0.7175664465	g1
0.7174590914	da uptake
0.7174070912	methionine
0.7170442355	key
0.7169359289	chromatin
0.7169252703	dopamine d2 receptors
0.7168068285	mammalian
0.7167380015	tolerability
0.7167048576	udp
0.7165529526	high resolution
0.7164679139	gel
0.7164465230	therapeutic targets
0.7162727281	mode of action
0.7161696687	progesterone
0.7159728822	performance
0.7159484064	short
0.7157791608	selective cox 2 inhibitors
0.7157737348	reduced glutathione
0.7156990724	identical
0.7156454811	matrix
0.7155740724	predict
0.7155696763	adenosine monophosphate
0.7153658374	agonistic
0.7152734778	chemistry
0.7151990664	protection
0.7151887759	transgenic
0.7151486417	epilepsy
0.7151237880	initial
0.7151165396	endometrial
0.7150740542	implications
0.7150578706	kg body weight
0.7147858223	fasting
0.7147548050	intervention
0.7143860853	extracellular
0.7143744151	bovine
0.7143590169	concentration dependently
0.7141768793	5 meo dmt
0.7141689621	substance
0.7139757358	c fos
0.7139167693	hd patients
0.7136806501	allosteric
0.7136611289	pharmacological properties
0.7136252307	neurotoxicity
0.7135720898	lung injury
0.7133822569	mutagenesis
0.7133637863	cognitive
0.7132198005	igf
0.7131843513	arginine
0.7131737581	smoking
0.7131588516	square
0.7131146130	future
0.7131048485	cation
0.7130849544	relevance
0.7127927748	adp
0.7127281671	dopaminergic neurons
0.7127121637	alcohol
0.7124076616	mortality
0.7122581142	antagonism
0.7122553562	delta
0.7119711738	act
0.7119700823	binding affinity
0.7118812820	hydroxy
0.7118524268	hek 293
0.7117725121	provide evidence
0.7117563263	signal transducer and activator of transcription
0.7117397102	kit
0.7115149361	principal
0.7114784155	breast cancer risk
0.7113940307	testing
0.7112942436	ho 1
0.7112403957	drf 2655
0.7111299741	negatively
0.7110662540	delayed
0.7110382667	infrared
0.7108224454	human lung
0.7102183570	lactate
0.7102109625	results demonstrate
0.7102077998	inflammatory cytokines
0.7101537528	cyclic
0.7101350643	bladder
0.7100416773	carnitine
0.7099270187	cyclooxygenase
0.7099097266	reverse
0.7099089887	motor
0.7098070911	estradiol
0.7098052690	beneficial effect
0.7097332684	sulfate
0.7097252263	mantle cell
0.7096716410	previous
0.7095506952	steroid
0.7094802685	double
0.7094569760	extraction
0.7093266697	european
0.7092160758	concentration range
0.7091457133	investigation
0.7090585826	dietary
0.7090086737	bone
0.7088567950	mph
0.7088058134	screening
0.7087640163	pregnancy
0.7087536854	characteristic
0.7087049953	ici
0.7086664731	confocal
0.7086664731	recombination
0.7086474551	nmr
0.7084838509	snake
0.7084695859	kainate
0.7083935267	conformation
0.7083421786	histamine
0.7083181574	testosterone
0.7082871708	heparin binding
0.7081245203	local
0.7080387304	ph
0.7079999857	gain
0.7079611089	95 confidence interval
0.7079386778	modelling
0.7079246304	peroxisome proliferator activated
0.7078458026	omega 3
0.7077838889	glucagon
0.7077449590	therapeutic agent
0.7075738168	rhesus
0.7075601217	glycine
0.7074536235	cold
0.7073904479	marked
0.7070263906	single agent
0.7069786440	org 214444 0
0.7068331507	urinary
0.7064521353	hypertension
0.7061711218	polymorphisms
0.7061510399	cigarette
0.7058841328	golgi
0.7057075490	target genes
0.7056953748	helix
0.7056678131	invasion and metastasis
0.7056143993	age and sex
0.7056079406	atpase activity
0.7055696688	biological activity
0.7055284308	unsaturated
0.7054394991	alpha 1a
0.7053927127	biological activities
0.7052967867	information
0.7052772605	truncated
0.7051142208	hypothalamic
0.7050465467	animal
0.7050174567	increasing
0.7048247912	common
0.7048161735	ovarian
0.7044068539	gas
0.7042299867	regression
0.7041496636	crucial
0.7041151275	pro
0.7038071468	cytotoxicity
0.7035851259	cell membranes
0.7033749539	lc
0.7032904296	central
0.7032499352	grown
0.7032281976	uv
0.7031750438	individuals
0.7031016745	glutathione
0.7030764632	bioavailability
0.7030590248	unique
0.7029924390	anti apoptotic
0.7029581579	response curves
0.7028932029	thymidine
0.7028599855	literature
0.7026788016	pretreatment
0.7026571339	additional
0.7026358792	d1
0.7026253432	low doses
0.7025621406	nasal
0.7025315817	ec50
0.7023639404	nanoparticles
0.7021866626	bearing
0.7021592745	conformational
0.7020973496	encoded
0.7020599643	genetic
0.7020269512	spinal
0.7018550568	sufficient
0.7015438780	serine
0.7015128884	surface
0.7014261425	proliferative
0.7014207363	intravenous
0.7013639012	atpase
0.7013049665	15d pgj2
0.7012316408	computational
0.7012015331	factors
0.7011234426	glur
0.7010413553	natural
0.7008350915	peripheral
0.7008013592	hepatocyte
0.7005491795	rationale
0.7004386492	respiratory
0.7003861132	fluorescence
0.7002936599	lead
0.7002406430	women with pcos
0.7002022710	poor
0.7001767287	aromatase
0.7001265400	basolateral
0.7001265400	storage
0.6999543431	p gp
0.6999516810	mass
0.6999036234	rna
0.6998550400	crystal structures
0.6997803485	unit
0.6997314242	ether
0.6996162645	pyruvate
0.6994528588	mismatch
0.6993851270	glucocorticoid
0.6993276371	mu
0.6991407513	evidence
0.6990736206	recent
0.6989986783	ms ms
0.6988180056	review
0.6987275872	lavage fluid
0.6987064255	bms 690514
0.6986270410	relation
0.6985933953	albumin
0.6985915897	differential
0.6985848871	gastrointestinal
0.6985565520	promoter
0.6984127205	chronic
0.6983719421	arterial
0.6983321523	thyroid
0.6980929262	subjects
0.6979052616	ligand binding
0.6979044157	heparin
0.6978900720	nucleotide binding
0.6978813032	cytokines
0.6976794534	mm
0.6975605155	catalytic
0.6974691368	secondary
0.6974385797	mammary
0.6974171898	all trans retinoic acid
0.6973693204	field
0.6973214297	ppar
0.6972474321	km
0.6972364201	kinase inhibitor
0.6971226820	basal
0.6970861816	cytotoxic
0.6970301283	human umbilical
0.6970022711	water
0.6969816364	ventricular
0.6969814479	memory
0.6968425547	interferon
0.6968363600	elicited
0.6968255005	life
0.6966263532	wnt signaling
0.6965956892	inflammatory responses
0.6964972667	actin
0.6964260539	ethanol
0.6963889925	potentiation
0.6963585524	aortic
0.6962343020	mixed
0.6962044299	inverse
0.6961993069	progression
0.6960850627	cholesterol
0.6960791335	low concentrations
0.6960020239	variation
0.6959905877	kb
0.6958324461	cos
0.6957315489	apple
0.6952421948	striatum
0.6952100781	bonding
0.6952081671	acute
0.6951419299	receptor antagonists
0.6951201013	enzymatic activity
0.6950933118	host
0.6950840719	antiproliferative
0.6950065949	cytokine
0.6949280243	norepinephrine reuptake
0.6949173947	relative
0.6948729161	method
0.6947590742	drosophila
0.6946126913	phase
0.6945553724	dhea
0.6944845394	vp 16
0.6944081785	cirrhosis
0.6944081785	relief
0.6943551535	hydroxylase
0.6942897071	thiamine
0.6941694600	dna topoisomerase
0.6940594780	natriuretic
0.6940584134	reductive
0.6940584134	ketone
0.6939887392	trans
0.6938458378	isolated
0.6936553060	combined
0.6936235734	blocking
0.6935425472	pyridoxal
0.6935140645	dld 1
0.6934913961	significantly decreased
0.6934638798	ampa receptors
0.6934191883	mild
0.6933647681	atom
0.6933608783	women
0.6933598607	molecular targets
0.6933316178	fine
0.6933316178	vital
0.6933316178	organisms
0.6933316178	visual
0.6933316178	testicular
0.6932784967	fgf
0.6931275907	pituitary
0.6930701429	high dose
0.6930407042	significantly improved
0.6930266119	muscarinic
0.6930177752	serotonin
0.6929516831	substitution
0.6928374139	pharmacological effects
0.6928341594	generation
0.6927371938	adhd
0.6926603424	induce apoptosis
0.6926126941	postmenopausal women
0.6925645275	metabolic
0.6924816364	trial
0.6924050329	carbon
0.6923578227	oral
0.6923202927	myeloid
0.6921258977	efflux transporters
0.6919063679	recombinant human
0.6918674476	clock
0.6916514449	dialysis
0.6916514449	psychiatric
0.6916514449	presentation
0.6916514449	methylene
0.6915511787	lung
0.6915441503	atypical
0.6914297045	chemical
0.6914078136	mk
0.6912408650	dna binding
0.6912174724	mineral
0.6911236694	abl
0.6910903395	current
0.6909396258	length
0.6907249484	captopril
0.6907249484	soy
0.6907248971	lymphatic
0.6906682395	repair
0.6906033522	ap
0.6906017526	flow
0.6905823084	poorly
0.6905706586	national
0.6905278380	hemorrhage
0.6905278380	random
0.6904470953	antipsychotic drugs
0.6903924844	postpartum
0.6903910194	female
0.6901991750	complex iv
0.6901946565	social
0.6901183846	partial
0.6900483736	il 2r alpha
0.6900098374	deletion
0.6899718146	vessel
0.6899240770	dna damage response
0.6898741910	binding domain
0.6898167084	thromboxane
0.6898167084	iodide
0.6896692446	approach
0.6895618820	air
0.6894746767	hematopoietic
0.6894187627	plant
0.6894171321	gsh
0.6893822960	sh
0.6893617651	plasminogen
0.6893418204	histone
0.6892940962	il 8
0.6892057190	acetyl
0.6892002733	affinities
0.6891948317	antipsychotic
0.6891362378	multiple
0.6890779065	class
0.6889593837	inducible
0.6889347587	sugar
0.6888459039	ethylene
0.6887817015	fas
0.6886055923	cho cells
0.6885701459	step
0.6885675130	arabidopsis
0.6884375357	assessment
0.6883214280	aspect
0.6883214280	birth
0.6883214280	reviews
0.6882666223	catalysis
0.6882607163	murine
0.6881786850	objective
0.6881382155	gnrh ii
0.6880650908	mutation
0.6880256837	canonical
0.6879524100	mrna level
0.6879212729	melanoma
0.6878114451	active form
0.6877533874	protein expressions
0.6877209679	xanthine
0.6877209679	dimethyl
0.6877209679	genetically
0.6876486030	bond
0.6876318681	topoisomerase
0.6876318525	statistical
0.6876121068	purpose
0.6875858701	alternative
0.6875565336	pre treatment
0.6875562565	lps induced
0.6875206172	tertiary
0.6875206172	carrier
0.6875015834	proposed
0.6872559095	se
0.6872253264	clearance
0.6872222462	gnrh
0.6872033108	cassette
0.6872033108	theory
0.6872033108	reproduction
0.6872033108	eukaryotic
0.6872033108	matter
0.6872033108	nutritional
0.6872033108	innate
0.6872010974	impaired
0.6871159574	intracellular calcium
0.6869500532	age
0.6868360859	ng
0.6867854731	prevention
0.6867826378	molecular mechanisms
0.6867348703	panel
0.6866085023	amyloid
0.6865533327	nature
0.6865533327	medicine
0.6865475358	materials and methods
0.6864860710	cultures
0.6863864486	competitive
0.6863776253	immune
0.6863246741	association
0.6863186339	linear
0.6861690990	mapk
0.6861580194	rapid
0.6860799892	charge
0.6857754385	median
0.6856665309	states
0.6856076042	ammonium
0.6856076042	strength
0.6854453171	lowering
0.6854335999	met
0.6854123196	temperature
0.6852633523	sexual
0.6852633523	caudate
0.6852364291	retinal
0.6852296186	column
0.6852274005	glucan
0.6852043285	liquid
0.6851893114	immunity
0.6851893114	fiber
0.6851802638	pre
0.6851407685	partially inhibited
0.6846889313	utility
0.6846851339	sulfide
0.6846473989	pharmacological
0.6846018489	electrical
0.6845259592	modeling
0.6844257015	diabetes
0.6843283816	p glycoprotein
0.6842845761	effective
0.6842742698	examination
0.6840851899	nf kappab activation
0.6839978884	cultured
0.6839581093	dopamine receptors
0.6839427093	biological
0.6839030937	anti metastatic
0.6838930805	degeneration
0.6838930805	follicular
0.6838666217	microsomal
0.6838666217	organophosphorus
0.6838462388	correlation
0.6838425425	efficacy and tolerability
0.6838385383	week
0.6837589055	freshly
0.6837093722	adaptive
0.6837080654	case
0.6837065839	kinases
0.6836753667	orally
0.6836236565	hs
0.6835882847	rar
0.6834664541	organic
0.6834643873	altered
0.6833939700	h1 receptor
0.6832834121	comparable
0.6831608572	glucose uptake
0.6831239604	state
0.6830899142	e3
0.6830007725	root
0.6829667198	fibers
0.6829667198	bromide
0.6829430364	pharmaceutical
0.6829032465	promising
0.6828433811	s adenosylmethionine
0.6828230475	light
0.6826914972	structural
0.6826445460	cross
0.6826143640	guanine
0.6825718574	hiv
0.6824932246	transduction
0.6824885126	large
0.6824727959	rolipram
0.6824676710	resolution
0.6824562599	catecholamines
0.6824062714	pyrimidine
0.6823044123	antioxidant
0.6822462227	hormone
0.6822083623	adenosine
0.6821693894	receptor agonists
0.6821403738	simvastatin
0.6821202128	inducing
0.6821181082	orphan
0.6821181082	cutaneous
0.6821181082	biphenyl
0.6820893772	dopamine d2 receptor
0.6820312356	fruit
0.6820312356	circulation
0.6820312356	physical
0.6818692807	tool
0.6818192790	neuron
0.6817996932	northern
0.6817808648	ms
0.6817237753	thiol
0.6817237753	dyslipidemia
0.6817237753	levodopa
0.6817143781	sensitivity
0.6815679036	oil
0.6815098806	optimization
0.6813389131	meta
0.6813352582	ephedrine
0.6812223428	catalyzed
0.6812126537	raf
0.6812114357	male and female
0.6812061684	insulin signaling
0.6811370692	anxiety
0.6811370692	tachycardia
0.6811370692	monkey
0.6810099691	randomized
0.6808536147	experimental
0.6808087325	cpe gene
0.6807882056	5 ht1b
0.6807758557	yohimbine
0.6807758557	topical
0.6807406770	mda
0.6807396619	dissociation
0.6807279228	etoposide
0.6806472870	recovery
0.6806113372	index
0.6805687412	supporting
0.6805687412	task
0.6805687412	cimetidine
0.6804517541	benign
0.6804237240	dry
0.6803180385	stomach
0.6802391167	macrophage
0.6802000423	mrna levels
0.6800488013	yeast
0.6799927801	recombinant
0.6798746176	culture
0.6798668098	acetylcholine
0.6798484806	anti inflammatory effect
0.6797805431	gemfibrozil
0.6797805431	cetirizine
0.6797317507	design
0.6797248454	potentials
0.6796364865	neurochemical
0.6796364865	aberrant
0.6796364865	adenocarcinoma
0.6796364865	shorter
0.6796364865	alters
0.6796056078	methoxy
0.6795695131	er
0.6795684297	cortex
0.6795106885	trigeminal
0.6792718374	hippocampal
0.6792307784	olmesartan
0.6791057633	solution
0.6789954341	allele
0.6789333405	cardiovascular
0.6788505111	understanding
0.6788003980	skin
0.6787905882	chondrocytes
0.6787905882	functionalized
0.6787905882	inter
0.6787905882	ectopic
0.6787905882	immunofluorescence
0.6787814967	kinetics
0.6786697245	cis
0.6785693639	epigenetic
0.6785693639	calculations
0.6785693639	deoxy
0.6784150160	respective
0.6783374917	ad
0.6783183713	negative
0.6782960684	adrenaline
0.6782345624	distinct
0.6782325517	elongation
0.6782143853	peritoneal
0.6781903519	acetyltransferase
0.6781822557	technology
0.6780992313	sphingosine
0.6780660684	haloperidol
0.6780660684	complications
0.6780048106	inositol
0.6780005036	activate
0.6779435752	morphological
0.6779435752	immunomodulatory
0.6779435752	radioactivity
0.6778808229	fruits
0.6778169353	antioxidant enzymes
0.6777774848	combination
0.6777644032	potassium
0.6776376665	organic anion transport
0.6775937482	adverse
0.6775688792	movement
0.6775649983	aggressive
0.6775649983	recommended
0.6774889749	findings provide
0.6774046242	tolerance
0.6773905396	hair
0.6773725846	apomorphine
0.6773725846	amiloride
0.6772699416	anabolic
0.6772699416	resting
0.6772699416	feature
0.6772507784	selenium
0.6772374004	comparative
0.6771838957	nonsteroidal
0.6771612181	sulfur
0.6771326831	rifampicin
0.6771287275	long
0.6770329862	loop
0.6770049723	force
0.6769896883	ic50
0.6769582911	clenbuterol
0.6769582911	weakly
0.6769582911	advantages
0.6769582911	pharmacophore
0.6769582911	isomer
0.6769582911	pediatric
0.6769582911	phosphatidylserine
0.6769582911	flurbiprofen
0.6769582911	decline
0.6769582911	nonspecific
0.6769257708	sirolimus
0.6769257708	vardenafil
0.6769257708	classification
0.6769257708	excessive
0.6768764798	hypothyroidism
0.6768048357	isoproterenol
0.6768036302	pancreatic
0.6768033527	imidazole
0.6768033527	salicylate
0.6768033527	mesenteric
0.6768033527	phenylephrine
0.6767434210	metabolic pathways
0.6766752008	5 ht2a
0.6766014988	prednisolone
0.6766014988	neuropeptide
0.6766014988	sulfonylurea
0.6766014988	scaffolds
0.6766014988	hyperthyroidism
0.6765244243	nucleus
0.6764757203	ucp 3 mrna
0.6764183437	maintenance
0.6764095856	cerebral
0.6763636702	protective
0.6761827565	neuroendocrine
0.6761827565	context
0.6761827565	hyperglycemia
0.6761494072	daily
0.6761236469	toxic
0.6761229689	total
0.6760831713	tuberculosis
0.6759725777	oregovomab
0.6759725777	intraperitoneally
0.6759725777	venlafaxine
0.6759725777	sensitization
0.6759320701	5 hydroxytryptamine
0.6759234749	arsenite
0.6758834437	5 ht1a
0.6758033744	american
0.6757683355	sulfasalazine
0.6757683355	considerable
0.6757371620	feeding
0.6756771495	akt
0.6756700268	east
0.6756595139	constant
0.6756564888	systolic
0.6755569557	favorable
0.6755569557	simultaneously
0.6754849055	competitive inhibitors
0.6754825842	procedures
0.6753478491	thymidylate
0.6753399842	antioxidant properties
0.6753168389	pathophysiology
0.6753168389	determinants
0.6753054150	neurotrophic
0.6752366393	fashion
0.6752358838	ros
0.6752298754	ldl
0.6752000248	wave
0.6751803858	coupling
0.6751507204	verapamil
0.6751507204	taking
0.6750918994	probenecid
0.6750597776	evn 50
0.6750429415	aryl
0.6749657401	epithelial
0.6749564160	diet induced obesity
0.6747275465	bosentan
0.6746668024	induced neurotoxicity
0.6746227774	incubation
0.6744366313	ferric
0.6744142732	laser
0.6744142732	thermal
0.6744142732	antisense
0.6744142732	hybridization
0.6744142732	bodies
0.6744142732	taste
0.6744142732	fresh
0.6744097683	transcripts
0.6743807204	robust
0.6743470877	tryptophan
0.6743470877	disposition
0.6742884920	metastatic
0.6742486887	single
0.6741696356	safety
0.6741226103	myeloma
0.6741226103	anemia
0.6740862705	estrogen
0.6740711900	salbutamol
0.6740365455	sitagliptin
0.6740365455	tadalafil
0.6739242048	terbutaline
0.6738760102	se deficiency
0.6738694923	radiation
0.6738166972	prostate
0.6737182857	samples
0.6737035314	apoptotic
0.6736783847	lateral
0.6736267382	fenoterol
0.6736267382	doxorubicin
0.6735745616	micro
0.6735745616	azole
0.6735584617	persistent
0.6735584617	cisapride
0.6735527646	absorption
0.6735071477	alkyl
0.6734696648	knockout
0.6733779107	physicochemical
0.6733779107	hepatoprotective
0.6733779107	reversal
0.6733779107	doxycycline
0.6733622498	motif
0.6733367523	distribution
0.6733095068	vector
0.6732661412	hemoglobin
0.6732661412	buffer
0.6732117933	block
0.6731698170	potential role
0.6731039109	differences
0.6730906144	aggregation
0.6730756310	tyrosine
0.6730473573	caffeine
0.6730431074	iv
0.6730317087	mutations
0.6729225281	mitogen
0.6727686696	activin
0.6727554843	significance
0.6727212740	prior
0.6727182968	soman
0.6726953693	vildagliptin
0.6726953693	pharmacologically
0.6726387859	methylphenidate
0.6726147705	whilst
0.6726147705	adequate
0.6726147705	polyamines
0.6726147705	assessing
0.6726053113	agonism
0.6726053113	phenoxybenzamine
0.6725245461	lps
0.6724961055	ampa
0.6724431776	strongly inhibited
0.6722914652	luciferase
0.6722520655	endothelial
0.6722451447	compound
0.6722181146	beta 1 adrenoceptor
0.6721930259	lipoprotein
0.6721793417	recently
0.6721181283	mtt
0.6720803604	map
0.6720579853	obese
0.6720416717	metabolite
0.6720394066	da
0.6720004259	cysteine
0.6718989377	amphetamine
0.6718984048	herb
0.6718984048	chlorpromazine
0.6718984048	kidneys
0.6718984048	sumatriptan
0.6718984048	cilazapril
0.6718984048	elastase
0.6718984048	olanzapine
0.6718984048	conjugate
0.6718984048	assembled
0.6718984048	childhood
0.6718984048	hemorrhagic
0.6718984048	neutrophils
0.6718984048	disrupted
0.6718984048	raised
0.6718239464	output
0.6718201915	targeted
0.6717880139	atp
0.6717782140	coronary
0.6717390598	survival
0.6715589223	living
0.6715589223	heavy
0.6715589223	supplement
0.6715589223	spatial
0.6715228438	dams
0.6715228438	fructose
0.6715228438	variations
0.6715228438	isolation
0.6715114689	strain
0.6714868526	nadph
0.6714698567	antinociceptive
0.6714203056	pylori
0.6714203056	herbal
0.6714050491	gastric
0.6713652482	diesel
0.6713599864	defective
0.6713599864	apparently
0.6713555324	radioligand
0.6712997716	exogenous
0.6712888345	estrogens
0.6712888345	cholinesterase
0.6712819340	aldosterone
0.6712505392	migraine
0.6712171072	pharmacodynamic
0.6712021515	dysfunction
0.6711713086	spermidine
0.6711102366	cataract
0.6710951333	arginase
0.6710795995	significantly higher
0.6710597740	wt
0.6710087831	fat
0.6710037698	antigen
0.6709760919	cat
0.6709584253	young
0.6709162452	primary
0.6707966829	diagnostic
0.6707966829	procedure
0.6707192840	meperidine
0.6706801871	membrane
0.6706477251	research
0.6706414346	dopa
0.6705844319	pyrilamine
0.6705844319	ritonavir
0.6705844319	submaximal
0.6705368191	starting
0.6705101793	passive
0.6705101793	weekly
0.6704473664	elevated
0.6704342618	velocity
0.6704342618	neu
0.6703948835	oxidation
0.6702919812	excess
0.6701602992	rosiglitazone
0.6701602992	chloro
0.6700308011	interactions
0.6700190410	iii
0.6699800132	glutamate
0.6699567226	fxi
0.6699540036	resveratrol
0.6698558760	desipramine
0.6698300886	product
0.6698092538	sequence
0.6697874114	iron
0.6697506542	atp sensitive
0.6696817034	gaba
0.6696735872	comprehensive
0.6696670964	d2
0.6695964017	main
0.6695872949	pairs
0.6695621432	entecavir
0.6695399433	animals
0.6694273057	remarkably
0.6694241415	atorvastatin
0.6694023089	intrinsic
0.6693834452	asymmetric
0.6693834452	glucuronidation
0.6693834452	clonidine
0.6693834452	entry
0.6693834452	inversely
0.6693819925	amprenavir
0.6692739254	small
0.6692162190	restriction
0.6692162190	pancreatitis
0.6692162190	newborn
0.6692162190	bowel
0.6691340199	death
0.6690688410	failure
0.6690503933	treated group
0.6689776080	half
0.6689397052	conjugates
0.6688776629	antitumor
0.6688750617	ace
0.6688091475	approval
0.6688091475	opiate
0.6688091475	connexin
0.6688091475	rituximab
0.6688091475	classical
0.6688091475	topically
0.6688091475	canine
0.6688091475	ultrasound
0.6688091475	antiarrhythmic
0.6688091475	ziprasidone
0.6688091475	catecholamine
0.6687436104	mitiglinide
0.6687362740	fenofibrate
0.6687362740	risperidone
0.6687362740	biomarker
0.6687279292	prostacyclin
0.6686529485	myeloperoxidase
0.6686529485	triclosan
0.6686529485	entacapone
0.6686521636	vascular
0.6686472244	prolonged
0.6686079639	murine model
0.6683297288	bile
0.6683246656	group iii
0.6683030508	contact
0.6682784170	brown
0.6682593258	ischemia
0.6682338464	treatments
0.6682338346	biotransformation
0.6682338346	predicting
0.6682338346	preferential
0.6682338346	diclofenac
0.6682295007	car
0.6681505907	pi3k
0.6681315089	fluoxetine
0.6680883013	vemurafenib
0.6680883013	procainamide
0.6680883013	tocopherol
0.6680295165	leptin
0.6680027800	abnormal
0.6679968027	interventions
0.6679785978	transaminase
0.6678988265	purification
0.6677321938	band
0.6676068322	hepatocytes
0.6675336999	ici 118
0.6675316144	aspirin
0.6674768866	growing
0.6674617272	onset
0.6674242121	intake
0.6673778293	phasic
0.6673589166	vesicles
0.6673589166	infections
0.6673428521	memantine
0.6673428521	immunoblotting
0.6672081026	result
0.6671838647	arrhythmias
0.6671173593	developmental
0.6670813260	nmda
0.6670794907	component
0.6669263593	sea
0.6668640650	completely inhibited
0.6668046639	carbonyl
0.6666889240	pyrophosphate
0.6666591327	β cell
0.6666566481	prostatic
0.6666390329	lumiracoxib
0.6666390329	postprandial
0.6666390329	database
0.6666390329	parental
0.6666390329	excitatory
0.6666263356	countries
0.6666106654	leucine
0.6665895846	dabigatran
0.6665895846	graphene
0.6665868708	citalopram
0.6665868708	eosinophils
0.6665802541	intracellular
0.6665431431	antofine
0.6665431431	tryptamine
0.6665185369	methyltransferase
0.6664839903	copper
0.6664810275	weight
0.6664554401	interleukin
0.6663497615	fisetin
0.6662651420	autism
0.6662651420	nicotinamide
0.6662651420	neck
0.6662493444	lipopolysaccharide
0.6662129550	bms
0.6661803273	patterns
0.6661636931	enhanced
0.6661222720	estramustine
0.6661222720	somatostatin
0.6660968947	offspring
0.6660968947	lisuride
0.6660968947	select
0.6660968947	responding
0.6660041078	calcineurin
0.6658915709	significant differences
0.6658852704	inhibitory effect
0.6658635321	triglycerides
0.6658635321	knowledge
0.6658402302	numerous
0.6658240090	experiment
0.6657872381	transport
0.6657833054	tomatidine
0.6657833054	ankyrin
0.6657773969	il 2r
0.6657563605	pseudoephedrine
0.6655806741	igfbp
0.6655658772	retinoids
0.6655637492	vascular smooth muscle cells
0.6654963872	studies revealed
0.6654569443	repeated
0.6654519815	longer
0.6654492550	detailed
0.6654492550	simultaneous
0.6654492550	comparing
0.6654278194	continuous
0.6654193674	corticosteroids
0.6654193674	covalently
0.6654193674	simulation
0.6654193674	pioglitazone
0.6654193674	metoprolol
0.6654193674	conditioned
0.6654193674	chronically
0.6654193674	pyridine
0.6654193674	bumetanide
0.6654193674	expansion
0.6654193674	reactivators
0.6654193674	etorphine
0.6654193674	advances
0.6654193674	concomitantly
0.6654193674	splice
0.6654193674	glioma
0.6654193674	initially
0.6653884625	angiogenesis
0.6652375818	cisplatin
0.6652229590	dominant
0.6651717667	assembly
0.6651698640	clopidogrel
0.6651134340	ca3
0.6650628714	predicted
0.6649942955	circulating
0.6649720477	ionic
0.6649189709	attenuation
0.6649189709	ribose
0.6647676168	n terminus
0.6647624031	carboxylase
0.6647468340	cho
0.6646465410	abciximab
0.6646448027	immunohistochemistry
0.6645666953	related genes
0.6644561004	neonatal
0.6643986573	oxymetazoline
0.6643986573	procaine
0.6643986573	isoflavones
0.6643986573	hydrophilic
0.6643986573	immature
0.6643986573	glycation
0.6643986573	dihydrotestosterone
0.6643986573	freshwater
0.6643986573	naltrexone
0.6643244571	genomic
0.6642965955	previously
0.6642656425	propranolol
0.6642413519	environmental
0.6641693322	critical
0.6641563156	enhancing
0.6641563156	investigations
0.6640160440	models
0.6639904570	conjugation
0.6639763566	opening
0.6639763566	tablets
0.6639763566	older
0.6639587392	therapeutics
0.6639266697	translational
0.6639158857	halothane
0.6638670255	pathology
0.6637938966	oxycodone
0.6637714202	bi
0.6637497449	dopamine d2
0.6637483042	baicalein
0.6636889732	iloprost
0.6636815605	percutaneous
0.6636815605	vesicle
0.6636755507	tyramine
0.6636540112	beta adrenergic receptors
0.6636458118	leukotriene
0.6635843716	fetal
0.6635274098	anastrozole
0.6635274098	histological
0.6635274098	hybrid
0.6635122239	serum
0.6634928668	minor
0.6634928668	fast
0.6634787392	porcine
0.6634342929	gamma
0.6633982464	endogenous
0.6633861340	antiproliferative activity
0.6633535444	kidney
0.6632375585	heart
0.6632348627	bmp
0.6631827159	antihypertensive
0.6631255228	follicle
0.6631118280	isoprenaline
0.6629674666	branch
0.6629674666	ribosomal
0.6629418504	antifungal
0.6629418504	neostigmine
0.6629418504	inhaled
0.6629418504	phenytoin
0.6629415318	attenuates
0.6628871255	material
0.6628444571	biotin
0.6628035813	nuclear receptors
0.6627538392	therapeutic potential
0.6627218624	driven
0.6627190089	nerve
0.6626248422	diets
0.6626124096	management
0.6626049895	mrna content
0.6625898465	carcinogenic
0.6625898465	triple
0.6625898465	proline
0.6625898465	radiolabeled
0.6625544156	abuse
0.6624925203	characterization
0.6624802547	separate
0.6624761690	ischaemia
0.6624519698	trained
0.6624519698	sulindac
0.6623924742	box
0.6623373667	estimated
0.6623314202	ratio
0.6622072979	fp
0.6621940430	population
0.6621553692	control group
0.6621414499	mitochondrial
0.6621356696	controlling
0.6621312748	na
0.6620252508	renal
0.6619993844	cohort
0.6618236138	tamsulosin
0.6617516605	mitochondrial membrane
0.6617234137	combining
0.6617204054	induces
0.6616169998	experiments
0.6616011920	chlorpheniramine
0.6616011920	checkpoint
0.6616011920	exposures
0.6615462582	gallium
0.6615087937	amphetamine induced
0.6614671494	extensive
0.6614417543	compensatory
0.6613615292	induction
0.6612341314	introduction
0.6612240768	csf
0.6612153101	assess
0.6611514043	duration
0.6611479163	ketamine
0.6611403193	feed
0.6610983436	amylin
0.6610969565	poly
0.6610843279	tea
0.6610730360	lipid
0.6610711780	stromal
0.6609658389	mature
0.6609602540	protein synthesis
0.6609486917	enantiomers
0.6609171728	metformin
0.6608236293	al
0.6608170031	silymarin
0.6608117609	melatonin
0.6607640596	mollugin
0.6607640596	comparisons
0.6607640596	flutamide
0.6606678401	particles
0.6606415334	opioids
0.6606408308	hazard
0.6606408308	manganese
0.6605655730	beneficial
0.6605158990	biomarkers
0.6605146940	polymorphism
0.6605112891	nuclei
0.6604636316	atrial
0.6604270872	mao
0.6603912704	efficacy
0.6603795092	food
0.6603717094	middle
0.6603532817	oxysterols
0.6603532817	acetazolamide
0.6603532817	irbesartan
0.6603423993	care
0.6603423993	locus
0.6603020919	morphine
0.6603015205	vasopressin
0.6602773402	ingredient
0.6602773402	coordination
0.6602127132	abstract
0.6601647415	icam 1
0.6601379337	a2
0.6601355167	approaches
0.6601254165	5 ht2
0.6600976767	odds
0.6600301487	morphology
0.6599080185	substantial
0.6598459627	utilizing
0.6598018191	formoterol
0.6597886748	mrna expression
0.6597623667	bupropion
0.6597533696	mhc
0.6597065974	cardiac function
0.6596664178	amp
0.6596163113	intense
0.6596163113	newer
0.6596163113	diacylglycerol
0.6596163113	dapagliflozin
0.6596163113	man
0.6596163113	leukotrienes
0.6595165126	junctions
0.6594598087	urine
0.6593784645	astrocytes
0.6590334393	mechanistic
0.6589876916	c57bl 6 mice
0.6588552929	cytoplasmic
0.6588528739	benzo
0.6588289679	pharmacokinetics
0.6588224826	processing
0.6587922343	electrophysiological
0.6587922343	embryos
0.6587922343	elderly
0.6587922343	substitutions
0.6587922343	cationic
0.6587922343	precursors
0.6587892182	inactivation
0.6587525675	glucose lowering
0.6587521866	tolcapone
0.6587462839	ki values
0.6587037059	noradrenaline
0.6585964365	carriers
0.6585649581	conversion
0.6583904001	e2
0.6583488054	cardiac
0.6583322726	glucose
0.6583208485	creatine
0.6583208485	ionization
0.6583208485	synuclein
0.6583208485	gonadotropin
0.6582965252	pcr
0.6582604757	membrane potential
0.6582515780	valine
0.6582515780	saturated
0.6582515780	extrinsic
0.6582515780	bacteria
0.6582515780	descending
0.6582515780	theoretical
0.6582515780	mimetic
0.6582515780	mimicking
0.6582515780	classic
0.6582515780	bosutinib
0.6582515780	prolactin
0.6582515780	uracil
0.6582515780	adaptation
0.6582515780	lowest
0.6582515780	immediately
0.6582515780	typically
0.6582515780	heterologous
0.6582515780	chemokines
0.6582515780	past
0.6582515780	increasingly
0.6582269214	venom
0.6582183710	neuronal
0.6582016989	hyperplasia
0.6581235365	troglitazone
0.6580961465	hydroxysteroid
0.6580497173	mouse
0.6580443192	breast
0.6580089178	mb
0.6579766066	dasatinib
0.6579766066	cyclothiazide
0.6579766066	pimozide
0.6579766066	norethisterone
0.6579766066	strikingly
0.6579675709	intervals
0.6578976688	carteolol
0.6578857257	linking
0.6578027670	emerging
0.6577821976	achieved
0.6577670429	maprotiline
0.6577118433	maternal
0.6576192299	viral
0.6576128994	lixisenatide
0.6576128994	galantamine
0.6576128994	program
0.6575394428	salivary
0.6575263490	summary
0.6574231886	efficacy and safety
0.6573533717	cells expressing
0.6572869252	bleeding
0.6572303747	adrenergic
0.6572231487	atropine
0.6571992742	terminal
0.6571698606	anti cancer
0.6571198398	jaceosidin
0.6571198398	dextromethorphan
0.6571041890	abnormalities
0.6571041890	synergistic
0.6568693523	pure
0.6568488936	ns
0.6568420903	st
0.6568360463	brugada
0.6567400722	scale
0.6567400722	mimic
0.6567400722	segments
0.6567400722	epinephrine
0.6567400722	progressive
0.6564866565	dl
0.6563447577	derivatives
0.6563436433	imatinib
0.6562071393	bis
0.6562052666	oxidase
0.6561928286	apoptosis
0.6561621759	conclusion
0.6561506600	workers
0.6561145625	controlled
0.6561083192	molecular
0.6561069031	insufficiency
0.6561043936	spontaneous
0.6560221455	clomipramine
0.6559339619	ligase
0.6558758145	nuclear factor kappa
0.6557857712	modafinil
0.6557640596	contrary
0.6557545842	wistar
0.6555482392	biology
0.6555237231	p450
0.6554934822	oxidized
0.6554747062	hearing
0.6553483757	patient
0.6551349851	cystine
0.6551311110	hek
0.6551217121	internal
0.6551025569	di
0.6550971606	selective cox 2 inhibitor
0.6550428855	muscle
0.6550003045	viability
0.6549223444	chinese
0.6549170332	vitamin
0.6548081637	duct
0.6547526445	astemizole
0.6547462187	ameliorates
0.6547462187	applying
0.6547462187	levonorgestrel
0.6547462187	separately
0.6547462187	cysteamine
0.6547462187	cinobufagin
0.6547462187	rebound
0.6547462187	location
0.6547462187	brains
0.6547462187	pump
0.6547462187	chemopreventive
0.6547462187	vertebrate
0.6547462187	breakdown
0.6547462187	embryo
0.6547462187	articular
0.6547462187	hepatoma
0.6547462187	chemotaxis
0.6547462187	saturable
0.6547462187	worldwide
0.6547462187	transamination
0.6547462187	streptozotocin
0.6547462187	similarities
0.6547462187	nitro
0.6547462187	bifunctional
0.6547462187	external
0.6546884066	curcumin
0.6545336438	δ
0.6545158167	carvedilol
0.6544616505	insulin
0.6544512843	μ
0.6543420907	functional
0.6543386680	oxygen
0.6541549151	probe
0.6541472085	mediator
0.6539933475	measurements
0.6539847996	d 1997
0.6539321561	region
0.6539199753	cpt
0.6538000402	end
0.6537456732	topotecan
0.6537266230	tyrosine kinase inhibitor
0.6536735404	nuclear
0.6536221732	pcos
0.6535881117	androgens
0.6535852049	trials
0.6535018930	identity
0.6535018930	prostaglandins
0.6535018930	osteosarcoma
0.6534766066	rivastigmine
0.6533996700	hypothesis
0.6533839418	phosphoinositide
0.6533839418	anesthesia
0.6532728720	quercetin
0.6531327607	impulsivity
0.6529728588	juice
0.6529149192	nucleotide
0.6529031848	preliminary
0.6528952242	99m
0.6528804111	aminopeptidase
0.6528285510	thioredoxin
0.6527380271	cpe
0.6525866504	ko
0.6525561004	eprosartan
0.6525549031	pharmacologic
0.6524133800	© 2013
0.6523719854	h1 receptor antagonists
0.6523620683	ci
0.6523577965	hif
0.6523474483	ki
0.6522340897	messenger
0.6522194475	cognition
0.6519903462	native
0.6518510819	non small cell lung cancer
0.6517847168	hit
0.6517580015	response curve
0.6517477277	binding assays
0.6516747340	test
0.6516243429	responses
0.6516205223	nadh
0.6516125156	preclinical and clinical
0.6515169925	tumor cells
0.6514332313	methodology
0.6513690254	monomeric
0.6513690254	ovalbumin
0.6513690254	normalized
0.6513690254	quantification
0.6513690254	quinidine
0.6513690254	atenolol
0.6513690254	tyrosinase
0.6513690254	enzymatically
0.6513690254	ingestion
0.6513690254	successful
0.6513690254	osteoporosis
0.6513690254	adulthood
0.6513690254	scavenging
0.6513690254	prospective
0.6513690254	physiologically
0.6513690254	ineffective
0.6513690254	stimulant
0.6513690254	adipocyte
0.6513690254	adenovirus
0.6513690254	nephrotoxicity
0.6513690254	focus
0.6513690254	biosynthetic
0.6512853211	focal
0.6512853211	lactic
0.6512853211	electrophoresis
0.6512631109	crp
0.6512012232	sorafenib
0.6511874776	signal
0.6511604878	scattering
0.6511049587	spectral
0.6511049587	timolol
0.6511049587	paroxetine
0.6511049587	controversial
0.6511049587	earlier
0.6511049587	naloxone
0.6511049587	phases
0.6511049587	cytoprotective
0.6511049587	influences
0.6510854664	epithelial cell
0.6510832596	significant reduction
0.6510655212	peak
0.6510624406	soft
0.6510610376	ec
0.6510223354	non steroidal anti inflammatory
0.6508358096	anti
0.6507180054	hpa
0.6507154297	reactive
0.6506892873	autophagy
0.6506520466	propofol
0.6506379999	argininosuccinate
0.6505635001	transporter
0.6505175500	ubiquitin
0.6505130158	stroke
0.6503061912	dose dependent
0.6502452306	chinese hamster ovary cells
0.6501510239	postsynaptic
0.6501410886	acrolein
0.6500753556	line
0.6499943346	salt
0.6499451523	plasma
0.6498974983	aldo
0.6498848771	radical
0.6497355927	zeta
0.6496997007	tube
0.6495791436	blood
0.6495573847	quantitative
0.6495334463	theophylline
0.6495334463	multi
0.6495334463	stimulatory
0.6495081293	alterations
0.6494944455	tamoxifen
0.6494626527	mmp
0.6494331055	bioactive
0.6493931217	adenosine receptor
0.6493437230	perfusion
0.6492804273	preincubation
0.6492073807	potential therapeutic
0.6492073040	glands
0.6491971936	selective agonist
0.6491698530	acth
0.6491306931	podocytes
0.6491306931	peroxynitrite
0.6491306931	retained
0.6491306931	modifying
0.6491306931	injuries
0.6491306931	mono
0.6491306931	endothelin
0.6491306931	interplay
0.6491306931	palmitate
0.6491306931	fenfluramine
0.6491306931	irradiation
0.6491306931	artificial
0.6491306931	upstream
0.6491306931	slight
0.6491229532	colony
0.6491229532	abdominal
0.6490888689	heterocyclic
0.6490888689	digestion
0.6490888689	pindolol
0.6490824232	a lesser extent
0.6489946134	pemetrexed
0.6489771970	criteria
0.6489617844	pressure
0.6489520407	dpp
0.6489430714	cells stably expressing
0.6488757383	coenzyme
0.6488757284	thiazolidinediones
0.6488642110	structure
0.6488581533	l1
0.6488380089	kinetic
0.6488378674	homocysteine
0.6487501678	polypeptide
0.6487456344	oxytocin receptor
0.6487127470	feedback
0.6486536234	rhinitis
0.6486033827	tnf
0.6485468094	post
0.6484432423	raw 264
0.6484184283	replication
0.6483791366	adjuvant
0.6482321879	upregulated
0.6481946220	erk1 2
0.6481140969	rabbit
0.6480592604	catalase
0.6480414510	glycerol
0.6480414510	ubiquitination
0.6480414510	elastin
0.6480414510	loops
0.6480414510	capillary
0.6480414510	retinaldehyde
0.6480414510	hypoglycaemia
0.6480414510	route
0.6480414510	analgesia
0.6480414510	androstane
0.6480414510	phencyclidine
0.6480414510	urokinase
0.6480414510	osteoclast
0.6478751105	docetaxel
0.6478742339	supplements
0.6478649168	magnetic
0.6478621633	property
0.6478313184	sulfated
0.6478313184	centrally
0.6478313184	electrically
0.6478313184	mianserin
0.6478313184	juglone
0.6478313184	integrated
0.6478313184	berberine
0.6478313184	cooperativity
0.6478313184	imipramine
0.6478090652	dimemorfan
0.6478090652	plasmin
0.6476047022	deficit
0.6475686857	ibritumomab
0.6475683892	rare
0.6475075018	np
0.6474104540	network
0.6474073794	retigabine
0.6473537571	histamine h1
0.6473518299	hdl
0.6473507119	exon
0.6473499322	thp 1
0.6473047646	synthesis
0.6472983872	epithelium
0.6471012283	da release
0.6470217900	intraperitoneal
0.6469931957	tacrine
0.6468950812	dexamethasone
0.6468936623	oxidative
0.6467889532	alzheimer
0.6465484962	data
0.6465370966	ketorolac
0.6465094183	slow
0.6464818661	histamine release
0.6464437064	scaffold
0.6464437064	mammals
0.6464437064	outcomes
0.6464089033	retardation
0.6464089033	bundle
0.6464089033	cruzi
0.6464089033	overload
0.6464089033	atomic
0.6463527632	restore
0.6463527632	white
0.6462852571	fulvestrant
0.6462589033	duloxetine
0.6462056767	atomoxetine
0.6461014682	aging
0.6460966824	peptide
0.6460841545	adenylate
0.6460841545	apparatus
0.6460201185	bisoprolol
0.6459613826	conivaptan
0.6458663767	transplant
0.6458575310	wound
0.6458530099	balance
0.6458463514	lncap
0.6458419127	finger
0.6456994753	polymerase
0.6456777851	ampk
0.6456506385	her2
0.6455958993	curves
0.6455673707	bevantolol
0.6455614399	aag
0.6454536862	acetaminophen
0.6453772007	metabolism
0.6453194032	egf
0.6453182445	differentiation
0.6453034878	histopathological
0.6452603404	biological evaluation
0.6452052014	occurs
0.6451913723	glut3
0.6449701763	silica
0.6449286215	il 2
0.6448809775	studies
0.6448428228	omeprazole
0.6447789641	lasting
0.6447789641	antiviral
0.6446712523	abundant
0.6446193688	reference
0.6445808572	pranlukast
0.6445729369	spectrum
0.6445042434	1r
0.6444117851	domain
0.6443724291	butyrylcholinesterase
0.6443518427	bdnf
0.6442698163	estimates
0.6441103352	wnt
0.6440564773	nf κb activation
0.6440265428	colonic
0.6440066894	methods
0.6439444032	nuclear factor kappa b
0.6439434308	cyslt1
0.6439407086	adducts
0.6439407086	islet
0.6439313068	exposure
0.6438851979	residues
0.6438040985	ii
0.6437699687	clinical
0.6436848444	alcohol dependent
0.6435023815	anticonvulsant
0.6433465440	induced contraction
0.6432867619	glucocorticoids
0.6432357587	intermediate
0.6431653418	species
0.6430916023	array
0.6430916023	chemotherapeutic
0.6430916023	medication
0.6430916023	indirect
0.6430916023	competition
0.6430916023	equally
0.6430916023	abundance
0.6430178203	hela
0.6429692339	loss
0.6429234730	tools
0.6428506763	retinol
0.6428372415	transfer
0.6428317363	enzyme
0.6427390013	sulfonylureas
0.6427390013	cysteinyl
0.6427209231	specifically
0.6426958173	screened
0.6425562457	pxr
0.6425450813	glibenclamide
0.6425450813	tolbutamide
0.6425450813	enhancer
0.6425153500	uvb
0.6424725578	pge
0.6424356305	inhibitory effects
0.6424225090	positively
0.6424225090	profiling
0.6424225090	genotypes
0.6424225090	stimuli
0.6422571467	cathepsin
0.6422571467	validation
0.6422571467	crystallographic
0.6422392878	homology
0.6421952801	gestational
0.6421214778	confirm
0.6421046589	roles
0.6419390958	lipids
0.6419090724	sodium
0.6418740309	org
0.6418556403	correlated
0.6418541084	mcp 1
0.6418197033	paw
0.6417851441	similar
0.6417518696	candesartan
0.6417213547	choline
0.6416883104	proteasome
0.6415818041	ca
0.6415608430	selenite
0.6415479297	p450 enzymes
0.6415460822	hepatotoxicity
0.6414553803	span
0.6413922367	rosuvastatin
0.6413868610	molecules
0.6413530121	exception
0.6413530121	access
0.6413530121	pigs
0.6413353997	vasoconstriction
0.6413353997	sample
0.6413010624	syndrome
0.6412830163	improve
0.6412535869	jnk
0.6412087939	prominent
0.6412087939	erythrocytes
0.6412087939	heme
0.6411926689	shmt
0.6410118991	glucuronide
0.6410001995	identification
0.6409977062	mibefradil
0.6409853360	resonance
0.6409579916	human breast
0.6409138491	cofactor
0.6408757738	dna
0.6408564872	beta end
0.6408065952	uterus
0.6408065952	medicinal
0.6408065952	electrophoretic
0.6407965035	injected
0.6407473607	adapalene
0.6407003547	omapatrilat
0.6406890568	amino
0.6406794438	fluid
0.6406777659	mobility
0.6406434686	weeks
0.6406280475	typical
0.6405811184	infusion
0.6404394042	intestine
0.6404054264	dopamine
0.6401926630	evaluation
0.6400525145	added
0.6400392410	supplementation
0.6400367264	hydroxyl
0.6400191747	demonstrates
0.6400180384	baseline
0.6400050197	losartan
0.6400017603	phosphatidylinositol
0.6398715787	findings
0.6398711863	stimulate
0.6398535869	sert
0.6398433849	organization
0.6398433849	detoxification
0.6398016698	2a13
0.6398016698	rectifier
0.6397803347	ocular
0.6397230520	strains
0.6397230520	osteoblast
0.6397230520	lysosomal
0.6396970883	hypertrophy
0.6396922339	free
0.6396883104	thrombin
0.6396508163	exchange
0.6395664980	bw
0.6395545141	disorders
0.6395522649	mglu2
0.6395180418	sb
0.6393609433	angiotensin
0.6392996872	healing
0.6391376437	largely
0.6391138055	forskolin
0.6391094472	ratios
0.6391000535	secretory
0.6390918914	receptor subtype
0.6390425474	complete
0.6390173499	3β
0.6390073656	infection
0.6389020278	impact
0.6389016661	fusion
0.6388975835	sources
0.6388528548	sympathetic
0.6388528548	extended
0.6388389149	mcl
0.6386964054	high level
0.6385930090	modify
0.6385703452	regulators
0.6384988646	gender
0.6384988646	sildenafil
0.6384988646	xenobiotic
0.6384988646	physiologic
0.6384988646	vesicular
0.6382300257	aminoglutethimide
0.6382300257	melamine
0.6382300257	testes
0.6382300257	transferrin
0.6382300257	reflex
0.6382300257	catalepsy
0.6382300257	methotrexate
0.6382280933	mol
0.6381590093	western
0.6380288482	pkc
0.6379750298	agents
0.6379462016	general
0.6379376437	prepared
0.6379102470	superior
0.6377794104	raw
0.6376739200	modulators
0.6376190698	gs
0.6376090735	evoked
0.6376035869	vegf
0.6375161537	cortisol
0.6375023367	soluble
0.6374950062	obtain
0.6374616000	pth
0.6374373046	mifepristone
0.6374294858	en
0.6374067734	proximal
0.6374015519	retinoid
0.6373922367	immunohistochemical
0.6373677251	metabolized
0.6373675836	controls
0.6373535869	gr
0.6373374040	targeting
0.6372391538	genotyping
0.6371238562	cp
0.6370345992	unlike
0.6369745566	group
0.6369489139	stable
0.6369468366	based
0.6368557116	challenge
0.6368389002	protocol
0.6368389002	intra
0.6368389002	suppressing
0.6368389002	profound
0.6368389002	indomethacin
0.6368389002	accelerated
0.6367860508	dynamics
0.6367521386	enhance
0.6366861854	exert
0.6366754766	making
0.6366541504	regulate
0.6366182578	enprofylline
0.6366182578	betaxolol
0.6366182578	routine
0.6365942402	5 ht3
0.6365525361	trastuzumab
0.6365524636	capacity
0.6364944362	cytoplasm
0.6364944362	frame
0.6364732773	il
0.6364565242	ppar alpha
0.6364267051	nad
0.6363225676	pharmacokinetic
0.6362973422	arteries
0.6361365449	detected
0.6360615536	harmaline
0.6360615536	allopregnanolone
0.6360615536	prednisone
0.6360615536	unfolding
0.6360414914	dpp 4
0.6360097304	op
0.6360083781	stimulus
0.6359890720	interestingly
0.6358961481	compounds
0.6358784214	minocycline
0.6355687667	sequential
0.6355040173	small cell lung cancer
0.6354743709	tpa
0.6354426449	cck
0.6353306173	chromosome
0.6353288431	significant
0.6353200920	hepg2
0.6352760394	heterozygous
0.6352760394	irreversible
0.6352633928	scavenger
0.6352535869	pr
0.6352487986	reversible
0.6352275749	active
0.6351162696	activated
0.6351123955	acetylcholinesterase
0.6351005804	maintain
0.6350999980	precursor
0.6350998594	pivotal
0.6350370077	n acetyl
0.6349341774	glomerular
0.6348348026	methamphetamine
0.6348238267	subsequent
0.6348084681	site directed
0.6347753401	mechanisms
0.6347686465	burst
0.6347081968	polyamine
0.6347034835	decarboxylase
0.6346689629	raft
0.6346478088	fsh
0.6346303382	sds
0.6346303382	esi
0.6346184045	smoke
0.6344608086	case control
0.6342544268	stage
0.6342163002	subsequently
0.6342023100	statins
0.6340307585	mdma
0.6339888649	signs
0.6339787183	direct
0.6339671296	curve
0.6339649178	interstitial
0.6338623265	adult
0.6338622928	significantly reduced
0.6338172807	level
0.6337963305	attention
0.6337734588	ponatinib
0.6337734588	glycolate
0.6337734588	folding
0.6337682581	low
0.6337650735	gh
0.6336810760	ne
0.6336680167	cc
0.6336089758	option
0.6335995567	spectra
0.6335739200	characterize
0.6335739200	finding
0.6335485253	similarly
0.6334732091	locomotor
0.6334649073	lavage
0.6334649073	cadherin
0.6334380000	selective beta
0.6333732821	uptake
0.6333276099	ifn
0.6333004629	acetate
0.6332537805	phenyl
0.6332437289	rats fed
0.6332066533	ischemic
0.6330603074	ltb
0.6330132050	cocaine
0.6329397654	alpha 1 adrenoceptor
0.6328911445	substituted
0.6328761705	iop
0.6328015434	hne
0.6327716493	plants
0.6327106112	liver
0.6326294219	sod
0.6325026685	glucagon like peptide 1
0.6324114274	antagonized
0.6323607774	hd
0.6323485832	neuroblastoma
0.6323208047	agonist
0.6322891575	interpretation
0.6322828752	published
0.6322828752	pathological
0.6322380284	leads
0.6321684420	renin
0.6321587260	working
0.6321551927	⁻
0.6320988099	model
0.6320826447	possibly
0.6320400989	protects
0.6320269320	amine
0.6320171302	agent
0.6319029072	efficient
0.6318556245	antibodies
0.6318016600	rasagiline
0.6317879736	phosphorylation
0.6317590945	300 microg kg
0.6317093254	lox
0.6316646982	nucleoside
0.6316528226	decreasing
0.6315947696	tcdd
0.6315475619	brain
0.6314229364	striatal
0.6313476513	dosing
0.6313337558	effectiveness
0.6313318114	tag
0.6312365223	ser
0.6311951079	glial
0.6311951079	progenitor
0.6311812233	promote
0.6311532523	ribonucleotide
0.6311527649	extracts
0.6309858800	significantly reduce
0.6309244416	optimal
0.6307938803	detect
0.6307938803	prolongation
0.6307837302	ass
0.6307534532	sr
0.6307472840	aqueous
0.6307472840	establish
0.6307388209	dendritic
0.6307388209	threonine
0.6307000729	confirmed
0.6306605378	participants
0.6305821674	severe
0.6305493419	degradation
0.6304894420	attached
0.6304717197	filtration
0.6304527649	delivery
0.6302998806	aims
0.6302418866	kcnq2
0.6301584818	replaced
0.6301497201	additionally
0.6301328900	keto
0.6301328900	rings
0.6300998766	setting
0.6300998766	selection
0.6299570247	reuptake inhibitor
0.6299389506	interleukin 6
0.6298591044	m2
0.6297522298	peroxide
0.6297522298	spontaneously
0.6297337558	pocket
0.6297108702	dha
0.6296604772	bonds
0.6296170892	chains
0.6295723652	caspase 9
0.6294981607	rheumatoid
0.6294835126	suppress
0.6294790411	healthy
0.6294714472	5 ht
0.6294702382	5 ht1
0.6294528772	equal
0.6294358844	endothelium
0.6294256464	consumption
0.6294229781	affected
0.6293791932	ic
0.6293466648	ornidazole
0.6293412548	nos
0.6291106505	3beta
0.6291106505	tubule
0.6290727751	stability
0.6290236877	rhs
0.6290235411	homologous
0.6289528337	stably expressing
0.6288410979	opioid
0.6287224688	ck
0.6287138884	beta2
0.6286959566	dopamine receptor
0.6286940504	uterine
0.6286722726	diastolic
0.6285232400	bmp 7
0.6284902293	approximately
0.6284468048	practice
0.6283833078	diuretics
0.6283833078	aggression
0.6283833078	lorcaserin
0.6283577277	channels
0.6283092770	antagonists
0.6282484417	chain
0.6281332551	ts
0.6281280244	mn
0.6281080791	high
0.6280888675	remodeling
0.6279977962	weak
0.6279514532	balb c mice
0.6279492871	apelin
0.6279161620	size
0.6278975380	stabilization
0.6278202524	creb
0.6277877387	cyp3a4
0.6277627268	adrenoceptor
0.6277214241	potent
0.6277021571	comparison
0.6276706103	hepatic
0.6276008027	inhibitors
0.6275373060	trna
0.6274790411	transcriptional
0.6274512584	tau
0.6272393129	proinflammatory
0.6272393129	plasticity
0.6272082508	acyl
0.6271360334	biochemical
0.6270927385	base
0.6270464853	cleavage
0.6269646454	glutamate receptor
0.6268402276	phe
0.6267879084	nc
0.6267396042	consecutive
0.6267275754	promotes
0.6266520783	results suggest
0.6265737893	obstructive
0.6265705272	disulfide
0.6265461274	significantly suppressed
0.6264697666	1alpha
0.6264697070	luciferase activity
0.6264027851	vx
0.6263929420	oh dpat
0.6263215088	hplc
0.6263019792	beta1
0.6262786482	egfr
0.6262048476	anti tumor
0.6261640503	reducing
0.6260334432	genome
0.6260194213	severity
0.6260194213	lipoxygenase
0.6260169255	target
0.6260076422	reactions
0.6259330894	candidates
0.6259330894	initiation
0.6259330894	vessels
0.6259161144	colorectal cancer cells
0.6258404540	closely
0.6258194373	cancer therapy
0.6258075951	density
0.6257796820	plp
0.6257429085	insight
0.6256920185	cl
0.6256116456	development
0.6255460312	de novo
0.6254559542	6 nc
0.6253335081	channel
0.6253149431	μg ml
0.6252794910	aim
0.6252276520	btx
0.6252276520	gsk
0.6251641814	selective
0.6250788647	values
0.6248564546	cox
0.6247141666	concentration dependent
0.6245508012	ct
0.6245142071	rate limiting
0.6245110542	recently reported
0.6243847597	drinking
0.6243229075	simple
0.6243229075	strand
0.6242722893	biologically
0.6242722893	measuring
0.6242714129	approved
0.6242078363	a549
0.6239964182	breast cancer cells
0.6239952087	mineralocorticoid
0.6239952087	attractive
0.6239749175	availability
0.6239552922	tyr
0.6239013658	suitable
0.6238941361	drug development
0.6238413523	aid
0.6238365660	c57bl
0.6235720518	phospho
0.6234957942	injury
0.6234443594	cancer
0.6233799850	ml
0.6233764975	d3
0.6233238899	study
0.6232931456	depressive
0.6232931456	undergoing
0.6232931456	constitutively
0.6231363121	sv
0.6230729734	inhalation
0.6230729734	polymers
0.6230729734	stereoselective
0.6230729734	anesthetized
0.6230729734	causative
0.6230729734	blockage
0.6230729734	hospital
0.6230729734	negligible
0.6230729734	pathophysiological
0.6230729734	prejunctional
0.6230729734	exemestane
0.6230729734	atosiban
0.6230729734	reconstitution
0.6230729734	hydroxyvitamin
0.6230729734	chemosensitivity
0.6230729734	fixed
0.6230729734	antibiotic
0.6230729734	polyplexes
0.6230729734	traffic
0.6230729734	organophosphate
0.6230729734	crude
0.6230729734	intercellular
0.6230729734	partner
0.6230729734	osteoarthritis
0.6230729734	toxicities
0.6230729734	configuration
0.6230729734	subchronic
0.6230729734	pesticide
0.6230729734	glucuronosyltransferase
0.6230729734	strictly
0.6230729734	haemodynamic
0.6230729734	quantitatively
0.6230729734	fetuses
0.6230729734	qualitative
0.6230729734	unfractionated
0.6230729734	phenylbutazone
0.6230685325	vii
0.6230387304	nr2b
0.6229653125	transmembrane
0.6228885814	injections
0.6228885814	traditional
0.6228273707	dorsal
0.6228114067	schizophrenia
0.6226665926	a1
0.6226343495	ventral
0.6226255396	apoe
0.6224910647	resistance
0.6224854435	investigate
0.6224259650	mediators
0.6223824758	antibody
0.6223558392	hydrolysis
0.6221488160	mixture
0.6221447318	platelets
0.6221447318	nicotine
0.6221414350	importantly
0.6221195580	braf
0.6220339934	ra
0.6220229918	bearing mice
0.6219428843	restricted
0.6219094179	copd
0.6218381407	micelles
0.6217038722	eye
0.6217006301	sirt1
0.6216851611	peptidase
0.6216851611	granules
0.6216256549	emission
0.6215658771	protecting
0.6215658771	requirement
0.6215634664	hcc
0.6215430349	omega
0.6215321310	sought
0.6214984821	hsd
0.6214923401	atra
0.6214574161	apo
0.6213858251	blocker
0.6213608938	pge2
0.6213364716	segment
0.6213343627	conversely
0.6213316469	related
0.6213151754	alteration
0.6212610285	cyp2d6
0.6211927789	cns
0.6211066443	rank
0.6210592823	stz
0.6210270677	ifenprodil
0.6210270677	piroxicam
0.6210270677	anthocyanidins
0.6210270677	dysregulation
0.6210270677	hepatitis
0.6210270677	ongoing
0.6210270677	employing
0.6210270677	flavonoids
0.6210270677	parkinsonian
0.6210270677	adding
0.6209343741	targets
0.6208373295	lower
0.6207919102	factor
0.6207141792	withdrawal
0.6206851627	prediction
0.6206600099	oocytes
0.6206477202	at1
0.6205594577	parent
0.6205507631	hepatocellular
0.6205507631	link
0.6205056554	g protein coupled
0.6204898064	alpha 2 adrenoceptor
0.6204873528	transfection
0.6204298795	axis
0.6204153702	coding
0.6203915792	cgp
0.6203493291	dat
0.6203332011	tiuxetan
0.6203034953	films
0.6202976462	measure
0.6202956923	brl
0.6202661939	bpa
0.6202592675	suppressor
0.6202592675	evidenced
0.6202544969	analogs
0.6201597755	nci
0.6201071806	data demonstrate
0.6200966347	hf
0.6199953358	alpha 2 adrenoceptors
0.6199881755	ga
0.6199821575	aged
0.6199696642	affecting
0.6199200309	dienogest
0.6199200309	copyright
0.6199200309	bisphenol
0.6199104761	fact
0.6199104761	magnitude
0.6198779244	rat
0.6198562201	transcription
0.6198373295	secretion
0.6198365660	g2
0.6198108512	surprisingly
0.6198024155	cyp
0.6198013392	inflammatory
0.6197953125	mutated
0.6197953125	safe
0.6197953125	hydrophobic
0.6197643923	extra
0.6197643923	spleen
0.6197643923	isomers
0.6197643923	classified
0.6197643923	cartilage
0.6197643923	glutamatergic
0.6197643923	physiology
0.6197643923	sensing
0.6197643923	maturation
0.6197153639	×
0.6196831625	circadian
0.6196799467	collectively
0.6196384208	metalloproteinase
0.6196051940	reverse transcription
0.6196040807	zn
0.6195616263	rar beta
0.6195523039	cb
0.6195518172	highly potent
0.6194451280	limiting
0.6193583110	transporting polypeptide
0.6193178731	tissue
0.6192206160	process
0.6191426235	cm
0.6191239252	panx1
0.6190900338	selectin
0.6190569205	selective antagonist
0.6190232510	saturation
0.6190232510	biodistribution
0.6190220405	pb
0.6189747874	contractions
0.6189370400	variants
0.6189293111	mtorc1
0.6189202502	employed
0.6188810990	defects
0.6188796219	lymphocytes
0.6188731108	max
0.6188722190	gnrh receptor
0.6187288266	synthase
0.6187074530	nsaids
0.6186952511	sgk1
0.6186539451	triphosphate
0.6186539451	anesthetics
0.6186472145	5 fu
0.6184712933	rankl
0.6184632308	shifted
0.6184632308	phenotypes
0.6184632308	transiently
0.6184632308	putrescine
0.6184632308	trend
0.6184632308	triggers
0.6184632308	gave
0.6184632308	telmisartan
0.6184632308	overcome
0.6184632308	3a4
0.6184632308	generating
0.6184632308	reversibly
0.6184632308	beginning
0.6184632308	reflect
0.6184632308	occupancy
0.6184632308	prognosis
0.6184632308	stronger
0.6184632308	molar
0.6184632308	attachment
0.6184632308	reached
0.6184632308	efficacious
0.6184632308	representing
0.6184632308	displays
0.6184632308	initiated
0.6184632308	morbidity
0.6184632308	phospholipids
0.6184632308	noradrenergic
0.6184632308	variable
0.6184632308	trafficking
0.6183949782	osteoblasts
0.6183939601	selegiline
0.6183923327	homozygous
0.6183923327	responsiveness
0.6183724438	putative
0.6183691336	proteasomal
0.6183691336	solubility
0.6183691336	hydroxycholesterol
0.6183498899	fraction
0.6183498733	reperfusion
0.6182978080	released
0.6182314385	interacting
0.6182033856	anaplastic
0.6180514578	toxicity
0.6180216736	alpha1
0.6179616449	chemicals
0.6179548896	prevalence
0.6179548896	consequences
0.6179515953	sdf
0.6179515953	kat
0.6179244074	cyp2e1
0.6177814385	virus
0.6177685196	ligands
0.6177356894	cyp3a
0.6176390616	glp
0.6176223632	positive
0.6175383259	recruitment
0.6174892508	promoter activity
0.6174272416	pmol
0.6174272416	immunoreactive
0.6174272416	quinone
0.6174099599	glycemic
0.6173979154	mr
0.6173931590	cholinergic
0.6173513096	coa
0.6173240838	atr
0.6172785487	insulin therapy
0.6172402582	addition
0.6172213244	invasion
0.6171699678	constitutive
0.6171699678	frequently
0.6171644258	corneal
0.6171526461	lysine
0.6171289338	conclusions
0.6170820256	elimination
0.6170634607	bs
0.6170306086	rats
0.6169598207	bap
0.6169576247	sensitizers
0.6169576247	limitations
0.6169370400	late
0.6168968965	hg
0.6167574919	ras
0.6167094379	cu
0.6167077355	chiral
0.6167077355	salts
0.6167077355	proton
0.6167077355	energies
0.6167077355	sibutramine
0.6166998116	l dopa
0.6166720889	menadione
0.6166649173	monkeys
0.6166096196	drug
0.6165175562	5 ht7
0.6164636888	small interfering
0.6164038528	calmodulin
0.6163816513	p2y12
0.6163559278	mrp2
0.6163124768	pyrene
0.6163124768	copolymers
0.6162879089	derivative
0.6162832789	gal
0.6162686661	japanese
0.6162254353	epa
0.6162126457	tests
0.6161925944	sk
0.6161925944	gmp
0.6161900532	words
0.6161760284	transactivation
0.6161760284	immunoreactivity
0.6161519944	qt
0.6160865090	rich
0.6160370364	dual
0.6160232510	almotriptan
0.6160232510	thirty
0.6160011265	flavonoid
0.6160011265	altering
0.6160011265	symptom
0.6160011265	subject
0.6160011265	schedule
0.6160011265	exclusively
0.6160011265	layers
0.6160011265	rodents
0.6160011265	superfamily
0.6160011265	defense
0.6160011265	paracrine
0.6160011265	obvious
0.6160011265	supports
0.6160011265	exists
0.6160011265	highlight
0.6160011265	undergo
0.6160011265	rescued
0.6160011265	evident
0.6160011265	noncompetitive
0.6160011265	micromolar
0.6160011265	vasodilation
0.6160011265	successfully
0.6160011265	psoriasis
0.6160011265	differed
0.6160011265	subcellular
0.6159443917	correlates
0.6159443917	achieve
0.6159045965	calcium
0.6158221718	attempt
0.6158142006	methyl
0.6158016975	aba3
0.6157573339	elements
0.6157447318	peptides
0.6157400498	cys
0.6157266988	la
0.6156622246	src
0.6156512088	fos
0.6155770175	chicks
0.6154886712	chemotherapy
0.6154878087	auc
0.6154526429	transferase
0.6154367811	reactivation
0.6154333818	users
0.6154333818	estrone
0.6154333818	antidiabetic
0.6154333818	luminal
0.6154333818	carboxylate
0.6154333818	cost
0.6154333818	retina
0.6154333818	recognized
0.6154333818	heparins
0.6154333818	lost
0.6154333818	encodes
0.6154127722	subset
0.6154081596	tt
0.6154047940	sgc
0.6154005448	hek293
0.6153683566	measurement
0.6153569331	asthma
0.6152984407	hl60
0.6152128653	glu
0.6151531974	vp
0.6150581296	herg
0.6150448875	osteocalcin
0.6149460572	sar
0.6149187153	bbb
0.6149021724	junction
0.6148546643	lh
0.6148212117	oatp1b1
0.6147978242	pelargonidin
0.6147978242	epidermis
0.6147978242	fenpropimorph
0.6147978242	gastrodin
0.6147978242	optimum
0.6147978242	phenothiazines
0.6147978242	progress
0.6147978242	glandular
0.6147978242	preeclampsia
0.6147655940	mcl 1
0.6147201983	chronic administration
0.6147151074	united
0.6146968922	resistant
0.6146802580	tumor
0.6146666389	ht
0.6146114370	h1
0.6146045193	progestins
0.6145686244	human
0.6145595142	bmi
0.6145552178	osteoclasts
0.6145552178	spermine
0.6145336902	trp
0.6145089436	mg
0.6144852941	min
0.6144434162	lyase
0.6144434162	score
0.6144434162	termed
0.6144434162	diffusion
0.6144434162	frequent
0.6144434162	delivered
0.6144434162	particulate
0.6144434162	intensity
0.6144434162	shape
0.6144434162	carrying
0.6144434162	oxidant
0.6144434162	pesticides
0.6144434162	hearts
0.6144434162	neurones
0.6144434162	1beta
0.6144434162	tubules
0.6144434162	sterol
0.6144343741	inhibiting
0.6143855656	edema
0.6142801033	ahr
0.6142743012	cyp1a2
0.6142743012	ccl4
0.6142675937	origin
0.6142675937	thrombosis
0.6142675937	hypoglycemia
0.6142675937	continued
0.6142675937	myosin
0.6142675937	seizure
0.6142675937	recovered
0.6142675937	orientation
0.6142675937	pregnant
0.6142675937	esters
0.6142675937	dimer
0.6142675937	cardiomyocytes
0.6142675937	reviewed
0.6142675937	steps
0.6142675937	dramatically
0.6142629966	flt3
0.6142015395	serotonergic
0.6141849602	risk
0.6141718456	sal
0.6140768221	prevents
0.6140201378	likewise
0.6139805102	ephrinb2
0.6139623569	nmol
0.6139214507	fragmentation
0.6138992953	ions
0.6138958863	atherosclerosis
0.6138446866	dentate
0.6138312146	p22
0.6137603730	bcrp
0.6137151074	iiia
0.6137057719	cpg
0.6136936656	cd4
0.6136653575	bnp
0.6136332855	seizures
0.6135920280	characteristics
0.6134960131	ar
0.6134911633	adhesion
0.6134026703	carboxylic
0.6133947088	synapses
0.6133947088	biliary
0.6133700126	relaxation
0.6133690381	cyp1a1
0.6133248749	positions
0.6133248749	histidine
0.6133248749	start
0.6133248749	∼
0.6133248749	carcinomas
0.6133019792	abcg2
0.6132979643	stat3
0.6132606150	sustained
0.6132389550	az
0.6131939815	mimicked
0.6131644243	mixtures
0.6131644243	monophosphate
0.6131425402	alleles
0.6131043236	apigenin
0.6131032642	bcl
0.6130820865	reduction
0.6130799359	expressions
0.6130781629	terminals
0.6130781629	≥
0.6130781629	label
0.6130410429	mpo
0.6130346290	rac1
0.6130168401	labeled
0.6129618945	preference
0.6129028209	potential
0.6128987180	nitroprusside
0.6128735466	constants
0.6128283030	affects
0.6127103210	explain
0.6127050482	deficiency
0.6126610910	induced pain
0.6126553024	studies demonstrate
0.6126146510	scn5a
0.6125917608	raas
0.6125656061	training
0.6125150908	gm
0.6124765281	close
0.6124700491	growth
0.6124455808	rat liver
0.6124343259	tk
0.6124343259	ltp
0.6124277246	left
0.6124007849	b1
0.6122980529	respond
0.6122980529	correlate
0.6122089581	directed
0.6122013658	pfc
0.6121930758	nf
0.6121485323	points
0.6121254615	tabun
0.6121254615	sham
0.6121254615	meloxicam
0.6121254615	particle
0.6121083428	analysed
0.6121083428	autocrine
0.6121083428	completed
0.6121083428	disrupting
0.6121083428	examining
0.6121083428	characterised
0.6121083428	stages
0.6121083428	displaying
0.6121083428	livers
0.6121083428	maintaining
0.6121083428	disrupts
0.6121083428	distributed
0.6121083428	constructed
0.6121083428	purine
0.6121083428	ternary
0.6121083428	analyze
0.6121083428	hydrogel
0.6121083428	formulations
0.6121083428	infiltration
0.6121083428	integrity
0.6121083428	proven
0.6121083428	lesion
0.6121083428	share
0.6121083428	essentially
0.6121083428	construct
0.6121083428	obstruction
0.6121083428	catabolism
0.6121083428	remarkable
0.6121083428	diagnosed
0.6121083428	neurotoxic
0.6121083428	verified
0.6121083428	abrogated
0.6121083428	depleted
0.6121083428	deposition
0.6121083428	insensitive
0.6121083428	behaviour
0.6121083428	validated
0.6121083428	excluded
0.6121083428	neurotransmission
0.6121083428	xenograft
0.6121083428	complexity
0.6121083428	myocytes
0.6121083428	intoxication
0.6121083428	accumulated
0.6121083428	count
0.6121083428	played
0.6121083428	knock
0.6121083428	flux
0.6121083428	neurotransmitters
0.6120995708	sperm
0.6120493865	number
0.6120443819	creatinine
0.6120127899	protect
0.6120060534	cardioprotective
0.6120060534	microglia
0.6120060534	alveolar
0.6120060534	atherosclerotic
0.6120060534	motility
0.6120060534	pools
0.6120060534	neoplastic
0.6120050392	glycosylated
0.6119365302	objectives
0.6118962561	homeostasis
0.6118744705	nac
0.6118723350	depressed
0.6118723350	polypeptides
0.6118723350	xenobiotics
0.6118723350	substituent
0.6118723350	temperatures
0.6118723350	17β
0.6118723350	predictive
0.6118723350	faster
0.6118723350	isozyme
0.6118691678	diabetic patients
0.6118670198	clinical studies
0.6118271145	synthesized and evaluated
0.6117509549	highly
0.6117370295	major
0.6117229814	significantly greater
0.6116699949	postnatal
0.6116045929	keratinocytes
0.6115568492	metastases
0.6115568492	senescence
0.6115568492	orthosteric
0.6115568492	nondiabetic
0.6115568492	cardiotoxicity
0.6115568492	avoidance
0.6115568492	minute
0.6115347050	5alpha
0.6115347050	stiffness
0.6115162407	gtp
0.6115107517	overexpressed
0.6115066036	g csf
0.6114880988	modulate
0.6114876959	flibanserin
0.6114618194	hour
0.6114560638	bay
0.6114104101	proteins
0.6113568921	bax
0.6112139086	intracellular ca
0.6111971093	6 nitrotryptophan
0.6111795281	pc
0.6111298379	mediating
0.6111298379	triggered
0.6111120537	ix
0.6110835488	octn2
0.6110774381	nps
0.6110274805	gyrus
0.6110274805	©
0.6110274805	occurrence
0.6110274805	believed
0.6109565594	oatp
0.6109514022	aspartate
0.6108986823	corticosterone
0.6108666873	nacl
0.6108327242	ablp
0.6108327242	meth
0.6108046697	included
0.6107636778	analogue
0.6107553235	polycyclic
0.6106989272	dependent protein kinase
0.6106676289	amounts
0.6106594378	avp
0.6106407376	assigned
0.6106116362	mc
0.6106050219	ss
0.6105891959	nucleotides
0.6105672989	selective inhibitors
0.6105613178	cases
0.6105048889	neurotensin
0.6104322545	myc
0.6104254399	hr
0.6104214375	localized
0.6103435794	metabolizing
0.6103330324	shift
0.6103231172	mdr
0.6102465625	fibroblast
0.6101972236	homa
0.6101924642	transmission
0.6101652330	contractile
0.6101560032	pde4
0.6101091179	family
0.6101060873	purified
0.6100869222	mt
0.6100488701	internalization
0.6100488701	infected
0.6100488701	apical
0.6100189302	oxide
0.6100183458	proliferation and differentiation
0.6099582948	extracted
0.6099582948	stably
0.6099577633	~
0.6099572467	exenatide
0.6099345451	children
0.6099286728	roflumilast
0.6099286728	fibrinogen
0.6099286728	ozone
0.6099286728	thalidomide
0.6098700126	marker
0.6098072144	metastasis
0.6097805362	enzymes
0.6096722093	differ
0.6096627586	tract
0.6096437704	hydrochloride
0.6096436837	commonly
0.6096302791	cdk2
0.6096267947	expected
0.6096038408	larger
0.6096038408	require
0.6095927927	insights
0.6095920875	goal
0.6095920875	explained
0.6095920875	coli
0.6095920875	hypertensive
0.6095608852	neurodegenerative
0.6095083665	epr
0.6093983993	adults
0.6093890732	paper
0.6093676084	v2
0.6093676084	a3
0.6093622539	nanomolar
0.6093197507	alter
0.6092449773	increased
0.6092276095	fviii
0.6092125065	separation
0.6092125065	deprivation
0.6092125065	contents
0.6092125065	recorded
0.6091944720	clinically
0.6091716202	organ
0.6091648753	point
0.6091527583	gated
0.6091401207	acting
0.6090837951	amino acid transporter
0.6090515247	final
0.6090265846	microtubule
0.6090094694	observations
0.6089905621	ht2c
0.6089372412	develop
0.6088987180	heparan
0.6088913333	understand
0.6088811790	relationships
0.6088552729	donor
0.6088430707	situ
0.6088278842	predominant
0.6088246741	include
0.6087801467	disease
0.6087709263	ligand
0.6087670984	preparations
0.6087670984	influx
0.6087638260	tubulin
0.6087534377	14c
0.6087534377	mv
0.6087527880	2r
0.6087478953	tp
0.6086616839	pk
0.6086231046	regions
0.6086094982	oatp1b3
0.6086018353	mthfr
0.6085497944	ala
0.6085441082	secreted
0.6085441082	zebrafish
0.6085300728	activates
0.6085300728	maximum
0.6085300728	permeability
0.6085150460	recognition
0.6084720559	independently
0.6084530014	salmeterol
0.6084473762	subtype
0.6084365203	µg
0.6084100683	5 ht1d
0.6083856284	variant
0.6083645699	catechol
0.6083645699	chimeric
0.6083645699	leukocytes
0.6083645699	citrulline
0.6083645699	loading
0.6083495544	understood
0.6083489331	shr
0.6083489331	rpe
0.6083427805	improvement
0.6083322683	heat
0.6083072070	tg
0.6083054403	tsh
0.6083054403	parp
0.6082904800	bm
0.6082572103	sp
0.6082554223	nm
0.6082433715	d galn
0.6082424281	synaptic
0.6082384155	mice
0.6082265996	significant increases
0.6082140681	turnover
0.6082140681	estrogenic
0.6082072629	leu
0.6081979841	3t3
0.6081979841	learning
0.6081452330	limit
0.6081452330	adduct
0.6081452330	potencies
0.6081452330	transformation
0.6081189418	phosphorylated
0.6079835319	finally
0.6079653617	t1
0.6079187259	null
0.6078989350	frequency
0.6078913205	cytosolic
0.6078896713	open
0.6078432226	clone
0.6078397849	activators
0.6078076463	kinase
0.6077807347	diverse
0.6077077446	hormonal
0.6077077446	triglyceride
0.6077077446	organs
0.6077077446	presynaptic
0.6077077446	carcinogenesis
0.6077077446	behavioural
0.6077077446	attenuate
0.6077077446	invasive
0.6077077446	allowed
0.6077077446	rodent
0.6077077446	reveals
0.6076129217	mglu
0.6075217127	disruption
0.6074897664	ppargamma
0.6074474413	nis
0.6074474413	tca
0.6074148148	involved
0.6074108034	nrf2
0.6074008208	hydrogen
0.6073995087	h9c2
0.6073843250	depletion
0.6073807347	dosage
0.6073786396	depolarization
0.6073601938	atc
0.6073119141	fda
0.6072730225	mucosa
0.6072379209	source
0.6072152537	dehydrogenase
0.6072114655	rp1
0.6071972311	higher concentrations
0.6071792109	bc
0.6071351154	ia
0.6071351154	dma
0.6070475682	units
0.6070230948	defect
0.6070230948	recurrence
0.6070230948	probes
0.6070230948	representative
0.6070057178	vmax
0.6070019004	families
0.6069764006	cancer cells
0.6069578455	onoo
0.6069578455	ld
0.6068933468	subtypes
0.6068565754	assays
0.6068460290	monocyte
0.6067558703	125i
0.6067063899	abstract truncated at
0.6066910121	cb1
0.6066910121	th2
0.6066910121	pkmζ
0.6066794944	decreased
0.6066261887	lymphoma
0.6066147005	antipsychotics
0.6064720694	considered
0.6064330014	tubular
0.6064330014	month
0.6063860435	search
0.6063860435	issue
0.6063748051	crh
0.6063440098	pte
0.6063338318	gad
0.6062895452	techniques
0.6062895452	malignancies
0.6062895452	randomly
0.6062895452	choice
0.6062895452	refractory
0.6062895452	dogs
0.6062740522	pd
0.6062545951	dhpg
0.6061470224	reuptake
0.6061219374	binding proteins
0.6059925461	islets
0.6059925461	amplitude
0.6059741258	proved
0.6059720333	grade
0.6059720333	conductance
0.6059450477	anp
0.6058568179	clamp
0.6058242934	tolerated
0.6057868017	ncam
0.6057768651	localization
0.6057672366	ugt
0.6057473703	incidence
0.6057310262	tricyclic
0.6057310262	susceptible
0.6056812445	pain
0.6056085308	releasing
0.6055896440	alt
0.6055896440	ldh
0.6055715318	inhibition
0.6055705549	enriched
0.6055705549	condition
0.6055705549	aggregates
0.6055705549	utilized
0.6055705549	downregulated
0.6055705549	readily
0.6055705549	absent
0.6055705549	binary
0.6055705549	suspected
0.6055705549	substances
0.6055705549	removed
0.6055705549	acutely
0.6055705549	threshold
0.6055705549	toxins
0.6055705549	phospholipid
0.6055705549	efforts
0.6055705549	moieties
0.6055705549	concept
0.6055705549	constituents
0.6055691423	green
0.6055432811	impdh
0.6055350278	ir
0.6055241082	tumour
0.6055241082	providing
0.6055241082	possesses
0.6055241082	interesting
0.6055241082	average
0.6055241082	differentially
0.6054993020	incorporation
0.6054919561	ova
0.6054470712	composition
0.6054068157	vdr
0.6054068157	mf
0.6053726253	dex
0.6053422670	markedly increased
0.6053277485	divided
0.6053272682	electron
0.6053158409	cd
0.6052944855	oa
0.6052064806	agt
0.6052028776	modulated
0.6052022556	patients
0.6050543278	chloride
0.6050092614	val
0.6049967699	bp
0.6049876900	benefits
0.6049876900	aorta
0.6049770064	early
0.6049445579	g gap
0.6048511805	gst
0.6048234674	mcf 7 cells
0.6047881757	ip
0.6047622855	injection
0.6046889472	lfa 1
0.6046608348	vitamin k dependent
0.6046237235	hfd
0.6046168523	ring
0.6045385731	malignant
0.6045149387	forming
0.6045149387	charged
0.6045149387	populations
0.6045149387	varying
0.6045149387	sensory
0.6045149387	simulations
0.6045149387	pronounced
0.6045149387	changed
0.6045149387	preparation
0.6045149387	symptomatic
0.6044925182	quality
0.6044895511	sirtuin
0.6044895511	commercial
0.6044895511	acidification
0.6044895511	partners
0.6044895511	monohydroxytamoxifen
0.6044895511	tumours
0.6044895511	esterified
0.6044895511	capsaicin
0.6044895511	rabbits
0.6044895511	inside
0.6044895511	tagged
0.6044895511	inducers
0.6044895511	alkaloids
0.6044092979	malondialdehyde
0.6044054068	pla
0.6042914430	iso
0.6042878046	foci
0.6042732200	set
0.6042560840	transfected
0.6042334362	arrest
0.6041819958	ecto
0.6041819958	stalk
0.6041576267	nicotinic
0.6041508968	producing
0.6041416662	regimens
0.6040851054	membranes
0.6040480976	pig
0.6039638159	alpha2
0.6039638159	experienced
0.6039638159	sensor
0.6039638159	problem
0.6039638159	tightly
0.6039638159	reconstituted
0.6039638159	severely
0.6039638159	absolute
0.6039638159	oxo
0.6039638159	hyperlipidemia
0.6039638159	similarity
0.6039638159	lineage
0.6039638159	reproductive
0.6039638159	integrin
0.6039638159	placenta
0.6039638159	erlotinib
0.6039638159	contractility
0.6039638159	prothrombin
0.6039638159	substantially
0.6039638159	unrelated
0.6039638159	underlie
0.6039638159	challenged
0.6039638159	clarithromycin
0.6039638159	paradigm
0.6039638159	slowed
0.6039638159	hydrogels
0.6039638159	tumorigenesis
0.6039638159	effector
0.6039638159	crossover
0.6039638159	revealing
0.6039638159	designated
0.6039638159	preserved
0.6039638159	existing
0.6039638159	formulation
0.6039638159	irreversibly
0.6039638159	separated
0.6039638159	parasite
0.6039638159	ameliorated
0.6039638159	medications
0.6039638159	correct
0.6039638159	copolymer
0.6039638159	recordings
0.6039638159	weaker
0.6039638159	biphasic
0.6039638159	presents
0.6039638159	constitute
0.6039638159	leaves
0.6039638159	polyphenols
0.6039638159	undergoes
0.6039638159	confers
0.6039638159	advantage
0.6039638159	recruited
0.6039638159	studying
0.6037850771	sc
0.6037620055	smad
0.6037620055	kvlqt1
0.6037299188	bind
0.6037165228	gabapentin
0.6037054343	pg
0.6036995282	supplemented
0.6036886870	rat model
0.6036796343	bche
0.6036770064	ecstasy
0.6036577880	h3
0.6036556888	volunteers
0.6036226765	5ht
0.6036056450	bok
0.6035908929	pm
0.6035846462	tbi
0.6035807740	identify
0.6035416279	rxr
0.6035416279	vta
0.6035399625	aminotransferase
0.6035394751	crystallography
0.6035394751	polyethylene
0.6035374562	signaling
0.6034868298	mmol
0.6034135914	cycle
0.6033932805	substrates
0.6033723106	improved
0.6033378898	mediates
0.6032848221	distant
0.6032841993	focused
0.6032622033	incorporated
0.6032622033	anions
0.6032622033	valuable
0.6032622033	discovered
0.6032622033	dimeric
0.6032622033	apixaban
0.6032622033	elicit
0.6032622033	converted
0.6032622033	transcript
0.6032622033	indirectly
0.6032622033	sections
0.6032622033	assayed
0.6032482988	d4
0.6031970317	selectivity
0.6031904563	scc
0.6031904563	ch
0.6031900911	tlr4
0.6031520966	candidate
0.6031462722	varied
0.6031462722	minimal
0.6031462722	interface
0.6031462722	genotoxic
0.6031462722	yield
0.6031462722	discuss
0.6031462722	alkaloid
0.6031462722	documented
0.6031462722	place
0.6031462722	associations
0.6031462722	slowly
0.6031462722	immunosuppressive
0.6031462722	quantified
0.6031462722	chemically
0.6031462722	acquired
0.6031462722	involve
0.6031274760	efficiency
0.6031248083	produce
0.6030052015	htr
0.6030052015	bmd
0.6029499751	ppi
0.6029499751	nsclc
0.6028776859	ketoconazole
0.6028240388	tumors
0.6028132195	carcinoma
0.6027718141	reversed
0.6027564542	degrees
0.6026682654	aggrecan
0.6026682654	trigger
0.6026682654	glucosidase
0.6026682654	vasodilator
0.6026682654	cyclophosphamide
0.6026682654	promise
0.6026682654	investigating
0.6026682654	blunted
0.6026682654	vasculature
0.6026682654	reductases
0.6026682654	protocols
0.6026682654	epileptic
0.6026682654	dermal
0.6026682654	corticosteroid
0.6026682654	exploited
0.6026682654	pancreas
0.6026682654	autoreceptor
0.6026682654	dihydroxy
0.6026682654	monotherapy
0.6026682654	subjective
0.6026682654	chaperone
0.6026682654	dihydropyridine
0.6026682654	compartments
0.6026682654	larvae
0.6026682654	cytosine
0.6026682654	transformed
0.6026682654	biologic
0.6026682654	repolarization
0.6026682654	nilotinib
0.6026682654	antioxidants
0.6026682654	spots
0.6026682654	proapoptotic
0.6026682654	proteomics
0.6026682654	immobilized
0.6026682654	enable
0.6026682654	ketanserin
0.6026682654	options
0.6026682654	address
0.6026682654	conscious
0.6026682654	cleaved
0.6026682654	antiinflammatory
0.6026682654	synaptosomes
0.6026682654	epithelia
0.6026682654	electrode
0.6026682654	contributed
0.6026682654	ibuprofen
0.6026682654	oestrogen
0.6026682654	tonic
0.6026682654	excitotoxicity
0.6026682654	slower
0.6026682654	systematically
0.6026682654	clarified
0.6026682654	outer
0.6026682654	implying
0.6026682654	evaluating
0.6026682654	stabilizing
0.6026682654	proportional
0.6026411618	appeared
0.6026119454	element
0.6025998344	developing
0.6025704568	ptz
0.6024917658	gap
0.6024130128	assay
0.6023075265	gland
0.6023043326	fragments
0.6023043326	isozymes
0.6023043326	yielded
0.6023043326	equivalent
0.6023043326	numbers
0.6023043326	monitored
0.6023043326	networks
0.6022853472	jak2
0.6022841234	sch
0.6022311897	toxin
0.6021898223	lv
0.6021846991	pe
0.6021846991	elisa
0.6021797473	standard
0.6021662391	psa
0.6021451907	drug metabolizing
0.6020746157	clc
0.6020598886	fa
0.6020201284	apparent
0.6019703877	microscopy
0.6019608427	combinations
0.6019391519	ara
0.6019289678	acs4
0.6019169025	significantly increased
0.6018725060	abt
0.6018307742	zns
0.6018278842	chromaffin
0.6018243821	erk
0.6018066355	range
0.6017537356	androgenic
0.6016717147	central role
0.6016581788	24h
0.6016581788	offer
0.6016581788	makes
0.6016581788	modest
0.6016581788	allowing
0.6016581788	firing
0.6016581788	xenografts
0.6016581788	inactivated
0.6016581788	called
0.6016581788	extensively
0.6016581788	determining
0.6016581788	behaviors
0.6016276456	≤
0.6015303482	iodo
0.6014261056	atm
0.6014129364	glyoxylate
0.6014129364	bolus
0.6014055320	contraction
0.6013289494	molecule
0.6012914099	clones
0.6012749956	unaffected
0.6012696000	unknown
0.6011740976	human skin
0.6011647100	rho
0.6011647100	gw572016
0.6011647100	su11248
0.6011352441	maps
0.6011075817	facilitate
0.6011075817	ceramide
0.6011075817	substituents
0.6010916326	occur
0.6010297396	statistically
0.6009746287	slope
0.6009227008	changing
0.6009227008	thickness
0.6009227008	syndromes
0.6009227008	meal
0.6009227008	warranted
0.6009227008	preferred
0.6009227008	question
0.6009227008	easily
0.6009227008	catalyze
0.6009227008	modes
0.6009227008	cytoskeleton
0.6009227008	fewer
0.6009227008	adjustment
0.6009227008	describes
0.6009227008	overexpress
0.6009227008	observation
0.6009227008	moderately
0.6009227008	cations
0.6009227008	power
0.6009227008	optimized
0.6009227008	switch
0.6009227008	accurate
0.6009227008	mucosal
0.6009227008	neuroprotection
0.6009227008	improving
0.6009227008	facilitated
0.6009227008	operated
0.6009227008	dimers
0.6009227008	spectroscopic
0.6009227008	comprised
0.6009227008	neurodegeneration
0.6009227008	effort
0.6009227008	episodes
0.6009227008	deleterious
0.6009227008	synergistically
0.6009227008	receive
0.6009227008	carcinogens
0.6009227008	acetylation
0.6009227008	sheep
0.6009227008	fit
0.6009227008	distance
0.6009227008	anticoagulant
0.6009227008	correlations
0.6009227008	phenomenon
0.6009227008	confer
0.6009227008	potentiate
0.6009227008	acquisition
0.6009227008	ubiquitous
0.6009227008	contributions
0.6009096855	colon
0.6008876841	overexpression
0.6008669955	μm
0.6008661187	μg kg
0.6007832784	galactose
0.6007832784	infused
0.6007745257	erα
0.6007329058	hypothalamus
0.6005917658	means
0.6005540593	induced apoptosis
0.6005258208	mellitus
0.6005192630	cla
0.6004767538	b12
0.6004597098	pma
0.6004324285	biosynthesis
0.6004186771	mononuclear
0.6004181976	studies suggest
0.6004029876	medium
0.6004008656	analysis
0.6003042016	greater
0.6002884301	anion
0.6002594929	ed
0.6002414492	specificity
0.6002413132	shock
0.6001798359	2b6
0.6001798359	detergent
0.6001798359	placental
0.6001798359	kynurenine
0.6001798359	dimerization
0.6001798359	lens
0.6001798359	implantation
0.6001798359	pyrazole
0.6001798359	regional
0.6001798359	fatal
0.6001798359	epsilon
0.6001584821	fully
0.6001172729	carnitine transport
0.6001085778	occurring
0.6001043253	b6
0.6000835847	bsa
0.6000540908	m1
0.6000463064	agonists and antagonists
0.6000402405	pca
0.5999885045	mitochondria
0.5999759725	display
0.5999536321	gc
0.5999522026	change
0.5999260613	detection
0.5998842668	pbmc
0.5998534902	epidermal
0.5998168392	cgmp
0.5997311897	barrier
0.5997297292	inhibit
0.5997239920	microsomes
0.5996351453	acs1
0.5996351453	du145
0.5996351453	schild
0.5996351453	nr2a
0.5996351453	cxcl8
0.5996351453	ac3174
0.5996179404	dht
0.5995615993	lp
0.5995519034	modulator
0.5995500781	niddm
0.5995500781	ftidc
0.5995324397	lsd
0.5994946949	extent
0.5994904112	clozapine
0.5994752641	receptors
0.5994039723	importance
0.5993664057	detectable
0.5993303538	pghs
0.5993046083	binding
0.5992584967	s100a4
0.5992584967	asct2
0.5992152122	doi
0.5991961669	deacetylase
0.5991314617	gpx1
0.5990745438	linked
0.5990661963	reuptake inhibitors
0.5990352032	interval
0.5990317506	enhancement
0.5988750769	million
0.5988750769	lactose
0.5988660678	results
0.5988642458	disorder
0.5988580925	knockdown
0.5987812918	tm
0.5987758302	sites
0.5986617648	pparγ
0.5986605155	fluoride
0.5986193576	ache
0.5985902599	proportion
0.5985708416	pa
0.5985336126	dif 3
0.5984500810	completely
0.5983935122	sensitive
0.5983690362	dog
0.5983379812	signal regulated kinase
0.5982708443	fshr
0.5981484394	nash
0.5981292341	suppressed
0.5980979451	24r
0.5980979451	phytochemicals
0.5980979451	virtual
0.5980979451	fungal
0.5980979451	glycoproteins
0.5980979451	recipients
0.5980979451	competitively
0.5980979451	donors
0.5980979451	cerebellum
0.5980979451	oxime
0.5980979451	oximes
0.5980979451	resolved
0.5980979451	loaded
0.5980979451	xct
0.5980979451	pool
0.5980979451	template
0.5980979451	pressor
0.5980979451	counterparts
0.5980979451	potentiates
0.5980979451	dihydro
0.5980979451	diameter
0.5980552373	treatment
0.5980106379	aldh2
0.5979915925	1α
0.5979763122	agreement
0.5979214452	broad
0.5978722768	fold greater
0.5978349804	regulator
0.5977300719	dimensional
0.5977050297	c1
0.5976650681	ach
0.5976335235	ba
0.5976187567	1b
0.5976149841	difficult
0.5976004639	emt
0.5975798569	leukemia
0.5975706075	order
0.5975653380	cox 1
0.5975614345	sd
0.5974728617	kd
0.5974397633	2s
0.5974274072	infarct
0.5974219184	culture medium
0.5973906042	oxidoreductase
0.5973906042	augmented
0.5973906042	considerably
0.5973906042	potentiated
0.5973906042	includes
0.5973906042	unchanged
0.5973906042	introduced
0.5973906042	greatly
0.5973906042	stimulates
0.5973856613	adh
0.5972949667	specific
0.5972873221	months
0.5972384793	gtk
0.5972384793	tss
0.5972384793	gdh
0.5972349074	lacking
0.5972026660	oat3
0.5972009595	decreases
0.5971501018	incubated
0.5971181314	activator
0.5969641874	promoted
0.5969641874	library
0.5969641874	define
0.5969641874	partly
0.5969641874	lowered
0.5969641874	calculated
0.5969324619	influence
0.5968907091	17 aag
0.5968786696	epo
0.5968697780	migration
0.5968282041	phosphatase
0.5968156262	discovery
0.5967037188	free survival
0.5966721700	nhe3
0.5966682200	ht2a
0.5965932229	gra
0.5965932229	fv
0.5965616619	bid
0.5965159866	cyclin
0.5964999714	abolished
0.5964486998	hours
0.5963285811	acs
0.5963168885	hydroxyphenyl
0.5963110542	modulation
0.5962752472	pretreated
0.5962126841	derived
0.5962087636	prevent
0.5961899817	human ether
0.5961866303	reaction
0.5961706967	hlm
0.5961683137	ovary
0.5960837513	cxcr7
0.5959586023	kappa
0.5959245648	tsa
0.5959124511	essential
0.5958541390	vegfr
0.5958381060	suppression
0.5958214290	susceptibility
0.5957487993	nqo1
0.5957031565	1β
0.5956858488	depend
0.5956837255	pet
0.5956689053	ho
0.5954934591	blockade
0.5953776399	cec
0.5953507295	racemase
0.5953505298	hamster
0.5952435071	hql
0.5952435071	kw
0.5952435071	page
0.5952282752	encoding
0.5952114178	gyki
0.5952003997	dehp
0.5952003997	tzd
0.5952003997	nsaid
0.5952003997	hsya
0.5951680766	relationship
0.5951346706	para
0.5951034777	gcs
0.5950577971	regulates
0.5949998428	pdgfr
0.5949840086	i1
0.5949709060	prostaglandin
0.5948618281	par4
0.5948618281	iks
0.5948618281	mrp1
0.5948618281	thr
0.5948552069	torpor
0.5948552069	butyl
0.5948202380	gip
0.5948202380	cml
0.5948104169	cort
0.5948091101	ide
0.5947307244	elucidate
0.5947307244	cyclase
0.5947150161	fibrosis
0.5946918836	perfused
0.5946918836	yields
0.5946918836	anionic
0.5946918836	adipogenesis
0.5946918836	hik1
0.5946918836	stretch
0.5946918836	17beta
0.5946918836	α2
0.5946918836	periods
0.5946918836	delay
0.5946918836	started
0.5946918836	melanocytes
0.5946918836	epoxide
0.5946918836	erythroid
0.5946918836	antibacterial
0.5946918836	ovine
0.5946918836	stabilized
0.5946918836	functioning
0.5946918836	transported
0.5946462716	downregulation
0.5945817426	nnos
0.5945367573	pdgf
0.5944397363	μg
0.5944156355	located
0.5944124946	rt
0.5942810484	chk1
0.5942417784	ethyl
0.5942091962	acts
0.5941873597	present
0.5941810230	excretion
0.5941226267	tgf
0.5940952294	additive
0.5940876711	p38
0.5940487805	cx43
0.5940324343	tgif
0.5939998428	bph
0.5939851567	mutant
0.5939592126	danazol
0.5939592126	international
0.5939100954	oatp2b1
0.5939100954	ly117018
0.5939100954	ephb4
0.5939100954	stat1
0.5938396382	supported
0.5938392248	cy
0.5938068024	pulmonary
0.5937881936	wky
0.5937881936	bal
0.5937881936	sm
0.5937881936	cpf
0.5937843616	cgrp
0.5937015429	turn
0.5936984954	edl
0.5936984954	ot
0.5936906123	spr
0.5936452319	potency
0.5936340945	ikk
0.5936098130	synthetase
0.5935888248	sensitizing
0.5935888248	entire
0.5935888248	improvements
0.5935734799	gp
0.5935199670	lags
0.5935043227	regulating
0.5934434731	preferentially
0.5934434731	cytosol
0.5934252204	peg
0.5933156355	myocardial
0.5933048214	higher
0.5932904583	pvn
0.5932802727	cows
0.5932802727	h5
0.5932202163	mug
0.5932202163	bridges
0.5932202163	mum
0.5932202163	metabolically
0.5932202163	eyes
0.5932202163	cardiolipin
0.5932080710	aprt
0.5932062301	akr1c1
0.5931047005	tail
0.5930708634	pf
0.5930628399	pcl
0.5930628399	iu
0.5930137801	interfering
0.5929509915	ep
0.5929243442	odc
0.5928315955	comt
0.5928204063	chromatography
0.5927000598	interact
0.5926740340	needed
0.5925678547	macrophages
0.5925592459	cotransporter
0.5925525778	hsc
0.5922963518	cellular
0.5922309612	adr
0.5921864961	cre
0.5921620471	stem
0.5921048217	colorectal
0.5920651362	primary cultures
0.5920169684	cddp
0.5918972186	sun
0.5918571142	occurred
0.5918571142	applied
0.5918391014	blocked
0.5918110935	fe
0.5917421641	gating
0.5916411786	humans
0.5915438745	spacrcan
0.5915438745	ain
0.5914116703	exerted
0.5914116703	laboratory
0.5914116703	blocks
0.5914116703	smaller
0.5912988347	tf
0.5912247838	influenced
0.5911811112	oat1
0.5911760052	ea
0.5911760052	ac
0.5911180257	background
0.5910678547	complexes
0.5909854045	m3
0.5909605462	conserved
0.5909194450	wild type mice
0.5908221737	p50
0.5908062596	artery
0.5907954720	lungs
0.5907954720	occlusion
0.5907954720	roots
0.5907479395	play
0.5906876303	ligand dependent
0.5906393356	types
0.5906382312	exposed
0.5906215798	body
0.5905405795	anticancer
0.5904736149	snail
0.5904597878	dye
0.5904319281	coa reductase
0.5904302785	reinforcing
0.5902969964	modification
0.5902514283	ubr2
0.5902514283	igf2r
0.5902461043	gpx
0.5902084910	tlr7
0.5901722110	4β
0.5901722110	cdnas
0.5901722110	nitrosative
0.5901722110	follicles
0.5901722110	naïve
0.5901722110	reactivity
0.5901722110	amines
0.5901722110	degrading
0.5901722110	mineralization
0.5901722110	myocardium
0.5901722110	osteogenic
0.5901722110	hyperglycaemia
0.5901722110	gavage
0.5901722110	pathologies
0.5901722110	inherited
0.5901722110	oligomerization
0.5901722110	bradykinin
0.5901722110	hemodynamic
0.5901722110	backbone
0.5901722110	impair
0.5901722110	granulosa
0.5901722110	augments
0.5901722110	polyunsaturated
0.5901722110	dioxin
0.5901722110	utilization
0.5901722110	determines
0.5901722110	antiapoptotic
0.5901722110	insertion
0.5901722110	phosphoribosyltransferase
0.5901722110	specificities
0.5901722110	possessing
0.5901722110	chemotactic
0.5901722110	deamination
0.5901722110	methylated
0.5901722110	largest
0.5901722110	undertaken
0.5901722110	capability
0.5901722110	thioridazine
0.5901722110	acceptor
0.5901722110	motifs
0.5901722110	supply
0.5901722110	genotyped
0.5901722110	takes
0.5901722110	viable
0.5901722110	returned
0.5901722110	inducer
0.5901722110	originally
0.5901722110	appetite
0.5901722110	closed
0.5901722110	dosed
0.5901722110	pan
0.5901722110	abilities
0.5901722110	randomised
0.5901722110	cyclosporin
0.5901722110	prove
0.5901722110	challenges
0.5901722110	neurotoxin
0.5901722110	heterogeneity
0.5901722110	adolescents
0.5901722110	extend
0.5901722110	compromised
0.5901722110	postulated
0.5901722110	rewarding
0.5901722110	detecting
0.5901657176	diabetic
0.5901585711	position
0.5901554353	experimental results
0.5901419317	action
0.5901271679	erosion
0.5900826912	placebo
0.5900806426	classes
0.5900422597	prolidase
0.5900422597	subfamily
0.5899752509	net
0.5899083258	±
0.5899014691	mglu5
0.5898464860	3h
0.5897916833	enos
0.5897808325	characterized
0.5896890882	damage
0.5896866253	stimulation
0.5896826777	dependence
0.5896517548	erk1
0.5896426839	enhances
0.5895965250	energy
0.5895706969	gssg
0.5895337945	liraglutide
0.5895337945	osteoclastogenesis
0.5895337945	muscles
0.5895337945	thio
0.5895337945	angiogenic
0.5895337945	sulpiride
0.5895337945	bivalirudin
0.5895269921	xc
0.5894617862	remains
0.5893743380	bound
0.5893403503	caco 2
0.5893388248	lesser
0.5893337477	k1
0.5893258645	br
0.5893254638	b5
0.5892131423	administered
0.5891118063	galn
0.5890933199	monoamine
0.5890931755	adrenoceptors
0.5890854737	kir6
0.5890852853	neurons
0.5888284489	explore
0.5888281113	modified
0.5888209894	fed
0.5887775837	content
0.5887734745	efflux
0.5887581627	1s
0.5887479437	smad4
0.5886514825	mas
0.5886092475	uc
0.5886092475	dm
0.5886092475	mptp
0.5885877529	iib
0.5884867358	aii
0.5884856424	attenuated
0.5884474511	fc
0.5884446603	p65
0.5884334584	tomudex
0.5884136476	strong
0.5883794378	terfenadine
0.5883794378	gliclazide
0.5883794378	liposomal
0.5883794378	mesencephalic
0.5883794378	inflammasome
0.5883794378	sets
0.5883683918	dox
0.5883657896	aβ
0.5883477293	glycoprotein
0.5883340814	h4
0.5882897116	ae
0.5882817156	t2dm
0.5882774752	ps
0.5882515707	activation
0.5881943803	prefrontal
0.5881900830	mpa
0.5881786601	ed50
0.5881490998	translocation
0.5881440512	type
0.5881273530	self
0.5879778904	expression
0.5878909560	screen
0.5878909560	males
0.5878909560	lesions
0.5878909560	media
0.5878601076	gemcitabine
0.5878469964	blockers
0.5878247787	profile
0.5877205792	zd1694
0.5877205792	cyp2c19
0.5876652011	pps
0.5876652011	gac
0.5876652011	icyp
0.5876023464	i2
0.5875873143	basis
0.5875672080	generate
0.5874700354	partially
0.5874107854	ecg
0.5873933962	beta2ar
0.5873692299	topo
0.5873457840	bcr
0.5873400622	translation
0.5873400622	steroids
0.5872621015	dependent fashion
0.5872545111	plexus
0.5871794560	pparα
0.5871020743	ob
0.5870904169	non small cell lung
0.5870745449	ka
0.5870334261	smooth muscle cells
0.5870147679	member
0.5870051513	dss
0.5870051513	pfos
0.5868301639	therapeutic agents
0.5868182631	central nervous system
0.5867780143	converting
0.5866441441	strongly
0.5866075942	tc
0.5865335441	endpoint
0.5865221244	2a
0.5865114923	conducted
0.5864867957	l cystine
0.5864535091	tfp
0.5864535091	gapdh
0.5863871447	mechanism
0.5861896610	gi
0.5861416676	mcp
0.5861361453	cs
0.5860686988	cam
0.5860429809	analyses
0.5859601300	underlying
0.5859242189	days
0.5859165429	upa
0.5858972402	normal
0.5858460069	prevented
0.5858209536	groups
0.5857880345	erbeta
0.5857880345	mecp2
0.5857880345	arg
0.5857686132	signals
0.5857686132	bacterial
0.5857686132	neutrophil
0.5857284445	pde5
0.5857261627	report
0.5856064433	skeletal
0.5855740205	engineering
0.5855475714	nachr
0.5854861700	pi
0.5854706148	impairment
0.5854015689	p95erbb2
0.5853879777	agonists
0.5853743692	mglu3
0.5852850444	extract
0.5852767741	application
0.5851518951	suggested
0.5850977779	trpa1
0.5850545887	adomet
0.5850248825	sci
0.5850126736	markedly
0.5850011710	reduced
0.5849154548	affinity
0.5848671902	ang
0.5848128940	generated
0.5847797243	phenolic
0.5847797243	underwent
0.5847261171	female mice
0.5846574090	cycling
0.5845697227	isomerase
0.5845697227	gestation
0.5844920897	mechanisms of action
0.5844663603	ca2
0.5844083777	established
0.5843842894	predominantly
0.5843842894	conventional
0.5843842894	collected
0.5843842894	applications
0.5843842894	elucidated
0.5843842894	parallel
0.5843481718	tandem
0.5841955562	synthetic
0.5841521011	multidrug
0.5841128253	products
0.5841110965	pt
0.5840938287	reduce
0.5840923712	rvt
0.5840766011	lpa1
0.5840766011	mdr1a
0.5840766011	cd3
0.5840766011	cxcr4
0.5840508786	antitussive
0.5840508786	diffuse
0.5840508786	aldehydes
0.5840508786	lorazepam
0.5840508786	deoxycytidine
0.5840508786	steroidogenic
0.5840508786	naproxen
0.5840508786	exons
0.5839758702	neurotransmitter
0.5839430280	rapidly
0.5839430280	limited
0.5839154749	hmc
0.5839082957	exist
0.5839082957	protected
0.5839082957	clear
0.5839082957	great
0.5838926607	results obtained
0.5838750233	form
0.5838647293	pocl
0.5838647293	v1a
0.5838647293	ly395153
0.5838647293	c4
0.5838647293	virexx
0.5838647293	nr2c
0.5838647293	michaelis
0.5838647293	rhoa
0.5838647293	hoechst
0.5837978090	 
0.5837467878	monitoring
0.5837467878	efficiently
0.5837467878	reports
0.5837467878	desensitization
0.5837467878	receiving
0.5837187276	n methyl d aspartate
0.5837157730	stimulated
0.5836995327	ages
0.5836990197	dgk
0.5836990197	eb
0.5836480882	transporting
0.5836299535	gstp1
0.5835756231	demonstrate
0.5834656113	hcec
0.5834656113	tunel
0.5834617518	strategy
0.5834564478	p21
0.5834532484	transporters
0.5834453726	removal
0.5834304157	environment
0.5834304157	concluded
0.5834304157	functionally
0.5834304157	cascade
0.5833788501	overexpressing
0.5833788501	slices
0.5832861799	actions
0.5832574413	obtained
0.5831797090	functions
0.5830919154	cell
0.5830879353	molecular mechanism
0.5830855859	bsep
0.5830456250	lymphocyte
0.5830395726	mechanism of action
0.5828939904	mcao
0.5828565387	accumulation
0.5828521353	therapeutic
0.5828520104	lpa
0.5828432788	tpo
0.5828432788	tic
0.5828274034	recycling
0.5828274034	isoenzymes
0.5828274034	endpoints
0.5828132708	nachrs
0.5827780787	rems
0.5826470432	h2o2
0.5826149031	evn
0.5825861817	analgesic
0.5825664610	features
0.5825513369	analysis showed
0.5825442727	pdgfra
0.5824564478	cortical
0.5824564478	causing
0.5824564478	improves
0.5824564478	showing
0.5823997715	coupled
0.5823476006	rb
0.5823468631	1c
0.5823349968	collagen
0.5823075107	alzheimer's
0.5822934442	catalyzes
0.5822364482	converting enzyme
0.5821403379	emax
0.5820717821	differs
0.5817180666	kg
0.5816446830	tr
0.5816446830	pam
0.5815903432	phosphate
0.5815195586	mediate
0.5814265930	substrate
0.5813503883	status
0.5812606169	mor
0.5811885055	3alpha
0.5811830306	parkinson's
0.5811725058	dcbn
0.5811377790	pde
0.5810756992	caspase
0.5810433706	possibility
0.5810121345	mmr
0.5810121345	ggqld
0.5809761153	untreated
0.5809761153	fractions
0.5809761153	antagonistic
0.5809654549	peroxidase
0.5809231145	adipocytes
0.5809138445	superoxide
0.5808854731	hormone receptor
0.5808772121	analyzed
0.5807707013	mek
0.5807639947	affect
0.5807484066	relevant
0.5806504399	fibroblasts
0.5806179419	compare
0.5805786158	diseases
0.5805483987	smokers
0.5805222002	dfbp
0.5804510828	abcb1
0.5804432025	fgf 7
0.5804268257	special
0.5804060578	pdk
0.5804060578	thf
0.5803878933	permanent
0.5803878933	cancerous
0.5803878933	synovial
0.5803878933	epitope
0.5803878933	upper
0.5803878933	testolactone
0.5803878933	ethephon
0.5803878933	ubiquinone
0.5803878933	wake
0.5803878933	antiestrogens
0.5803878933	filgrastim
0.5803878933	1b1
0.5803878933	reorganization
0.5803878933	antigens
0.5803878933	dehydratase
0.5803878933	dicarboxylate
0.5803878933	generates
0.5803878933	exchanger
0.5803878933	hyponatremia
0.5803878933	atoms
0.5803878933	quipazine
0.5803878933	disrupt
0.5803878933	hydroxylated
0.5803878933	carrageenan
0.5803878933	shifts
0.5803878933	homogenates
0.5803329119	exerts
0.5803329119	benefit
0.5803329119	remain
0.5802957510	bde
0.5802663032	suggests
0.5802493699	bromfenac
0.5802493699	4f2hc
0.5802179821	docking studies
0.5801683841	alkaline
0.5801619156	deficient cells
0.5800856688	1a
0.5798530597	deficient
0.5798513385	zol
0.5798052283	residue
0.5797689010	inducible nitric oxide
0.5797601108	sequences
0.5797015327	proinsulin
0.5796928841	hct116
0.5796646346	glcnac
0.5796175535	mouse models
0.5795985189	dbh
0.5795881685	required
0.5795305911	pahs
0.5795213429	interfering rna
0.5794710500	spions
0.5793364581	developed
0.5792721929	widely
0.5792308100	pka
0.5792283607	h2
0.5792283607	c3
0.5790903432	events
0.5790383716	genes
0.5790087692	mutants
0.5789124252	mcf
0.5788766499	appears
0.5787803944	2h
0.5787601108	primarily
0.5787547581	tested
0.5787267030	formed
0.5787205495	manner
0.5786557256	oxygenase
0.5785506167	acid
0.5784446947	isa
0.5784443295	diet
0.5780092285	induce
0.5780051795	pah
0.5778482215	cr
0.5777919028	involves
0.5776991764	pattern
0.5776405092	ester
0.5776405092	redox
0.5776225945	unclear
0.5776225945	produces
0.5776225945	neutral
0.5776225945	slightly
0.5776225945	moiety
0.5776225945	behavioral
0.5775259331	µm
0.5774375655	structures
0.5774226441	fl
0.5774200957	measured
0.5773848149	critical role
0.5773787550	par
0.5773774987	nkcc1
0.5773772041	95 ci
0.5772919028	generally
0.5772919028	therapies
0.5772249536	l arginine
0.5772063592	microm
0.5771825344	individual
0.5771786938	orf
0.5771786938	qe
0.5771786938	mrp
0.5771786938	rage
0.5771071464	trauma
0.5770870391	yet
0.5770471131	gjic
0.5770471131	inr
0.5770471131	dmi
0.5770471131	hrpc
0.5770471131	edta
0.5770363281	dec
0.5770190843	drugs
0.5769885181	sur1
0.5769351464	ih
0.5769351464	pots
0.5769351464	pgis
0.5769351464	ik
0.5769351464	nmdar
0.5768767421	produced
0.5768602776	hba1c
0.5768601194	®
0.5768136861	reductase
0.5768032842	xa
0.5767601108	suppresses
0.5767523054	egcg
0.5767523054	es
0.5767523054	fak
0.5767440235	regulated
0.5766199264	down regulation
0.5765982733	currents
0.5765971976	transfected cells
0.5765487836	cpr
0.5764881208	os
0.5764663512	antagonist
0.5764590190	β1
0.5764464112	rharg
0.5764464112	limb
0.5763407581	synthesized
0.5760806607	nonselective
0.5760806607	represents
0.5760806607	restored
0.5760806607	retention
0.5760806607	strategies
0.5760746763	tissues
0.5760715078	midazolam
0.5760681162	potent and selective
0.5760069137	dose related
0.5759882586	vmat2
0.5759163484	defined
0.5758817397	aa
0.5758326113	v600e
0.5757919028	explored
0.5757919028	maintained
0.5756956654	delta1
0.5755915027	brain tissue
0.5754786108	resulting
0.5753967324	tft
0.5753967324	wev
0.5753015643	anti inflammatory activities
0.5752590741	amides
0.5752590741	luteolin
0.5752590741	died
0.5752590741	molybdenum
0.5752590741	administrated
0.5752590741	hache
0.5752590741	thrombus
0.5752590741	stroma
0.5752590741	ovariectomized
0.5752498373	notably
0.5751822536	mrnas
0.5751176921	cells
0.5750810064	huvecs
0.5750402589	polar
0.5750402589	deiminase
0.5750402589	gonadotrophin
0.5750402589	nano
0.5750402589	dehydrogenases
0.5750402589	cycles
0.5750402589	allergen
0.5750402589	forced
0.5750402589	coactivator
0.5750402589	operation
0.5750402589	hypersensitivity
0.5750402589	leukaemia
0.5750402589	normotensive
0.5750402589	consumed
0.5750402589	bromo
0.5750402589	complexed
0.5750402589	eliminated
0.5750402589	greatest
0.5750402589	depolarizing
0.5750303347	once
0.5750215175	core
0.5749583744	risc
0.5749583744	chop
0.5749583744	ope
0.5749583744	qd
0.5749583744	apj
0.5749583744	nfa
0.5749352722	b raf
0.5749349903	dif
0.5749215175	highest
0.5749056607	potently
0.5749056607	contained
0.5749056607	demonstrating
0.5748944638	dopac
0.5748944638	nir
0.5747911286	bps
0.5747652275	icam
0.5745882663	proliferation
0.5745035605	lbl
0.5745035605	aldh
0.5745035605	rr
0.5745035605	lpl
0.5744991559	har
0.5744197406	pcp
0.5744148837	interaction
0.5743258331	series
0.5743177519	binds
0.5743040233	retinopathy
0.5743040233	deferens
0.5742830074	kda
0.5742401193	reductions
0.5742226263	fold increase
0.5742173932	intestinal
0.5741074469	p2y
0.5741074469	mat1a
0.5741074469	atp8a1
0.5741074469	ag490
0.5741074469	urb597
0.5741074469	rnas
0.5740846020	sem
0.5740723274	matched
0.5740723274	reveal
0.5740723274	noted
0.5740723274	monocytes
0.5740556626	leydig
0.5739854190	independent
0.5739658667	xenopus
0.5739060109	involvement
0.5738937465	designed
0.5738176669	epc
0.5738176669	trh
0.5738176669	faah
0.5737088006	ptp1b
0.5736331613	microg
0.5735500535	induced obesity
0.5735034727	lectin
0.5734823871	upregulation
0.5734820674	phip
0.5734467351	enac
0.5733338968	aldh1b1
0.5731937989	ucp
0.5731415441	lacz
0.5730701407	identified
0.5729930345	minutes
0.5729098798	oral glucose
0.5727370887	difference
0.5726885019	saline
0.5726710169	etoh
0.5725806258	missense
0.5725773536	eralpha
0.5725336530	signalling
0.5724991430	hippocampus
0.5723929713	pn
0.5722506552	muscle cells
0.5720985311	dfp
0.5720985311	ddah
0.5720985311	dca
0.5719575558	complex formation
0.5719539550	reporter
0.5719247525	paclitaxel
0.5719247525	coefficients
0.5719247525	hoat4
0.5719247525	alpha1b
0.5719247525	propidium
0.5719247525	prostanoid
0.5719247525	bands
0.5719247525	subgroups
0.5719247525	solutions
0.5719247525	piperidine
0.5719247525	sulfonamides
0.5719247525	prognostic
0.5719247525	antinociception
0.5719247525	relapse
0.5719247525	ideal
0.5719247525	acted
0.5719247525	enoxaparin
0.5719247525	asthmatic
0.5719247525	suspension
0.5719247525	progestin
0.5719247525	desogestrel
0.5719247525	proteases
0.5719247525	stained
0.5719247525	dried
0.5719247525	coated
0.5719247525	beta3
0.5719247525	compartment
0.5719247525	microdialysis
0.5719247525	7a
0.5719247525	surfaces
0.5719247525	₂
0.5719247525	breaks
0.5719247525	conditional
0.5719247525	polarization
0.5719247525	opposite
0.5719247525	pleiotropic
0.5719247525	sertraline
0.5719247525	overweight
0.5719247525	undetectable
0.5719247525	blots
0.5719247525	carbamazepine
0.5719247525	headache
0.5719247525	reliable
0.5719247525	modulatory
0.5719247525	impairs
0.5719247525	window
0.5719247525	heteromeric
0.5719247525	augmentation
0.5719247525	entered
0.5719247525	methyltransferases
0.5719247525	testis
0.5719247525	slowing
0.5719247525	precipitation
0.5719247525	rotation
0.5719247525	nausea
0.5719247525	ensure
0.5719247525	impacts
0.5719247525	2c19
0.5719247525	glycolytic
0.5719247525	bleomycin
0.5719247525	monolayer
0.5719247525	subgroup
0.5719247525	tension
0.5719247525	responded
0.5719247525	dextran
0.5719247525	inactivating
0.5719247525	reflected
0.5719247525	metabolize
0.5719247525	sizes
0.5719247525	quaternary
0.5719247525	raises
0.5719247525	ranges
0.5719247525	fundamental
0.5719247525	hyperinsulinemia
0.5719247525	relaxations
0.5719247525	accelerate
0.5719247525	wounds
0.5719247525	perform
0.5719247525	confirming
0.5719247525	frequencies
0.5719247525	conformations
0.5719247525	bioactivity
0.5719247525	highlighted
0.5719247525	proteomic
0.5719247525	hydroxylation
0.5719247525	repress
0.5719247525	precise
0.5719247525	encode
0.5719247525	accepted
0.5719247525	constructs
0.5719247525	explanation
0.5719247525	true
0.5719247525	exhibiting
0.5719247525	coexpressed
0.5719247525	flanking
0.5719247525	chosen
0.5719247525	lumen
0.5719247525	therapeutically
0.5719247525	electrostatic
0.5719247525	neurite
0.5719247525	instability
0.5719247525	dramatic
0.5719247525	diaphorase
0.5719247525	adjacent
0.5719247525	surrounding
0.5719247525	prophylaxis
0.5719247525	prescribed
0.5719247525	belonging
0.5719247525	mobilization
0.5719247525	dione
0.5719247525	reabsorption
0.5719247525	compatible
0.5719247525	created
0.5719247525	displacement
0.5719247525	lipoproteins
0.5718840206	snps
0.5718536315	times
0.5717693123	mo
0.5717456367	micrograms
0.5716917667	postoperative
0.5716917667	film
0.5716917667	4b
0.5716917667	vitiligo
0.5716196550	8 oh dpat
0.5714619172	oat
0.5714469569	α
0.5713863882	examined
0.5713675496	fold
0.5713171479	mi
0.5713167033	2p
0.5712689596	account
0.5711845347	pec
0.5711480435	boc
0.5710781633	inhibitory
0.5710428496	ars
0.5710163484	modulating
0.5710163484	technique
0.5710163484	preventing
0.5710163484	promoting
0.5709756292	lo
0.5709641001	rs
0.5709632676	receptor
0.5708708119	folate
0.5708419424	stress
0.5708143096	flip
0.5707755062	ltc4
0.5707663533	expressing
0.5707482569	old
0.5707383140	rat brain
0.5707049793	shown
0.5706841663	performed
0.5706476453	phosphate dehydrogenase
0.5706426520	regulatory
0.5706098912	che
0.5705754128	pei
0.5704991430	moderate
0.5704597336	protein
0.5703811249	ghr
0.5703553749	pak1
0.5703334054	necrosis
0.5703215114	labeling
0.5702891466	plasma glucose
0.5702212115	inflammation
0.5702077741	if
0.5700859251	ssat
0.5700247770	cdc2
0.5699358545	monw
0.5699018973	wnt6
0.5698988452	complex
0.5698655934	inactive
0.5698655934	analog
0.5698606556	acids
0.5697949641	alpha
0.5697459982	tat
0.5696679572	hdac
0.5696606901	decrease
0.5696335131	keap1
0.5696198965	caucasian
0.5696160401	aspects
0.5696160401	naturally
0.5695973994	examine
0.5694793116	hcy
0.5694545959	patch
0.5694036449	mcs
0.5693671631	lfa
0.5693348917	propose
0.5693348917	requires
0.5692401750	expressed
0.5691948994	blotting
0.5691307555	properties
0.5690363353	calves
0.5690363353	cyanopindolol
0.5690363353	→
0.5690363353	tablet
0.5690351833	response
0.5689274165	drd3
0.5689178114	rhbg
0.5689178114	k562
0.5689178114	muc2
0.5688991250	reward
0.5688991250	humanized
0.5688897275	des
0.5688640002	kinase inhibitors
0.5688590673	findings demonstrate
0.5688209504	cyp2c9
0.5687557102	oh
0.5685973994	degree
0.5685646110	asp
0.5684448534	isoform
0.5683308786	cn
0.5681845150	exhibits
0.5681845150	represent
0.5681845150	responsive
0.5680452176	highly selective
0.5680296212	high affinity binding
0.5680056636	metabolites
0.5679411463	rates
0.5677547827	hypothesized
0.5676600748	selectively
0.5675599356	hm74
0.5675599356	gtpase
0.5675599356	kcl
0.5675599356	ht29
0.5675599356	p450s
0.5675599356	chem
0.5675599356	u50
0.5675599356	raw264
0.5675378080	microl
0.5674971085	cbp
0.5674269544	hsp90
0.5672578691	2c
0.5672571951	angiotensin ii type 1
0.5672288980	nude
0.5672288980	iontophoresis
0.5672288980	cerebrospinal
0.5672117710	fluorouracil
0.5672003740	provide
0.5671411463	differentiated
0.5671411463	presented
0.5671411463	intact
0.5671245261	physiological
0.5670696349	females
0.5670296795	mekk2
0.5670296795	cyp2b4
0.5670245423	important
0.5669480431	sirna
0.5668077437	erβ
0.5667543032	cyclooxygenase 2
0.5667375071	e cadherin
0.5667041126	sa
0.5666540535	opn
0.5666148222	site
0.5666022336	abca1
0.5665754110	p2
0.5665244330	zr
0.5665167096	ethanol induced
0.5665149275	t3
0.5664896057	down regulated
0.5664173590	whether
0.5663842473	pathway
0.5663695389	4a
0.5663568116	mtap
0.5663568116	lev
0.5662117710	reading
0.5662117710	eicosapentaenoic
0.5662117710	discriminative
0.5661694552	annexin
0.5660656779	hbv
0.5660151793	c myc
0.5660146131	3a
0.5659485037	alpha and beta
0.5659181802	foxo1
0.5659181802	nr1
0.5659181802	δnp63
0.5659117394	mrna and protein levels
0.5657811465	tpp
0.5657546039	fmlp
0.5657546039	vi
0.5656148671	pathogenesis
0.5655350758	tandem mass
0.5654996066	few
0.5652930427	significantly
0.5652869049	serve
0.5652781909	potential mechanism
0.5652147426	pthrp
0.5652147426	galpha
0.5652147426	tlr8
0.5652147426	clfn
0.5651862957	lack
0.5650835818	assessed
0.5650091873	plot
0.5649989267	carried
0.5647882428	1h
0.5647193010	db
0.5647007176	ni
0.5645692971	modulates
0.5645692971	diminished
0.5645692971	possess
0.5645692971	structurally
0.5644764201	methods and results
0.5644298667	interacts
0.5642649785	article
0.5642578566	receptor agonist
0.5642355949	glp 2
0.5641643782	yl
0.5639722272	mrna
0.5639347143	wide
0.5638134735	acinar
0.5637011426	long term treatment
0.5635502150	concentration
0.5635227886	discussed
0.5635188824	s1
0.5635027886	frontal
0.5635027886	postmenopausal
0.5634348000	release
0.5634163688	m6p
0.5634163688	bartter's
0.5634163688	nh3
0.5634163688	kv7
0.5634163688	jzl184
0.5634163688	muller
0.5634163688	k3
0.5634026497	production
0.5633827078	volume
0.5632634850	human embryonic kidney 293 cells
0.5632142340	sori
0.5631686927	consistent
0.5631223168	a4
0.5631200099	thd
0.5631200099	f3
0.5630367669	mig6
0.5630240404	percentage
0.5629120113	pias1
0.5625027886	inotropic
0.5624755037	protein level
0.5621962723	app
0.5621393332	pc12
0.5620376298	trpv1
0.5620376298	hz
0.5620284633	contributing
0.5620284428	consequence
0.5620284428	depending
0.5619665818	three dimensional
0.5619058125	vmh
0.5619058125	dedtc
0.5617914834	pla2
0.5616583825	administration
0.5616139115	β
0.5615664568	pparbeta
0.5615209074	enzyme activity
0.5614822765	ly294002
0.5614617710	pgc
0.5614414993	versus
0.5612938541	gb
0.5612938541	cbr1
0.5612938541	pcbs
0.5612545982	mediated
0.5609693519	reticulum
0.5609108272	treated
0.5608626713	elevation
0.5608477454	et al
0.5607934088	pathways
0.5607831995	belongs
0.5607831995	autosomal
0.5607831995	consists
0.5606366779	concentrations
0.5605693816	caused
0.5605217326	129
0.5604568852	hand
0.5603322003	respect
0.5601033574	currently
0.5600588438	il 6 production
0.5600236355	mtor
0.5598636098	so
0.5598417069	function
0.5597845781	axl
0.5597845781	hm74a
0.5597845781	kcc1
0.5597845781	hcl
0.5597845781	ulva
0.5597845781	gw660511x
0.5597845781	ly541850
0.5597845781	danshen
0.5597845781	rad9
0.5597845781	g6pc2
0.5597845781	fam36a
0.5597845781	gsk1292263
0.5596967626	arbs
0.5594992758	well tolerated
0.5594275675	cll
0.5593410222	ptdser
0.5592193519	marrow
0.5590311615	runx2
0.5590311324	inhibitor
0.5589785580	rate
0.5589598427	d2r
0.5588041516	ecl2
0.5588041516	gtpgammas
0.5588041516	mcf7
0.5588041516	i3a
0.5587944149	beta
0.5587932018	type 2 diabetic patients
0.5586873688	lines
0.5585238910	pon1
0.5584696719	5 ht2c
0.5584417970	¹
0.5583419349	date
0.5583419349	confidence
0.5582764499	determined
0.5582201538	akrs
0.5582201538	a1c
0.5582201538	cb2
0.5581695244	ephrina5
0.5581660187	investigated
0.5580900819	stat5
0.5580494037	α2a
0.5579907469	therapy
0.5578822003	ranging
0.5578542079	revealed
0.5577368292	2b
0.5576549328	glur5
0.5575606378	peroxidation
0.5575019281	crbn
0.5574125365	vs
0.5573064893	compared
0.5573031709	gene
0.5572591919	second
0.5572518911	bak
0.5569954227	rac
0.5568249685	steady
0.5567762196	lqt3
0.5567697847	adipose
0.5567567087	contrast
0.5567288493	involving
0.5566310448	rise
0.5565135033	angii
0.5564848449	lys
0.5564125129	doses
0.5562740832	contribution
0.5562535399	throughput
0.5562478637	provided
0.5562094935	brbk1
0.5561552573	p300
0.5560760712	cell apoptosis
0.5559033049	pbmcs
0.5559033049	tio2
0.5559033049	drd2
0.5558893915	full
0.5557642783	med31
0.5557642783	iialpha
0.5557549286	taken
0.5556689164	remained
0.5556689164	shows
0.5554516448	terms
0.5552505664	potentially
0.5552288493	express
0.5552288493	domains
0.5551795526	determination
0.5551689164	phenotype
0.5551500272	hdls
0.5551010429	inhibited
0.5550533090	beta cell
0.5550331995	regard
0.5550331995	participation
0.5548895411	pparalpha
0.5548607719	gly
0.5547039635	dismutase
0.5543610115	dose
0.5540558883	dose response
0.5538369995	processes
0.5534866871	demonstrated
0.5533764439	systems
0.5533364367	markers
0.5532321520	cv
0.5532075062	tmem106b
0.5532075062	rhob
0.5529924527	genotype
0.5529615114	effect
0.5528882581	sub
0.5527113058	type 2 diabetic
0.5526119359	monoclonal
0.5525428100	accompanied
0.5524709522	regulation
0.5523507858	mode
0.5523481968	sec
0.5519379518	p53
0.5518774938	increase
0.5518031721	side chain
0.5517627391	ε
0.5515634383	control
0.5515483754	real
0.5515025251	anti inflammatory effects
0.5512866479	nqo2
0.5512710257	catenin
0.5511738825	treat
0.5511629990	tnap
0.5511113052	active compounds
0.5510683330	increases
0.5505340747	angiotensin ii type 1 receptor
0.5504414216	tomography
0.5504121592	exhibit
0.5503522226	suggest
0.5502697202	vsmcs
0.5502216602	supplemental
0.5502040685	nervous
0.5499322192	neuropathic
0.5499322192	cerevisiae
0.5497173890	profiles
0.5496975754	none
0.5490303414	cholesterol levels
0.5488993661	colq
0.5488355367	cdk1
0.5488355367	gnrhr
0.5487915107	formation
0.5487586927	indicative
0.5487586927	infarction
0.5487529449	calcium dependent
0.5486029147	receptor blockade
0.5485661093	crystal
0.5484760148	showed
0.5484086429	implicated
0.5483929216	members
0.5483062613	studies demonstrated
0.5480473819	subunit
0.5479954470	γ
0.5477567854	catalytic activity
0.5477467801	mapks
0.5477395269	protein expression
0.5476798854	dependent
0.5475556791	human liver
0.5472887778	rauwolscine
0.5472168300	pyk2
0.5470158913	consisting
0.5469906748	high performance
0.5469583985	staining
0.5465970555	activities
0.5464028346	cox 1 and cox 2
0.5459790834	camp
0.5459663690	selected
0.5459530409	nlrp3
0.5459530409	tnfalpha
0.5458626841	leading
0.5458581372	fpps
0.5457699994	hif1α
0.5454969148	evaluated
0.5454690283	star
0.5454599839	whole
0.5450469567	contributes
0.5449319246	svmps
0.5446447323	reported
0.5446022468	evaluate
0.5444983208	src1
0.5444983208	trpc6
0.5444780656	studied
0.5443886853	subunits
0.5442120572	parameters
0.5439519233	together
0.5438775846	activity
0.5438174013	once daily
0.5437770199	exhibited
0.5436870680	akr1b10
0.5436826454	indicating
0.5436718479	years
0.5435828481	observed
0.5435070724	kappab
0.5434007418	ptps
0.5434007418	irf5
0.5432320728	rxralpha
0.5432053520	effectively
0.5430576731	serotonin reuptake inhibitors
0.5429009498	smo
0.5428895531	variety
0.5428774512	igfbp 2
0.5426977233	afb1
0.5426977233	hmgb1
0.5425515854	vein
0.5425142364	food and drug
0.5420501499	mrna and protein
0.5418704167	de
0.5418546208	levels
0.5417829776	period
0.5416454547	participate
0.5416454547	transforming
0.5416454547	carbonic
0.5416333944	hh
0.5415515854	follow
0.5415115148	downstream
0.5413582459	failed
0.5413182020	s1p
0.5413182020	asmase
0.5413167578	hba
0.5413167578	dgkgamma
0.5413167578	h115w
0.5412981419	ccl
0.5412275683	c jun n terminal
0.5409270003	conditions
0.5407862226	depends
0.5407115148	reduces
0.5407115148	behavior
0.5406640921	retinoic acid receptors
0.5405573850	wild
0.5404353581	top2a
0.5403242226	cytochrome
0.5401488514	absence
0.5400560948	resulted
0.5400409498	receptor mediated
0.5399945966	dnmt1
0.5399945966	dags
0.5398558553	fdurd
0.5398184044	contribute
0.5398138857	up regulated
0.5396391104	ability
0.5396339405	full length
0.5395222136	aimed
0.5394681092	under
0.5394567895	fatty
0.5393417961	csa
0.5390501499	expression and activity
0.5389653584	human recombinant
0.5388913403	cancers
0.5385917573	hu
0.5385788581	hydrocarbon
0.5385518794	first
0.5384532451	cdna
0.5383227020	protein tyrosine
0.5383146790	ta1
0.5382896055	led
0.5382651257	glutamate receptors
0.5380289656	5 fluorouracil
0.5380197649	p4
0.5380197649	lrrk2
0.5380197649	cyp2c8
0.5378999065	determine
0.5377207836	cord
0.5376156114	ccr5
0.5376156114	icam2
0.5376156114	pi3kgamma
0.5376156114	gpr55
0.5375510857	receptor antagonism
0.5375099187	interfere
0.5374532451	forms
0.5373620061	alpl
0.5373620061	u46619
0.5373620061	pept2
0.5371781814	components
0.5370018108	rrm1
0.5367271317	history
0.5362078376	symptoms
0.5360350881	metabolizing enzymes
0.5356805547	micromol
0.5354096911	term
0.5353989717	what
0.5352287870	atp binding
0.5352039873	ph 7
0.5351859433	neuronal cell
0.5350431749	g protein coupled receptor
0.5349395412	significantly inhibited
0.5348317866	ex vivo
0.5348035319	part
0.5346842808	t4
0.5346842808	fgf23
0.5345889511	plays
0.5344965270	blind
0.5341756076	nonsteroidal anti inflammatory
0.5341146739	inhibits
0.5339730905	mmp 2
0.5338757123	conclude
0.5336550584	acetylcholine receptor
0.5334216638	down
0.5333489719	patients with advanced
0.5331633116	κb
0.5331019025	t
0.5330192539	new
0.5329838148	follow up
0.5329067835	x
0.5328905526	good
0.5327600051	ex
0.5326345234	results suggested
0.5325281076	responsible
0.5324281009	induced
0.5323355608	cloned
0.5322289987	d2 receptors
0.5322116988	next
0.5321697008	novel
0.5321146739	suggesting
0.5316265097	airway smooth
0.5313300225	support
0.5312466891	isoforms
0.5311884195	analogues
0.5311098695	co
0.5309550225	directly
0.5308921339	only
0.5307491586	thought
0.5301753472	each
0.5300550225	received
0.5293621633	peroxisome
0.5293593107	inos
0.5292610645	k
0.5291836510	play important
0.5287332146	considering
0.5284291942	arachidonic
0.5284072259	play important roles in
0.5282466891	displayed
0.5281640632	smooth
0.5279919807	118
0.5279205168	computer
0.5276700016	most
0.5275541887	effects
0.5274205545	potent inhibition
0.5270125173	nine
0.5268466121	sb224289
0.5265230625	rather
0.5264593119	j
0.5259639595	seven
0.5259186265	later
0.5256047000	adrenoceptor mediated
0.5255632866	before
0.5251655247	l glutamate
0.5249579122	mao b
0.5248283444	including
0.5247649411	dependently
0.5246929604	role
0.5243103636	instead
0.5233725281	glucose dependent
0.5233297074	more
0.5231841419	similar results
0.5229052361	low density
0.5227064636	positive allosteric
0.5223655512	perhaps
0.5223655512	normally
0.5223109438	presence
0.5218684480	p selectin
0.5218147682	depressive disorder
0.5217214514	regarding
0.5215860423	human brain
0.5215129486	go
0.5214477002	such
0.5212219722	neurotrophic factor
0.5211732128	induced acute
0.5211131391	three
0.5210724643	consequently
0.5191198916	&
0.5190042256	f
0.5188781644	potent anti
0.5186983901	at
0.5186621195	l
0.5184035734	decreased significantly
0.5181529545	another
0.5180289749	further
0.5179862111	insulin levels
0.5179293525	5 lox
0.5175429167	though
0.5174794405	n
0.5173475514	o
0.5169325063	e
0.5169212511	d mph
0.5165113039	g
0.5163978824	throughout
0.5162357734	cultured cells
0.5159199565	way
0.5156389592	r
0.5153916220	after
0.5153198574	re
0.5153186532	as
0.5151567733	cyclin dependent
0.5150708718	v
0.5148504167	does
0.5148502809	mg kg body
0.5148353155	m
0.5145179049	again
0.5144542536	vitro
0.5143559613	° c
0.5142095189	molecular basis
0.5138839558	twice daily
0.5138672062	vivo
0.5137141061	almost
0.5133990057	until
0.5133413971	except
0.5133341368	even
0.5127312722	c57bl 6
0.5122050296	related protein
0.5120881685	six
0.5120054939	two
0.5118902859	induced cytotoxicity
0.5118623236	a go go related gene
0.5117082434	all
0.5116126993	time
0.5115880570	using
0.5113832315	b
0.5112868296	about
0.5110644133	treatment of alzheimer's disease
0.5105489905	a dose dependent manner
0.5103364044	receptor ligand
0.5102670860	human breast cancer
0.5101579253	neither
0.5098327229	presumably
0.5097134703	inner
0.5096479460	this
0.5094369300	2013
0.5094335688	c
0.5091732666	like
0.5087892957	likely
0.5087741750	d
0.5084754987	h
0.5081813515	treated cells
0.5081287686	near
0.5080432163	ten
0.5077778890	102
0.5076050633	th
0.5073955838	during
0.5073424161	off
0.5072370103	an
0.5070590915	in
0.5070168255	fold lower
0.5067233573	very
0.5066036133	related compounds
0.5065976690	y
0.5064555829	et
0.5062849487	n terminal
0.5062767155	hi
0.5061260514	kinase activity
0.5059632321	increased risk
0.5058179897	ie
0.5057943876	renal cell
0.5057804915	eight
0.5055131591	hypertensive rats
0.5052911660	induced toxicity
0.5051692893	both
0.5051258704	s
0.5049620674	selective antagonists
0.5048364777	the
0.5048008717	no
0.5045440067	× 10
0.5044879638	binding protein
0.5044509148	plasma concentrations
0.5042178589	w
0.5041776864	substrate binding
0.5039368337	protein levels
0.5035740575	alpha 2a
0.5030789936	inotropic effect
0.5029634633	us
0.5027514062	these
0.5025251112	am
0.5019173697	a
0.5018325125	herein
0.5017822150	tumor cell
0.5017303245	important role
0.5013992538	inward
0.5009511113	z
0.5007868116	± 0
0.5006183943	mean
0.5003169750	besides
0.4995919930	ucp 3
0.4995775230	showed significant
0.4994367520	following
0.4992496927	renin angiotensin
0.4992344244	receptor ligands
0.4992321704	brief
0.4982838787	changes
0.4982824498	anti inflammatory drugs
0.4981237525	name
0.4976623692	upon
0.4975811425	p
0.4971894648	five
0.4970198976	concerning
0.4970198976	uses
0.4969393203	up
0.4964029265	nor
0.4958287936	nevertheless
0.4957525704	u
0.4956986420	systolic blood
0.4955902145	side chains
0.4954004261	best
0.4952186593	il 4
0.4949427073	protein and mrna
0.4949367774	i
0.4948160461	reactive oxygen
0.4947973603	find
0.4942878991	twice
0.4941430636	concentration dependent manner
0.4940258004	human colorectal
0.4939524080	then
0.4932322774	given
0.4930763048	high glucose
0.4928609947	serotonin reuptake
0.4926138498	top
0.4923534931	annexin 1
0.4923051556	through
0.4922495914	within
0.4919540974	four
0.4917587384	over
0.4910747958	β cells
0.4907654483	72
0.4902109360	other
0.4891165108	seem
0.4890875081	4 hydroxyphenyl
0.4887078794	different
0.4886748549	overall
0.4883297349	moreover
0.4880602965	hypothalamic pituitary
0.4879417941	results showed
0.4878854681	stress induced
0.4878417325	indeed
0.4869103828	neuronal cells
0.4868397789	accordingly
0.4867969933	certain
0.4867394269	hence
0.4864664388	many
0.4861783681	some
0.4860786836	despite
0.4859536836	since
0.4859421735	first line
0.4858076626	furthermore
0.4856981782	available
0.4855433711	no significant difference
0.4844733717	liver disease
0.4844608663	third
0.4844523619	possible
0.4842289567	human serum
0.4841994898	twelve
0.4831449200	his
0.4829567456	twenty
0.4828341002	264
0.4826634831	specific binding
0.4823334932	*
0.4823193467	inflammatory effects
0.4822766017	across
0.4809798581	significant effects
0.4807071070	serious
0.4803946274	higher affinity
0.4803147697	they
0.4801434075	reductase inhibitor
0.4800271913	clearly
0.4797808255	acetylcholine receptors
0.4796487769	interest
0.4792390354	231
0.4788598615	mononuclear cells
0.4787832098	along
0.4786937581	indicate
0.4785093487	various
0.4774592651	induced oxidative stress
0.4772426112	cell based
0.4763362342	positive cells
0.4763147697	among
0.4763147697	because
0.4762071576	especially
0.4758458790	example
0.4758077424	better
0.4756118994	q
0.4753728638	for
0.4745911344	micromol l
0.4745432357	95
0.4743929385	value
0.4743245380	48
0.4742173267	appear
0.4742064931	mg kg day
0.4741695221	third generation
0.4741539436	high density
0.4738474309	from
0.4738312579	results provide
0.4735058281	year
0.4733448457	several
0.4721979639	course
0.4721979639	last
0.4720356623	study demonstrates
0.4720224461	while
0.4714501724	on
0.4714031302	structure activity
0.4713953731	mrna and protein expression
0.4710067651	seems
0.4707225020	me
0.4706818368	therefore
0.4706564960	particular
0.4695576109	far
0.4695243051	around
0.4692539782	there
0.4691012896	polymerase chain
0.4689802087	one
0.4689681083	the concentration response
0.4689200115	compared with placebo
0.4685985034	although
0.4685518951	47
0.4681683053	d serine
0.4681618729	when
0.4680278060	real time
0.4677571284	by
0.4676743350	here
0.4670243127	nan
0.4668643416	cell lymphoma
0.4663152092	398
0.4661358010	work
0.4661257655	latter
0.4656271964	300
0.4649951627	significant difference
0.4649823229	use
0.4648271856	thus
0.4643109199	side effects
0.4641094272	non
0.4640390438	cancer patients
0.4632695463	growth factor receptor
0.4631852956	forty
0.4625944197	seen
0.4620670000	necessary
0.4619880319	followed
0.4617929589	stress related
0.4610326682	250
0.4610093991	without
0.4608335196	ldl c
0.4607994807	alone
0.4604948068	293
0.4603573542	sup sup
0.4602423565	their
0.4601073718	it
0.4599481334	il 5
0.4598126665	our
0.4597581655	we
0.4589298391	also
0.4588992201	235
0.4587941968	24
0.4585384033	binding studies
0.4580362761	14
0.4579273755	right
0.4579036182	need
0.4578835094	16
0.4578106170	corresponding
0.4577155617	per
0.4572588055	her
0.4571142051	unlikely
0.4571142051	59
0.4566558671	allows
0.4566558671	onto
0.4565504976	002
0.4565504976	87
0.4565277287	however
0.4565092642	ca2 +
0.4563802886	09
0.4562386272	dependent kinase
0.4559515664	003
0.4558952106	an overview
0.4558500652	to
0.4554501603	studies showed
0.4550897542	200
0.4549148287	became
0.4549148287	89
0.4549148287	140
0.4549148287	76
0.4549148287	beyond
0.4549148287	always
0.4547229594	above
0.4543103542	100
0.4535541139	cause
0.4535051768	18
0.4534479626	chronic treatment
0.4534478673	who
0.4533585584	116
0.4533585584	91
0.4532634499	compared with controls
0.4531007133	c terminal
0.4525140756	whereas
0.4521683006	2012
0.4515655367	described
0.4514523644	130
0.4514523644	81
0.4514523644	becomes
0.4514523644	give
0.4514523644	71
0.4514523644	160
0.4510998192	88
0.4509314909	little
0.4507459442	mostly
0.4507459442	every
0.4507459442	08
0.4502043916	86
0.4498515076	channel activity
0.4498288958	amount
0.4497753163	15
0.4494788831	able
0.4493714344	58
0.4493100865	system
0.4490848032	112
0.4490848032	immediate
0.4490848032	needs
0.4490848032	own
0.4490848032	700
0.4484598173	3d
0.4482862761	12
0.4482820919	binding of 3h
0.4482209639	ap 1
0.4477886729	those
0.4475424454	2008
0.4475424454	former
0.4471463562	92
0.4471333978	30
0.4471227948	80
0.4469863269	relatively
0.4468284286	438
0.4467723854	06
0.4467723854	57
0.4467723854	done
0.4467723854	detail
0.4467723854	namely
0.4467723854	94
0.4466793632	without affecting
0.4466206460	its
0.4465675364	l cysteine
0.4465264812	well
0.4464178072	+
0.4464111205	useful
0.4463831572	day
0.4458452337	out
0.4457417427	1000
0.4455578784	37
0.4452108627	how
0.4451851680	interleukin 2
0.4444057225	side
0.4443672317	17
0.4442862684	99
0.4441959738	least
0.4441957112	particularly
0.4440696543	others
0.4440696543	must
0.4436440650	5 lipoxygenase
0.4434643288	2d
0.4434499324	patients with type 2 diabetes
0.4433250960	07
0.4432972955	cancer cell
0.4432918712	107
0.4431276452	caco 2 cells
0.4428875307	50
0.4428502073	high concentrations
0.4428434436	83
0.4424928450	cannot
0.4424928450	64
0.4421725189	second generation
0.4421279553	oxygenase 1
0.4416642735	500
0.4414141448	74
0.4413343457	less
0.4412848154	96
0.4409751306	do
0.4408559630	between
0.4405902921	any
0.4405810511	2005
0.4405761509	85
0.4401623046	04
0.4399150785	97
0.4398919567	serum albumin
0.4396779403	terminal kinase
0.4394450507	69
0.4393595629	005
0.4393595629	become
0.4393595629	63
0.4393595629	already
0.4391166388	39
0.4389568062	93
0.4389568062	allow
0.4388962119	with
0.4388801884	indicated
0.4386976581	51
0.4386976581	make
0.4386976581	29
0.4385014821	400
0.4383950875	cpt 1
0.4381184823	contain
0.4380766844	61
0.4379681377	but
0.4379105782	below
0.4377667552	  mg kg day
0.4377304599	usually
0.4377304599	49
0.4377304599	84
0.4377276395	ones
0.4375984661	or
0.4375309688	20
0.4374991658	600
0.4374991658	people
0.4374405367	68
0.4372480760	82
0.4372480760	itself
0.4372480760	78
0.4363428370	seemed
0.4363428370	710
0.4363428370	back
0.4363428370	180
0.4363428370	110
0.4363428370	quite
0.4362782358	24 hours
0.4358394843	54
0.4356240927	dose dependent manner
0.4351609235	66
0.4351430539	62
0.4351071991	thereby
0.4350942105	98
0.4350591481	therapeutic target
0.4350430243	due
0.4350256295	receptor binding
0.4344310079	0001
0.4340471867	pyridoxal 5
0.4338604706	5
0.4338496641	2
0.4338324834	anti inflammatory activity
0.4331915230	79
0.4331915230	73
0.4331915230	whose
0.4331675061	beta cells
0.4328451112	same
0.4325572986	negatively correlated with
0.4324814849	still
0.4322910391	0
0.4322565669	3
0.4320927261	9
0.4319902881	125
0.4319387888	120
0.4319387888	56
0.4319387888	53
0.4317631941	selective cyclooxygenase
0.4316941556	34
0.4315227407	tolerance test
0.4315040045	4
0.4314570097	8
0.4313368082	these results suggest
0.4312987888	77
0.4312852693	induction of apoptosis
0.4312387503	5 meo
0.4306414974	receptor function
0.4305496023	46
0.4303905780	into
0.4302211848	much
0.4299589310	mechanisms involved
0.4298337883	g feed
0.4293590402	44
0.4293428287	did
0.4288031186	67
0.4287763455	emax =
0.4285323134	6
0.4284091739	show
0.4283563271	against
0.4281009164	than
0.4280877497	03
0.4280190663	no significant differences
0.4279792160	hydroxy 5
0.4279094638	g2 m
0.4278743530	cyclic adenosine
0.4278162276	hypoxia inducible
0.4276709778	02
0.4272056358	probably
0.4269136477	specific activity
0.4269070824	agonist activity
0.4267569179	indicates
0.4266840664	clinical activity
0.4265720416	150
0.4263425764	7
0.4263032327	41
0.4258221553	expressing human
0.4256915935	100 microm
0.4256028211	regulated kinase
0.4255780401	1
0.4251243539	help
0.4249995062	31
0.4249043434	the present study
0.4245454024	10
0.4244819392	acute liver
0.4244210830	plus
0.4238954872	via
0.4238635588	52
0.4236864085	=
0.4236110318	akt pathway
0.4235100667	000
0.4234822687	associated
0.4230836658	33
0.4229298613	balb c
0.4228247047	known
0.4224475177	1d
0.4222226778	extracellular signal
0.4222180840	appropriate
0.4220858817	significant inhibition
0.4220324932	cell function
0.4217437738	protein kinases
0.4216556092	23
0.4215885044	cat 1
0.4214365629	selective serotonin
0.4211787580	toward
0.4211787580	made
0.4206849702	found
0.4205435594	increased intracellular
0.4204908778	significant increase
0.4203435138	55
0.4194735813	annexin v
0.4192466012	38
0.4192466012	42
0.4191494710	ki =
0.4190651254	c kit
0.4189299977	insight into
0.4187646554	describe
0.4185281228	body mass
0.4182454246	often
0.4182196284	not
0.4175997187	45
0.4173740521	32
0.4170084965	43
0.4169852742	of
0.4162873687	containing
0.4162332860	towards
0.4160591470	selective inhibitor
0.4159895319	40
0.4158057999	35
0.4156634263	competitive inhibitor
0.4155562167	study suggests
0.4155409788	cultured human
0.4150225067	these findings suggest
0.4143707218	having
0.4143707218	nearly
0.4140958048	mitogen activated
0.4137274214	75
0.4136482934	this article
0.4136216557	36
0.4134901501	25
0.4132377429	65
0.4132174801	diet induced
0.4131692401	a special issue entitled
0.4131019199	disease activity
0.4130135933	used
0.4129671931	human colon
0.4128160068	tumor necrosis
0.4124378200	whole blood
0.4123973211	contains
0.4123752234	70
0.4119173578	single nucleotide
0.4118197073	protein protein
0.4117429915	26
0.4115552993	cancer cell line
0.4111420773	mg2 +
0.4094086492	large number
0.4092890144	important roles
0.4092338340	study demonstrated
0.4091900056	now
0.4087466848	cell derived
0.4079454899	11
0.4074078604	27
0.4069113108	ec50 =
0.4068930744	loss of function
0.4065742786	13
0.4064355169	might
0.4063209305	and
0.4060377370	them
0.4052994628	can
0.4051898066	caspase 1
0.4038469455	90
0.4037653821	expression levels
0.4031222472	05
0.4027107150	being
0.4018817565	either
0.4017795370	human tumor
0.4015327599	01
0.3997145781	causes
0.3997145781	001
0.3995342034	are
0.3992202599	should
0.3991575714	28
0.3986359714	acid synthase
0.3985990490	platelet derived
0.3983395781	provides
0.3983060554	conformational changes
0.3982965997	phosphatidylinositol 3
0.3979430600	dhea s
0.3978455002	60
0.3973812447	will
0.3967145781	would
0.3966672866	respectively
0.3963812447	where
0.3963812447	mainly
0.3963593009	21
0.3962398419	may
0.3958109138	19
0.3958104143	had
0.3957213447	is
0.3956348610	nonsteroidal anti
0.3955495949	nervous system
0.3952112704	been
0.3952112704	has
0.3948104143	could
0.3946433692	have
0.3946433692	be
0.3946433692	which
0.3939711648	during pregnancy
0.3938095950	oxidase activity
0.3936433692	was
0.3936433692	that
0.3936433692	were
0.3935666017	insights into
0.3933462431	24  
0.3931219222	dose dependent increase
0.3927280022	22
0.3920952278	protein kinase c
0.3919487226	brain natriuretic
0.3915920322	cyclin e
0.3908857152	80 mg
0.3902479839	methyl 4
0.3899991350	mice showed
0.3893093232	mammalian cells
0.3889746015	10 ⁻
0.3876214718	these results demonstrate
0.3874192383	degrees c
0.3872802976	l methionine
0.3871670078	coupled receptor
0.3869632226	ci = 0
0.3865499133	control cells
0.3858320611	increased mrna
0.3835984714	present study
0.3835750783	side effect
0.3832049185	drug administration
0.3828321771	a concentration dependent manner
0.3818997930	taken together
0.3816778075	kidney 293 cells
0.3814956382	possible role
0.3812692033	mediated inhibition
0.3811159810	up regulation
0.3799425919	coupled receptors
0.3795429817	these data suggest
0.3784965754	protein coupled receptor
0.3784189256	mmol l
0.3783974852	cyp2b6 *
0.3781274256	cox 2 expression
0.3775649122	receptor activation
0.3774429935	study showed
0.3773862231	did not differ
0.3759447505	2 yl
0.3757377533	cox 2 inhibitor
0.3756652513	100 fold
0.3748753899	correlation between
0.3716015976	4 yl
0.3711468710	a go go
0.3710607423	postmenopausal women with
0.3706494253	activated protein kinase
0.3699600539	divided into
0.3685132738	well established
0.3680179193	cell lung cancer
0.3665498149	receptor gene
0.3653287849	receptor expression
0.3632640843	t cell
0.3628749734	sub 2 sub
0.3627978632	widely used
0.3624781961	so far
0.3613592914	emerged as
0.3611761387	20 mg kg
0.3607805201	receptor alpha
0.3604801981	± 4
0.3601071908	cos 1
0.3593345893	cyclooxygenase 1
0.3581016539	acid induced
0.3578855966	100 nm
0.3578651297	5 ht2 receptor
0.3546532650	the current study
0.3542940046	shown to inhibit
0.3536451198	cells stably
0.3526660517	hup a
0.3515158374	compared to controls
0.3505756766	in vitro
0.3504459301	greater than
0.3500117437	30 mg kg
0.3499688781	year old
0.3495940633	term treatment
0.3484815922	an important role
0.3478681423	subjected to
0.3472583809	ic50 value
0.3469084052	3 yl
0.3455406777	ic50 =
0.3455011842	vitamin k
0.3438562901	s phase
0.3425273903	in vivo
0.3420475683	patients treated
0.3418432281	relatively low
0.3414500900	the other hand
0.3410994902	phosphodiesterase 4
0.3409088270	± 1
0.3407770092	nmol l
0.3406778207	30 min
0.3390923160	mg day
0.3387652785	enzyme linked
0.3381462489	vivo effects
0.3377592041	mol l
0.3334278510	il 2 receptor
0.3321440319	o β d
0.3317747684	apolipoprotein e
0.3308305235	the authors
0.3287141255	14 days
0.3285506929	rather than
0.3283885894	200 mg
0.3279086938	10 mg kg
0.3275830210	no detectable
0.3272082616	300 mg
0.3270367947	8 weeks
0.3253285081	= 0
0.3245689526	induced inflammatory
0.3234589169	histamine release from
0.3211375689	km =
0.3202806339	ranging from
0.3202645104	n methyl
0.3200836174	the blood brain barrier
0.3196238746	the renin angiotensin
0.3185931576	12 weeks
0.3182877260	binding activity
0.3178971685	present results
0.3176903630	an attractive
0.3175078047	these findings demonstrate
0.3171515487	attributed to
0.3147540929	this paper
0.3125579986	responsible for
0.3125074557	in 3t3 l1
0.3121217302	did not alter
0.3120009466	cox 2 inhibitors
0.3119965094	these results provide
0.3117924945	very low
0.3113840079	peptidase 4
0.3104138243	100 mg kg
0.3101738019	g proteins
0.3094117868	these observations
0.3089704097	vitamin d
0.3088934032	time and dose dependent
0.3083094110	to determine
0.3083023562	prostaglandin e
0.3069175183	cytochrome c
0.3066889471	do not
0.3066633198	vitamin c
0.3065746204	attributable to
0.3059611629	determine whether
0.3050461218	non steroidal
0.3047366865	did not affect
0.3046397939	link between
0.3023604542	depends on
0.3016581640	10 microm
0.3016429553	p = 0
0.3011177480	15 min
0.3010847117	differs from
0.3006114918	cell carcinoma
0.3005663866	commonly used
0.2996787151	protects against
0.2977024613	approximately 100
0.2973989511	vitamin b
0.2966142064	accompanied by
0.2955193377	+ 0
0.2952077383	area under
0.2947750712	protection against
0.2937283413	unable to
0.2935479356	10 fold
0.2931317881	these data demonstrate
0.2929141403	alone or in combination
0.2925020582	serve as
0.2904500500	protect against
0.2897585137	owing to
0.2891601779	cells transfected with
0.2884410709	interferes with
0.2880527085	vitamin e
0.2878633452	crystal structures of
0.2877238020	does not
0.2866916113	whole cell
0.2846285127	this review
0.2838359106	in vivo and in vitro
0.2836599941	il 1
0.2832074026	belong to
0.2828446686	300 microg
0.2797527085	to investigate
0.2796036277	effects of chronic
0.2785275520	24 h
0.2776057216	hydroxy 3
0.2773925837	inhibitory activity against
0.2763975250	min 1
0.2763421469	serum levels
0.2762467220	dose dependent increase in
0.2752348428	et 1
0.2747620230	induced cell
0.2730443769	to evaluate
0.2722024281	time course
0.2713179334	depending on
0.2709723847	high degree of
0.2703295248	human cells
0.2699362007	led to
0.2682529399	  h
0.2679427992	a major role
0.2678720959	expression of genes
0.2673905999	wide range of
0.2671634563	thought to
0.2671602039	clinically used
0.2658520059	devoid of
0.2653587228	capable of
0.2645516235	rank order of
0.2631792759	primary human
0.2630376964	kg day
0.2617552847	irrespective of
0.2600529627	inflammatory activities
0.2599372526	to date
0.2593452097	plasma levels
0.2591117249	100 mg
0.2590488043	immune system
0.2587984797	no synthase
0.2587365934	to clarify
0.2584881405	non steroidal anti
0.2573205314	in postmenopausal women
0.2565493569	induced increase
0.2563039377	well known
0.2562352533	at least
0.2556894177	determine if
0.2552465580	rats treated
0.2548142343	any significant
0.2546357914	5 ht1a receptor
0.2546276103	findings indicate
0.2543898781	less potent
0.2541746959	0 mg kg
0.2535834195	+ prazosin
0.2534214754	referred to
0.2527129277	study aimed to
0.2521509261	3 hydroxy 3
0.2518141872	50 microm
0.2517851284	this study
0.2516342981	composed of
0.2514497214	large number of
0.2511707589	receptor beta
0.2510186007	at high concentrations
0.2497339498	g kg
0.2486854037	significant effect
0.2483268117	less effective
0.2476856375	a key role
0.2476618440	na + k +
0.2472593235	to explore
0.2460678411	previously described
0.2457174430	a time and dose
0.2450234444	p 0
0.2449069281	differences between
0.2441591385	activated receptor
0.2434051597	17 beta
0.2418812705	type 1
0.2416027860	n =
0.2413539642	5 ht release
0.2407971336	the culture medium
0.2396410092	data indicate
0.2395432724	interfere with
0.2385271061	high levels
0.2382599450	therapeutic target for
0.2377573509	with ki values
0.2366544997	mg kg i
0.2364841285	these findings
0.2357440492	referred to as
0.2346325081	the majority
0.2344992345	focused on
0.2338724102	x 10
0.2338698080	by flow cytometry
0.2337495144	did not
0.2316675645	48 h
0.2316339934	used to treat
0.2312521770	a specific inhibitor
0.2312287060	to compare
0.2309699196	t cells
0.2307003246	to treat
0.2304924173	according to
0.2303913582	belongs to
0.2298941355	consistent with
0.2294283022	and activator of transcription
0.2281729914	contribute to
0.2278112030	primary cultures of
0.2276293932	relationship between
0.2266027660	three times
0.2261700546	apoptotic cell
0.2257184316	association between
0.2242234673	lower than
0.2235371407	crystal structure of
0.2235247475	to examine
0.2223859297	apparent k
0.2213198416	related gene
0.2211952144	existence of
0.2200657967	currently available
0.2195978334	pre treatment with
0.2193570127	inhibitory effects on
0.2192970367	failed to
0.2192111212	examined whether
0.2189807148	a time and
0.2187925759	compared with
0.2185686926	a high fat diet
0.2181724315	kg per
0.2180670284	did not inhibit
0.2172063024	associated proteins
0.2169581022	in silico
0.2168650521	glur a
0.2162732730	na +
0.2158356088	6 phosphate
0.2157364953	depend on
0.2154600527	the dentate gyrus
0.2154343774	to assess
0.2147762478	requirement for
0.2140621553	the hypothalamic pituitary
0.2140565083	higher levels
0.2139509428	methyl 1
0.2125877538	or in combination
0.2125135238	7 days
0.2125096705	inhibitory effect on
0.2120590839	released from
0.2116075096	extracted from
0.2112439813	potent inhibitor of
0.2105523471	5 mg kg
0.2104776017	less than
0.2098565526	leading to
0.2095157984	synthesis and biological evaluation of
0.2091467473	in xenopus oocytes
0.2085691521	beta 1
0.2083922807	an important
0.2079106430	3 mg kg
0.2077438070	type i
0.2071660863	more effective
0.2068643440	potent inhibitors
0.2065299144	1 mg kg
0.2064568041	acid residues
0.2055933160	isolated from
0.2055810592	by measuring
0.2055357016	4 weeks
0.2051476372	more potent
0.2045853089	aimed at
0.2043692246	ca2 + i
0.2040603255	rats exposed to
0.2037013792	10 mm
0.2031019667	resulted in
0.2028483403	the guinea pig
0.2027930902	low levels
0.2026855239	non selective
0.2026048812	activity in vitro
0.2019901787	in addition
0.2018974167	investigated whether
0.2013613218	regardless of
0.2010031243	interaction between
0.1996699928	c peptide
0.1995524805	structure activity relationships of
0.1995319216	at least in part
0.1990206748	interacts with
0.1986994234	serum levels of
0.1977523459	promising new
0.1973189749	to generate
0.1972698033	differ between
0.1970556605	contributes to
0.1962997020	times more
0.1957081063	able to
0.1956884563	assigned to
0.1951293579	account for
0.1947834169	per day
0.1946333737	chronic treatment with
0.1941171952	low levels of
0.1940963488	this finding
0.1937820336	a high throughput
0.1934022934	4 fold
0.1929206957	before and after
0.1927929003	due to
0.1909714603	vs 0
0.1906574446	majority of
0.1900034406	inotropic effects of
0.1899870908	fold increase in
0.1898406321	nuclear translocation of
0.1896137666	interactions between
0.1895444715	in wild type mice
0.1894597055	293 cells
0.1891953791	contributing to
0.1882631941	compared to
0.1881288543	no significant effect
0.1877088897	potent inhibitors of
0.1873395715	protein 1
0.1873237793	to detect
0.1872234762	72 h
0.1860605028	patients treated with
0.1852227619	influenced by
0.1844795857	appears to
0.1844023676	6 months
0.1842856354	5 methyl
0.1842077338	7 fold
0.1835283125	known about
0.1834473515	a significant decrease
0.1830102444	in chinese hamster ovary
0.1826044244	10 μm
0.1825936151	results indicate
0.1821980071	mimicked by
0.1814588863	8 fold
0.1813632964	like growth factor
0.1812018211	acid metabolism
0.1810055463	correlated with
0.1806698579	the endoplasmic reticulum
0.1806246165	higher levels of
0.1799515507	1 yl
0.1798311472	clinical use
0.1797017990	the active site
0.1793312230	10  
0.1785983267	high affinity for
0.1785742034	a highly conserved
0.1784531327	drug drug
0.1775764928	therapeutic use
0.1772769612	the rate limiting
0.1769617908	such as
0.1768622043	insulin like
0.1766279924	based on
0.1759057382	factor receptor
0.1750576638	acts as
0.1748094437	as well as
0.1744495194	with regard to
0.1742590614	impact on
0.1739426521	required for
0.1737742123	serotonin 5
0.1736241166	the nucleus accumbens
0.1735903288	an alternative
0.1734448559	hours after
0.1733879978	3 fold
0.1733115362	alpha 1
0.1732601871	type 2
0.1720437805	to elucidate
0.1720040405	at position
0.1714888511	complex i
0.1711088370	alpha 2
0.1710247322	100 microg
0.1702312617	3 hydroxy
0.1685395198	this work
0.1685232171	ability to
0.1684807402	by western blot
0.1682703553	10 mg
0.1682567134	beta 2
0.1682265760	5 fold
0.1681323020	in animal models of
0.1674976015	a highly potent
0.1672106921	involved in
0.1664928371	no effect
0.1662091206	to obtain
0.1653863860	plasma levels of
0.1648689514	at ph
0.1644048693	2 fold
0.1643358870	x =
0.1639642836	central role in
0.1639469016	evidenced by
0.1637533566	* 6
0.1626316285	these agents
0.1624472318	cells in vitro
0.1623924945	an essential
0.1623106707	in order to
0.1621913328	a time and dose dependent
0.1621220245	time dependent
0.1607057765	dopamine d
0.1606110147	leads to
0.1603775995	this hypothesis
0.1603350985	those obtained
0.1596826703	these data
0.1593715515	the control group
0.1590412739	over expression
0.1585664125	the positive inotropic
0.1583594631	proteins involved in
0.1572034613	respond to
0.1568398335	higher than
0.1564209604	high levels of
0.1562670114	significant decrease in
0.1560743075	in situ
0.1558817733	the affinity of
0.1555934173	40 mg
0.1553863707	induced increase in
0.1549674432	to identify
0.1548830070	the presence or absence of
0.1548730623	cells exposed to
0.1548490132	better understanding of
0.1548300703	recovery from
0.1548089257	these results
0.1546309975	anti inflammatory effects of
0.1546173913	pretreated with
0.1542246583	a total of
0.1537996922	assessed using
0.1537782845	in vitro and in vivo
0.1536373426	to measure
0.1533828219	in contrast
0.1533603685	but rather
0.1529401517	believed to
0.1527594896	with ic50 values
0.1521620285	non specific
0.1519287120	mg d
0.1518817733	the addition of
0.1516776559	provide new
0.1513489389	current study
0.1512479442	catalyzed by
0.1512372700	genes involved in
0.1510507043	apoptosis induced by
0.1509716618	unaffected by
0.1508310328	supplemented with
0.1507883428	the progression of
0.1506006160	these results indicate
0.1504497679	ic50 values of
0.1501969040	results indicated
0.1501885560	two distinct
0.1499660168	patients with
0.1497627017	the roles of
0.1497015811	interact with
0.1490973537	all trans
0.1490954485	the growth of
0.1489417848	derived from
0.1487020336	attempt to
0.1483262178	the synthesis of
0.1482099408	the present work
0.1478648169	supported by
0.1476986724	replaced by
0.1472208244	equal to
0.1471642075	correlate with
0.1471077022	susceptible to
0.1470954485	the objective of
0.1470954485	the control of
0.1470084920	the purpose of
0.1468544190	key role in
0.1466182792	three groups
0.1465580400	both cell lines
0.1462906494	significant inhibition of
0.1458817733	the rate of
0.1458718869	2 amino
0.1457541700	5 mm
0.1456195285	co administration
0.1450395118	not affected
0.1450235320	act as
0.1449391606	affinity binding
0.1449310112	the most potent
0.1448817733	the design of
0.1448304330	most potent
0.1445211632	these drugs
0.1445094329	induces apoptosis in
0.1443898086	competitive inhibitor of
0.1441555894	with high affinity
0.1441467491	a critical role in
0.1440799296	resulting from
0.1440534697	the cerebral cortex
0.1438817733	the metabolism of
0.1438817733	the potency of
0.1436235068	6 fold
0.1434572358	factor 2
0.1434064956	9 + 0
0.1433562757	20 mg
0.1431996806	a dose dependent
0.1431093253	mao a
0.1431007808	both groups
0.1430632274	no significant
0.1426108170	important roles in
0.1422058230	associated with
0.1417742728	performed using
0.1417046771	10 nm
0.1415498857	to achieve
0.1414420107	2 mg kg
0.1411720017	explained by
0.1410978722	transporter 1
0.1410954485	the proliferation of
0.1410160712	measured using
0.1410084920	the uptake of
0.1407987364	characterized by
0.1407390686	expression levels of
0.1398348980	rats treated with
0.1396457212	as expected
0.1396090563	consisting of
0.1395516174	the dopamine d2 receptor
0.1389719783	selective inhibition of
0.1387545969	blocked by
0.1386435979	days after
0.1383603446	8 + 0
0.1383354307	obtained from
0.1380635915	the toxicity of
0.1379458481	increased risk of
0.1376521162	significant reduction in
0.1376366905	human cancer
0.1374560422	kappa b
0.1373635008	data indicated
0.1373212471	modulated by
0.1373034943	in spite of
0.1372552293	agreement with
0.1370242773	the transcription factor
0.1364527125	kg 1
0.1364203057	participation of
0.1361850628	d glucuronide
0.1360726631	with and without
0.1359701609	the end of
0.1354258167	blood cells
0.1350635915	the association of
0.1350241905	aimed to
0.1349033174	more potent than
0.1346363672	study examined
0.1345916955	biological evaluation of
0.1342078988	further studies
0.1339506874	an initial
0.1338930392	oral administration of
0.1338666401	studies indicate
0.1338554344	ci 1
0.1331679638	induced phosphorylation of
0.1331264162	this effect
0.1330070671	the entire
0.1329558888	and safety of
0.1328297345	= 12
0.1325697629	affinities for
0.1323054389	indicative of
0.1323034943	a group of
0.1322591104	50 mg
0.1322488365	participate in
0.1320635915	the surface of
0.1320202153	dependent protein
0.1319360408	mice treated with
0.1318606983	correlates with
0.1317778532	the sensitivity of
0.1316669358	effect on
0.1314476670	decreased expression of
0.1313687304	significant effect on
0.1313370465	g protein
0.1313034943	the generation of
0.1312446392	the most important
0.1311774201	the results showed
0.1309906184	d aspartate
0.1306312997	an excellent
0.1304559458	a concentration dependent
0.1304451731	factor 1
0.1304016599	a mouse model
0.1303034943	the viability of
0.1303034943	the expressions of
0.1299287481	relatively high
0.1297689824	role of
0.1297287428	induced reduction in
0.1295809806	protective effect of
0.1293034943	the mechanisms by
0.1289565431	incubation with
0.1285836133	an increased risk
0.1285206999	consists of
0.1283449100	reductions in
0.1281997128	down regulation of
0.1277946223	2 weeks
0.1275613217	caused by
0.1275001983	β d
0.1274381407	but not
0.1274323170	increased expression of
0.1273969248	the concentration of
0.1273701527	these findings indicate
0.1273560298	5 μm
0.1272772667	the order of
0.1271395073	inhibitory effects of
0.1265395959	preference for
0.1263643593	most common
0.1261070495	interacting with
0.1260378555	6 + 0
0.1257026196	mediated inhibition of
0.1256725004	the long term
0.1252594648	than placebo
0.1249140920	significant increase in
0.1246501401	in vitro and in
0.1242736435	the ratio of
0.1242442693	followed by
0.1240193007	an additional
0.1240060300	induced increases in
0.1236433791	reversed by
0.1236106001	the affinities of
0.1235827462	in vivo and in
0.1235459169	mrna levels of
0.1234568902	receptor 1
0.1230563493	proved to
0.1230411562	1 microm
0.1229624765	binding sites for
0.1228409922	this class
0.1226106001	as inhibitors of
0.1226106001	the increase of
0.1225236435	the secretion of
0.1224582970	a competitive inhibitor
0.1224222675	the plasma membrane
0.1223016782	treated with
0.1220269941	the treatment of type 2 diabetes
0.1217013128	synthesized and evaluated for
0.1216106001	the oxidation of
0.1216106001	the cytotoxicity of
0.1215620458	to understand
0.1215421312	effects on
0.1215077230	on chromosome
0.1213969248	and synthesis of
0.1212930387	receptor 2
0.1209847506	the results obtained
0.1209382121	with respect to
0.1209347548	more effective than
0.1205816822	evoked by
0.1205758423	a significant increase
0.1204627893	shown to
0.1204304470	the cell cycle
0.1196317802	the molecular mechanisms
0.1195860731	cells treated
0.1193143753	25 mg
0.1193074872	mrna expression in
0.1191686722	selective inhibitor of
0.1190384965	the ligand binding
0.1187431342	in vitro studies
0.1186362177	potential role of
0.1182862725	5 mg
0.1182780586	susceptibility to
0.1182442202	increased levels of
0.1179973958	by inhibiting
0.1175675166	oxidative stress in
0.1175528710	= 8
0.1173416442	with or without
0.1171802835	not altered
0.1170357419	inhibitory effect of
0.1169689941	mediated through
0.1169146108	currently used
0.1168531044	the same
0.1166912792	not significantly different
0.1166257912	possible mechanism
0.1164612607	a high affinity
0.1164529736	5  
0.1164262719	effects of
0.1160015317	all patients
0.1158766918	a high fat
0.1158249644	appeared to
0.1157106918	8 microm
0.1157088964	n methyl d
0.1156043892	implicated in
0.1154227187	these effects
0.1153414425	role in
0.1153181643	important role in
0.1152027091	induced oxidative
0.1150763333	attached to
0.1148041720	selective inhibition
0.1147967731	the possibility
0.1147010994	induced inhibition of
0.1145807829	new therapeutic
0.1145688400	result from
0.1143555913	6 nm
0.1143125460	the present results
0.1142938329	dependent activation of
0.1141955112	needed to
0.1140316315	sought to
0.1138812539	aspects of
0.1137099428	gene expression in
0.1132752442	adverse effects of
0.1132181658	2 months
0.1131954925	in rat brain
0.1127663538	or placebo
0.1127546607	prior to
0.1126025253	inhibition of
0.1125391869	8 oh
0.1125263468	close to
0.1124344983	5 days
0.1123750965	no effect on
0.1123261779	in mammalian cells
0.1121730382	option for
0.1121184392	4 days
0.1120823464	the most common
0.1119995148	the crystal structure
0.1115520865	n = 6
0.1115086103	receptor gamma
0.1114707466	up regulation of
0.1114358684	observed between
0.1113345667	significantly higher in
0.1109477102	suitable for
0.1108572065	antitumor activity of
0.1107631885	access to
0.1107256848	in cultured human
0.1106090446	distinct from
0.1103151431	kinase 1
0.1098887959	plasma concentrations of
0.1096557727	low dose of
0.1096005968	individuals with
0.1095882490	iontophoresis of
0.1095836424	the glucocorticoid receptor
0.1095625234	an effective
0.1093414981	similar to
0.1093181854	specific inhibitor
0.1091384643	binding sites of
0.1086973253	8 ±
0.1086649079	prepared from
0.1082462924	a wide range of
0.1082374234	appear to
0.1079349131	mice treated
0.1076970345	effective against
0.1075709453	to develop
0.1074024918	a single
0.1073701968	catalytic activity of
0.1073514379	protective effects of
0.1073460027	essential for
0.1072261050	the dopamine d2
0.1070830052	binding sites in
0.1069144554	the presence of
0.1068829772	associated protein
0.1066964057	fold more
0.1064595769	more than
0.1063638905	in human cancer
0.1061837890	x receptor
0.1059337899	1 μm
0.1059104156	an open
0.1059037367	children with
0.1055448414	those observed
0.1053977087	mrna expression of
0.1053420858	percentage of
0.1053374722	cell death in
0.1050981181	+ 9
0.1050634076	investigate whether
0.1048783578	the androgen receptor
0.1048696915	elicited by
0.1047762120	binding site of
0.1047412844	induced expression of
0.1047046966	not yet
0.1046891289	for treating
0.1046133552	effect of
0.1045378837	basis for
0.1044563141	these enzymes
0.1044446945	to produce
0.1044368021	these include
0.1039959094	encoded by
0.1039733194	improvements in
0.1039596853	the results suggest
0.1038106974	novel therapeutic
0.1036171839	cells treated with
0.1032702527	controlled by
0.1031732296	these differences
0.1030899871	a comprehensive
0.1027377294	abolished by
0.1024899232	binding affinity of
0.1023900348	candidates for
0.1020007542	induced apoptosis in
0.1019658839	studies show
0.1019430620	induced by
0.1018344065	all three
0.1014757004	kinase 2
0.1010608458	an allosteric
0.1010072681	to determine whether
0.1007842692	the rat brain
0.1007799683	triggered by
0.1007269524	a time dependent
0.1004289789	= 6
0.1001997521	1 mm
0.0999483460	seem to
0.0996770362	these compounds
0.0992816582	glutathione s
0.0989112699	necessary for
0.0983412138	b cell
0.0981249648	also inhibited
0.0980610412	the most active
0.0979432735	in conclusion
0.0979095089	studied using
0.0978584405	induced activation of
0.0977816812	mouse model of
0.0977435946	incubated with
0.0977170040	more sensitive
0.0975800553	in rat liver
0.0975155115	inflammatory response in
0.0973261136	data show
0.0972529003	mrna levels in
0.0972309295	24 h after
0.0971931419	search for
0.0967939117	6 microm
0.0967324037	two groups
0.0966135444	dependent increase in
0.0965349239	activated t
0.0964991751	mg m
0.0964254516	contribution to
0.0962949720	of elacridar
0.0962354538	implications for
0.0959585936	history of
0.0959556963	upregulation of
0.0958709026	identical to
0.0956347820	also suppressed
0.0954632282	biological activity of
0.0952133318	the first time
0.0951681730	mediated via
0.0951420663	the cell surface
0.0946748659	k +
0.0945784722	development of new
0.0945341059	determination of
0.0945292518	in protecting
0.0944934009	rise to
0.0941017949	no production
0.0940404859	the ability of
0.0940163936	significant changes in
0.0939713988	0 mg
0.0939156012	purified from
0.0938602488	most effective
0.0938069644	a marked
0.0937083508	2 +
0.0936837245	along with
0.0935785712	information on
0.0933379922	members of
0.0932714117	antagonized by
0.0928497395	3 microm
0.0928169230	strategy for
0.0925867501	the hypothesis
0.0925634896	pretreatment with
0.0924513858	candidate for
0.0918685874	as effective as
0.0917672721	3 months
0.0916657468	this process
0.0915824235	to restore
0.0915672696	the main
0.0915004632	for example
0.0914167311	in summary
0.0913712093	a central role
0.0913280645	dependent inhibition of
0.0912640184	p =
0.0912617146	characterization of
0.0908162421	significantly increased in
0.0908019155	30 mg
0.0907906660	an apparent
0.0907693814	n = 4
0.0905973059	coding for
0.0905092915	used to study
0.0902332272	a wide
0.0900885888	confirmed by
0.0900809640	mediated by
0.0899933071	co administration of
0.0899619979	not fully
0.0894869081	1 week
0.0894691261	each other
0.0892747589	a consequence
0.0891215331	to determine if
0.0890622799	protein expression of
0.0887718233	by decreasing
0.0884865277	+ 3
0.0882791944	produced by
0.0882053393	n 3
0.0881272372	bind to
0.0877504733	for 7 days
0.0876992522	to prevent
0.0876987110	results show
0.0874178560	to maintain
0.0874085296	= 7
0.0873202175	exposed to
0.0872986986	also studied
0.0872322558	prevented by
0.0872110221	+ 6
0.0859245032	rationale for
0.0859064074	metabolized by
0.0858732035	removal of
0.0855813935	receptor α
0.0854711981	lead to
0.0854477697	regulated by
0.0852235491	5 microm
0.0851905290	binding to
0.0849451891	+ 1
0.0847339945	related to
0.0846036644	8 mg
0.0845738996	did not significantly
0.0844525415	novel series of
0.0842608143	inhibited by
0.0842289957	tools for
0.0841590308	this enzyme
0.0841300971	protein levels of
0.0837264201	injected with
0.0836170018	determined by
0.0835547358	women with
0.0835344726	a strong
0.0832800218	activation of
0.0831466319	proportion of
0.0829679055	3 o
0.0827994088	the molecular basis
0.0825980924	these data indicate
0.0824798153	achieved by
0.0822670836	gene expression of
0.0822147587	the respective
0.0817105941	analyzed by
0.0815591859	to establish
0.0814163056	the central nervous system
0.0812869456	+ 5
0.0812410596	the parent
0.0810053044	resulting in
0.0807003687	the final
0.0805766953	as evidenced
0.0803790355	considered as
0.0803425012	did not show
0.0802488781	these studies
0.0801260527	to predict
0.0800587233	reactivation of
0.0798962486	to modify
0.0795081371	the structure activity
0.0794167986	n = 5
0.0793744161	a unique
0.0793521570	the inhibitory effect
0.0792426442	the alpha 1 adrenoceptor
0.0792349735	response to
0.0792209250	an experimental
0.0790965507	an increase in
0.0790380190	examined using
0.0789863443	exposure to
0.0786836765	men with
0.0786622880	4 microm
0.0785174811	screened for
0.0782879436	signaling pathway in
0.0782792415	a variety of
0.0782713356	linked to
0.0780845461	treatment with
0.0778967755	expression of
0.0778166911	effective at
0.0776934322	a poor
0.0775485923	= 1
0.0774777424	non small
0.0774545387	+ 4
0.0774417550	of antioxidant enzymes
0.0769031949	this disease
0.0767877393	presence of
0.0765650874	mixture of
0.0765162551	to promote
0.0764389860	the circadian
0.0759180451	an inhibitory
0.0759138029	two drugs
0.0758744794	treatments for
0.0757687399	6 h
0.0757571294	+ 2
0.0757519535	evaluation of
0.0757350170	classes of
0.0756952956	a special
0.0755930805	approved for
0.0753877603	induced increases
0.0753624571	disruption of
0.0752321517	tool for
0.0751247538	set of
0.0749593848	data from
0.0749409990	this report
0.0749026898	the enzyme
0.0748632621	by inducing
0.0746556213	after oral
0.0741158619	proposed to
0.0740909143	after exposure
0.0740698026	and time dependent
0.0739484506	these cells
0.0737819815	rise in
0.0735425346	by real time
0.0735228863	injections of
0.0735127129	adults with
0.0733343366	point to
0.0732215462	other drugs
0.0731699308	variation in
0.0730790364	the cytoplasm
0.0730457084	to gain
0.0730235256	in turn
0.0726678546	no significant effect on
0.0725827957	novel class of
0.0725380909	comparable to
0.0725220433	to characterize
0.0724465525	a novel mechanism
0.0724061867	cultures with
0.0722920767	marker for
0.0721026282	a concomitant
0.0720950325	affinity for
0.0720461058	to confirm
0.0720379500	a promising
0.0720114803	investigated using
0.0718620326	a simple
0.0715441897	protein 2
0.0715008886	inflammatory effect of
0.0715007960	also observed
0.0714947200	formed by
0.0713779694	act on
0.0712568405	sufficient to
0.0711289110	expressed at
0.0711165654	the potential to
0.0709757211	severity of
0.0707307242	measurement of
0.0705564131	role for
0.0705141849	difficult to
0.0703856629	not known
0.0700247113	respect to
0.0700222238	231 cells
0.0697755275	the aim of
0.0697645530	replacement of
0.0696368922	these results show
0.0696015334	5 nm
0.0694713521	report on
0.0694482094	critical for
0.0693073315	a lesser
0.0691954633	a key
0.0690991012	by activating
0.0690659897	detectable in
0.0688217052	generated by
0.0687957248	interaction with
0.0687403935	affected by
0.0684246267	attenuation of
0.0683855807	also demonstrated
0.0683048922	2 + 0
0.0682207480	regulators of
0.0681523817	an endogenous
0.0680926210	identified as
0.0680796166	a common
0.0680766675	this compound
0.0680480949	a large
0.0680163650	2 methyl
0.0678583829	suppressed by
0.0677473021	the predominant
0.0676738716	by increasing
0.0673267272	variety of
0.0672798931	an important role in
0.0672207999	the literature
0.0669673016	a significant
0.0669260244	a series of
0.0666985423	influence on
0.0666494205	3 days
0.0666072334	= 2
0.0665350002	an increased risk of
0.0662452950	downregulation of
0.0662290728	selectivity for
0.0661254703	also determined
0.0661115747	significantly different
0.0659841740	restricted to
0.0658525228	combined with
0.0658432394	this pathway
0.0654699813	spectra of
0.0653451933	in combination with
0.0652599541	elevation in
0.0651792842	effects against
0.0650298103	effectiveness of
0.0649904572	employed to
0.0648479160	bound to
0.0647850635	active site of
0.0647445810	by blocking
0.0646434158	a novel
0.0646334120	obtained by
0.0645879919	detoxification of
0.0645658421	performed on
0.0644056155	the most effective
0.0642981166	found to
0.0642038614	the potential of
0.0641926345	a crucial
0.0638935464	identification of
0.0636287455	relation to
0.0635977889	functions as
0.0631991030	organization of
0.0630625093	to test
0.0630308601	consequence of
0.0629873589	detected by
0.0628311587	amounts of
0.0626158786	= 4
0.0625789453	association with
0.0625492685	types of
0.0625443898	activity against
0.0623660239	the uterus
0.0622868595	both compounds
0.0622265204	resistance to
0.0621880417	a small
0.0621408525	6 mg
0.0620070069	relative to
0.0618713934	derivatives as
0.0618684322	to suppress
0.0618161862	a resolution
0.0617950754	widely used in
0.0617848891	a significant increase in
0.0617342282	determinants of
0.0616414671	regulator of
0.0615066711	considered to
0.0613389954	not only
0.0611269355	exception of
0.0609460670	r =
0.0609379122	also decreased
0.0608678535	seems to
0.0608068073	modifications of
0.0606049803	an enzyme
0.0605329346	3 mm
0.0605183312	attenuated by
0.0604728330	1 methyl
0.0602584590	relaxation of
0.0602301612	to investigate whether
0.0602240099	in terms of
0.0600784014	this model
0.0599933940	defects in
0.0599442138	action on
0.0598179076	an oral
0.0597762327	occurrence of
0.0596023222	= 10
0.0595541886	cytotoxic effect of
0.0594415272	grown in
0.0593239648	the treatment of
0.0593055701	an increase
0.0592287841	nm for
0.0592179079	lack of
0.0591882269	subjects with
0.0591462297	predicted to
0.0590752537	development of novel
0.0590728075	modulation of
0.0590341912	this increase
0.0589193913	expected to
0.0589101355	1 mg
0.0587087841	tumors with
0.0585976749	a major
0.0585749765	to protect
0.0585022294	sensitivity to
0.0584667967	resistant to
0.0584580094	but did
0.0584549397	a broad
0.0583678058	a low
0.0583161131	as indicated by
0.0581513982	to form
0.0579453364	targets for
0.0578912085	added to
0.0578841038	beneficial effects of
0.0576478440	to improve
0.0576320733	by reducing
0.0575987666	to induce
0.0575474604	also reduced
0.0574618596	these proteins
0.0573803703	at least two
0.0573310008	bioavailability of
0.0573195573	expressed in
0.0572844724	a high
0.0572126303	strategy to
0.0571765149	up regulated in
0.0571525930	differences in
0.0571109849	a subset of
0.0570405793	activity of
0.0569240540	h after
0.0568555606	a potent
0.0567684092	the development of
0.0567295179	values for
0.0563355703	an inhibitor of
0.0561109849	a panel of
0.0558713088	arrest in
0.0558672028	3 phosphate
0.0558507839	localized to
0.0557943286	degree of
0.0556849443	dependent on
0.0556742710	a key role in
0.0554990003	a potential
0.0554273792	need to
0.0553935007	an association
0.0553832336	by regulating
0.0553106397	utility of
0.0552764552	the present
0.0552589702	a patient with
0.0551165764	comparison of
0.0550997997	also showed
0.0550356054	not affected by
0.0549991215	prevalence of
0.0549720873	regulation of
0.0549592059	mediators of
0.0546795380	results from
0.0545482831	or = 1
0.0543322302	also increased
0.0542906033	prolongation of
0.0541310089	binds to
0.0539747958	the hypothalamus
0.0538325830	the pore
0.0531882340	assay for
0.0531762943	stabilization of
0.0530435778	method for
0.0530200697	understanding of
0.0528537389	approach for
0.0528461078	modified by
0.0527528684	three different
0.0526548052	the anticonvulsant
0.0526319115	enhancement of
0.0525943275	the rat
0.0525176437	a case
0.0524654457	the catecholamines
0.0522672033	initiation of
0.0522396702	mixtures of
0.0521558471	to reduce
0.0520922817	prediction of
0.0517986551	effects through
0.0517092061	in mediating
0.0515471413	sites on
0.0515075201	comparison with
0.0515018466	= 3
0.0514606558	known to
0.0514468563	alteration of
0.0513411127	to inhibit
0.0511245392	discovery of
0.0509823840	magnitude of
0.0508462477	release from
0.0506208176	measured with
0.0503651932	a dominant
0.0502556656	+ s
0.0502404090	more sensitive to
0.0502181036	a new class of
0.0501777804	the effect of
0.0500395707	measured by
0.0499276995	by means of
0.0498551413	to stimulate
0.0498402836	to activate
0.0498278089	two different
0.0497720617	the dorsal
0.0497120734	examination of
0.0495883067	the effects of
0.0495734032	little or
0.0495716549	applied to
0.0494932158	overexpressed in
0.0494217508	optimization of
0.0493883067	the expression of
0.0492624321	recruitment of
0.0491282843	in comparison to
0.0490575552	not significantly
0.0490222724	assessed by
0.0489712595	no changes
0.0489688795	overexpression of
0.0487893067	shift in
0.0485621525	observed at
0.0483723648	the last
0.0480976493	series of
0.0480497477	1 year
0.0480291010	quality of
0.0480227087	used as
0.0479225998	important for
0.0478705341	time course of
0.0477131488	after treatment
0.0477032485	to regulate
0.0476883724	kg i
0.0476657882	consequences of
0.0474861304	incidence of
0.0474791647	abundant in
0.0473573174	nature of
0.0472883215	mode of
0.0472601487	associated with increased
0.0469215749	modification of
0.0468925521	a natural
0.0468679906	an antagonist
0.0468369193	an ic50
0.0467983570	treatment of
0.0467351972	induction of
0.0467275168	together with
0.0467140197	levels of
0.0467068523	source of
0.0466836222	therapy for
0.0466643470	an active
0.0466579884	administration of
0.0465765843	frequency of
0.0465613819	selective 5
0.0465512197	to enhance
0.0464961231	interactions with
0.0464617027	analysis of
0.0463683257	a new
0.0463393961	a critical
0.0461791594	detected in
0.0460979449	loss of
0.0460386801	an alpha
0.0459964346	elevation of
0.0458735002	after administration
0.0457963954	expression in
0.0457720617	the fact
0.0457410776	the basis of
0.0456171223	the molecular basis of
0.0454720793	substrate for
0.0454695158	a combination of
0.0454680944	with ic50 values of
0.0454508324	the cytotoxic effect of
0.0453767013	importance of
0.0453454995	these changes
0.0451933014	transfected with
0.0451222249	the role of
0.0450788474	administered by
0.0450425393	occurs in
0.0450274765	induced changes in
0.0448840419	agent for
0.0448714867	activated by
0.0447527513	action of
0.0446589340	developed for
0.0446311964	suppression of
0.0446091351	the ventral
0.0445659210	significance of
0.0445192739	combinations of
0.0444702402	the beta 2
0.0444296448	stimulated by
0.0444179634	independently of
0.0444171528	assessment of
0.0441797760	modulator of
0.0441082523	evidence for
0.0440633379	aim of
0.0438619909	the pathophysiology of
0.0435946821	a rapid
0.0435913312	mechanism of action of
0.0434371776	member of
0.0431631654	evaluated by
0.0430887116	the pathogenesis of
0.0430723900	conformation of
0.0425903491	necessary to
0.0425879938	consumption of
0.0423228504	the first
0.0421220548	a member of
0.0418401755	knockdown of
0.0418343810	incorporation of
0.0418307467	terms of
0.0417149935	an effect
0.0416135897	amount of
0.0415927007	duration of
0.0415506867	m phase
0.0415441810	a weak
0.0414998042	conducted to
0.0414874051	cleavage of
0.0413177318	component of
0.0410401480	absence of
0.0410336220	a number of
0.0410168351	a concentration
0.0409662617	capacity to
0.0409015200	tested for
0.0408518913	also significantly
0.0408390974	sensitive to
0.0408121202	mutations in
0.0407891640	located in
0.0406414794	pattern of
0.0405671047	involvement of
0.0404414794	decreases in
0.0402093291	coupled to
0.0401075017	designed to
0.0400490623	complex with
0.0400458185	observed in
0.0399786198	application of
0.0399399585	established by
0.0398954527	diagnosis of
0.0397701992	secretion from
0.0397553594	potentiation of
0.0396702136	the presence
0.0396120391	associated with reduced
0.0393870669	activity in
0.0393080086	target for
0.0392032456	increases in
0.0391808112	as determined
0.0390430865	actions of
0.0389455184	structures of
0.0389372809	improvement in
0.0388113283	truncated at
0.0388104482	prevention of
0.0387166458	randomized to
0.0385919710	present in
0.0385820041	the existence of
0.0385470735	as assessed
0.0384986483	the use of
0.0383886108	need for
0.0383007975	as assessed by
0.0382614683	enhanced by
0.0381729134	modulators of
0.0381712239	but does
0.0379643021	to explain
0.0379474528	contribution of
0.0379264463	inactivation of
0.0378766390	uptake by
0.0378125151	pathogenesis of
0.0377254786	altered by
0.0373692735	injection of
0.0372843366	depletion of
0.0372719937	features of
0.0371582486	outcome of
0.0371267800	required to
0.0371068402	the absence of
0.0370431322	detection of
0.0369728175	the beta 1
0.0368682063	hydrolysis of
0.0366431587	the majority of
0.0365376586	found between
0.0364493456	a decrease in
0.0363689735	maintenance of
0.0363309605	2  
0.0361559221	fraction of
0.0360842800	properties of
0.0360574843	binding of
0.0360482482	on day
0.0359659344	identified by
0.0358737170	doses of
0.0358658252	increased by
0.0357386344	to exert
0.0356820581	field of
0.0356108181	with vehicle
0.0355637102	studies on
0.0355552943	cells against
0.0354482647	increase in
0.0353835356	demonstrated by
0.0353550527	alone or
0.0352553692	administered to
0.0352081033	1  
0.0350699487	reported to
0.0350564116	decrease in
0.0350296594	availability of
0.0350174460	changes in
0.0349345691	the need for
0.0349092336	number of
0.0349034962	5 +
0.0348766198	evaluated for
0.0348734903	structure of
0.0348459331	synthesized by
0.0348366882	likely to
0.0347888574	reduction of
0.0347522150	roles in
0.0347492484	3 mrna
0.0346911562	the discovery
0.0346871311	characteristic of
0.0344773595	8 +
0.0343718682	spectrum of
0.0343536173	accumulation of
0.0343022382	observed with
0.0342721304	a significant decrease in
0.0342497040	= 5
0.0342438521	conversion of
0.0340978029	useful for
0.0339887736	areas of
0.0339848860	but does not
0.0339816109	localization of
0.0338861290	to occur
0.0338365524	result in
0.0337738259	to modulate
0.0337196705	sites for
0.0336222980	specific for
0.0336177183	release of
0.0334940534	potential for
0.0333343410	blockade of
0.0333149442	difference in
0.0332546322	region of
0.0332018794	site of
0.0330969981	function as
0.0330806877	the eye
0.0330718516	combination with
0.0330072303	approach to
0.0329699897	the beneficial effects of
0.0329285150	kinetics of
0.0327506938	change in
0.0326963261	means of
0.0326793691	studied by
0.0325942910	or = 0
0.0325321720	an inhibitor
0.0325127189	4 h
0.0324854130	site on
0.0324250126	deletion of
0.0324149641	benefits of
0.0321754961	level of
0.0321643477	the binding of
0.0321479438	the results
0.0320810208	known as
0.0320374317	as compared to
0.0319973108	a population
0.0319653511	dose of
0.0319296369	domain of
0.0319254445	but also
0.0319244686	reduction in
0.0319114025	examined by
0.0318459331	experiments with
0.0318452840	management of
0.0318089442	alterations in
0.0316736408	in contrast to
0.0316634179	incubation of
0.0316408245	phosphorylation of
0.0316383119	9 +
0.0315737622	substitution of
0.0315731089	profile of
0.0315671173	the inner
0.0315477760	b 6
0.0315054859	the results of
0.0314883693	cells from
0.0314876399	class of
0.0314801591	a few
0.0314099478	but did not
0.0313310892	decreased by
0.0313246333	determined for
0.0313053296	the kinetics of
0.0312844830	degradation of
0.0311160593	to provide
0.0310037560	a competitive inhibitor of
0.0309560808	reduced by
0.0309556921	in addition to
0.0309544438	3 +
0.0309478754	as well
0.0309442581	suggested to
0.0309128657	subset of
0.0309058415	a result
0.0308916730	none of
0.0307502855	the mechanism of action
0.0307275127	efficiency of
0.0306820581	patterns of
0.0306203993	mechanism for
0.0305930938	distribution of
0.0304086640	to block
0.0303208705	the production of
0.0302424035	the importance of
0.0302275127	occurred in
0.0301925540	a competitive
0.0301663239	mechanism of
0.0301492181	expressed by
0.0301059272	clearance of
0.0299863966	the percentage of
0.0299471639	tissue from
0.0299052079	the regulation of
0.0298514181	demonstrated to
0.0298090301	as measured by
0.0298051035	observed for
0.0298022382	activation by
0.0297653150	the formation of
0.0297556905	a history of
0.0296507597	introduction of
0.0296416038	daily for
0.0296015495	stimulation of
0.0295153915	measures of
0.0295064529	the interaction of
0.0292979359	a decrease
0.0291837821	transfection of
0.0291697357	a reduction in
0.0291309117	activity at
0.0290719571	mortality in
0.0290384388	used to
0.0290121474	revealed by
0.0289903776	impact of
0.0289553468	model of
0.0289205180	obtained with
0.0289192947	combination of
0.0288838464	the latter
0.0288115890	the need
0.0283646753	concentrations of
0.0283303292	performed to
0.0283205663	efficacy of
0.0282129702	formation of
0.0281419339	elevated in
0.0281052079	the level of
0.0280844377	inhibitor of
0.0280269146	a role for
0.0278483710	a lack of
0.0278146796	new class of
0.0278141793	occur in
0.0278090845	the discovery of
0.0277931692	localized in
0.0277931692	elimination of
0.0277659742	assembly of
0.0277639649	the percentage
0.0277625998	relevant to
0.0276389649	to interact
0.0275846555	derivative of
0.0273874269	the most
0.0273257293	the inhibitory effect of
0.0272741082	a good
0.0272210192	benefits in
0.0271261292	excretion of
0.0271037753	included in
0.0270508901	also found
0.0270294817	model for
0.0269383934	the inhibition of
0.0268656120	seen with
0.0268340908	activities of
0.0267795080	studied in
0.0267579847	the activity of
0.0267339157	relevance of
0.0267030682	impairment in
0.0266758413	in response to
0.0265934075	the influence of
0.0265705663	development of
0.0265402111	conserved in
0.0264945285	or =
0.0264615158	used for
0.0263437145	the absence
0.0262927955	a range of
0.0261957666	pharmacology of
0.0260772805	the alpha 1
0.0260293025	the activation of
0.0258931722	a model
0.0258772920	step in
0.0258460391	the impact of
0.0258281875	and possibly
0.0258148298	a role in
0.0257976764	3 mg
0.0257659148	developed to
0.0256850449	the structure of
0.0256492768	to find
0.0256052954	a marker
0.0255149702	the search
0.0254821493	part of
0.0254469073	the goal of
0.0253626359	the levels of
0.0253232932	a potent inhibitor of
0.0252147679	the relationship between
0.0251960991	influence of
0.0251957666	stability of
0.0251719571	ratios of
0.0251484461	mechanism by
0.0250619341	the release of
0.0248917576	the involvement of
0.0248601783	constant of
0.0248042393	other than
0.0247661809	investigation of
0.0247653150	the number of
0.0247253199	range of
0.0246573289	to play
0.0246084464	the development of new
0.0245960391	in comparison with
0.0244330450	activator of
0.0243845043	cells via
0.0243648911	metastasis in
0.0243504171	mechanisms of
0.0242196705	risk for
0.0241723103	a result of
0.0238042393	but only
0.0237868154	after administration of
0.0237306708	apoptosis in
0.0237221696	formed in
0.0237134916	after exposure to
0.0237006903	after treatment with
0.0236850449	the reduction of
0.0236268354	significantly more
0.0236205663	risk of
0.0235452859	6 +
0.0235338822	the action of
0.0235059447	the amount of
0.0234381150	different from
0.0234248161	independent of
0.0232105731	the pathophysiology
0.0231881444	the contribution of
0.0230369681	and biological evaluation of
0.0230091653	use as
0.0229501350	a consequence of
0.0228579643	the mechanism of
0.0227879541	the goal
0.0227694870	the increase in
0.0227542920	pharmacokinetics of
0.0227542920	contraction in
0.0227370506	extent of
0.0227021696	case of
0.0224137709	the active site of
0.0223432411	the contribution
0.0223117898	the interaction between
0.0222495455	seen in
0.0222139314	the mechanisms of
0.0221957666	onset of
0.0221939314	a loss of
0.0221683968	production of
0.0221025525	basis of
0.0220846555	translocation of
0.0219910250	the phosphorylation of
0.0219745434	function of
0.0217641744	the introduction of
0.0216869449	relationships of
0.0216864781	value of
0.0216864046	this system
0.0216333913	goal of
0.0215486535	but not in
0.0214154695	the identification of
0.0213397119	a dose of
0.0212961561	but not by
0.0212666662	as determined by
0.0212503892	the risk of
0.0211793617	to bind
0.0211045323	corresponding to
0.0210483968	interaction of
0.0207694870	for treatment of
0.0207221696	conducted in
0.0206208201	the results indicate
0.0205921836	the crystal structure of
0.0205486535	the activities of
0.0204835189	through inhibition of
0.0204417798	a model for
0.0204354695	the function of
0.0204354695	the accumulation of
0.0204203344	the blockade of
0.0204203344	the distribution of
0.0204141477	contrast to
0.0204095680	a dose
0.0204039416	effective as
0.0204003404	possible to
0.0203131905	ability of
0.0202739951	the mechanism by
0.0202447789	or in combination with
0.0202203344	the loss of
0.0201771155	the interactions between
0.0200258112	the frequency
0.0200048382	the degree of
0.0199799857	the occurrence of
0.0199680150	the extent of
0.0199082709	to bind to
0.0197694870	and apoptosis in
0.0197542763	course of
0.0197494870	the structures of
0.0196970701	the number
0.0196156833	but not to
0.0195740512	the management of
0.0195486535	the induction of
0.0195037953	through activation of
0.0194290806	the mechanism of action of
0.0194269006	use of
0.0193937709	the mrna expression of
0.0193795101	the combination of
0.0193694870	the reduction in
0.0193371286	the frequency of
0.0193071155	a function of
0.0191928227	a model of
0.0191694870	the decrease in
0.0190411275	panel of
0.0189481122	the determination of
0.0188972648	the modulation of
0.0188647789	the actions of
0.0188397119	the efficacy of
0.0187812432	to cause
0.0186139314	the response to
0.0186092004	the inhibitory effects of
0.0185740512	the onset of
0.0185699544	expression of p
0.0185472648	the potential for
0.0183916299	the aim
0.0183694870	the dose of
0.0183071155	in association with
0.0183071155	the results show
0.0182961768	the conversion of
0.0182926136	but not for
0.0182917898	the association between
0.0179779630	the incidence of
0.0179271155	the ability to
0.0179145007	both in vitro and
0.0178972648	the degradation of
0.0177779630	the stimulation of
0.0177616041	the case of
0.0176331170	the effects on
0.0174722271	by treatment with
0.0174593313	by pretreatment with
0.0173071155	a target for
0.0170601277	the administration of
0.0170563269	the pathogenesis
0.0170279179	the lack of
0.0166727129	7 +
0.0166331170	the analysis of
0.0165964167	the changes in
0.0165140121	by binding to
0.0165140121	the prevention of
0.0164737822	also observed in
0.0163290864	as compared with
0.0156315682	alone or in
0.0154241945	by activation of
0.0153883860	indicated by
0.0152024643	the hydrolysis of
0.0149707456	the mode of
0.0148356640	comparison to
0.0147024643	not associated with
0.0146096773	found in
0.0146096773	used in
0.0145663999	pathophysiology of
0.0145235556	or absence of
0.0136144441	day for
0.0134118615	a member
0.0131747331	the best
0.0128009363	interest in
0.0125933754	a role
